[
  {
    "id": 214713,
    "drug": {
      "current_status": "MARKETED",
      "id": 27802,
      "drug_code": 90016,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260105,
          "ingredient": {
            "id": 3770,
            "ingredient_code": 20642,
            "en_name": "TAPENTADOL",
            "fr_name": "Tapentadol (Chlorhydrate de tapentadol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415577",
      "brand_name": "NUCYNTA EXTENDED-RELEASE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152846001"
    },
    "created_date": "2024-01-03T18:29:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415577",
    "company_name": "ENDO VENTURES LTD.",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2023-12-15T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "en_drug_common_name": "TAPENTADOL",
    "fr_drug_brand_name": "NUCYNTA EXTENDED-RELEASE",
    "fr_drug_common_name": "Tapentadol",
    "en_ingredients": "TAPENTADOL",
    "fr_ingredients": "Tapentadol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214716,
    "drug": {
      "current_status": "MARKETED",
      "id": 100369,
      "drug_code": 98740,
      "updated_date": "2020-06-16T21:32:37-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8264935,
          "ingredient": {
            "id": 11129,
            "ingredient_code": 22925,
            "en_name": "SEMAGLUTIDE",
            "fr_name": "Sémaglutide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02497581",
      "brand_name": "RYBELSUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159870003"
    },
    "created_date": "2024-01-03T20:01:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02497581",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10BJ",
    "anticipated_start_date": "2024-01-05T00:00:00-05:00",
    "estimated_end_date": "2024-01-09T00:00:00-05:00",
    "actual_start_date": "2024-01-05T00:00:00-05:00",
    "actual_end_date": "2024-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "supply remains at the wholesale level",
    "fr_comments": "L'approvisionnement des deux formats reste disponible au niveau des grossistes pendant cette période",
    "en_drug_brand_name": "RYBELSUS",
    "en_drug_common_name": "RYBELSUS",
    "fr_drug_brand_name": "RYBELSUS",
    "fr_drug_common_name": "RYBELSUS",
    "en_ingredients": "SEMAGLUTIDE",
    "fr_ingredients": "SEMAGLUTIDE",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214721,
    "drug": {
      "current_status": "MARKETED",
      "id": 100371,
      "drug_code": 98742,
      "updated_date": "2020-06-16T21:32:37-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8264937,
          "ingredient": {
            "id": 11129,
            "ingredient_code": 22925,
            "en_name": "SEMAGLUTIDE",
            "fr_name": "Sémaglutide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "14",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02497611",
      "brand_name": "RYBELSUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0159870005"
    },
    "created_date": "2024-01-03T20:14:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02497611",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10BJ",
    "anticipated_start_date": "2024-01-05T00:00:00-05:00",
    "estimated_end_date": "2024-01-09T00:00:00-05:00",
    "actual_start_date": "2024-01-05T00:00:00-05:00",
    "actual_end_date": "2024-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "supply remains at the wholesale level",
    "fr_comments": "L'approvisionnement des deux formats reste disponible au niveau des grossistes pendant cette période",
    "en_drug_brand_name": "RYBELSUS",
    "en_drug_common_name": "RYBELSUS",
    "fr_drug_brand_name": "RYBELSUS",
    "fr_drug_common_name": "RYBELSUS",
    "en_ingredients": "SEMAGLUTIDE",
    "fr_ingredients": "SEMAGLUTIDE",
    "drug_strength": "14MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214771,
    "drug": {
      "current_status": "MARKETED",
      "id": 19678,
      "drug_code": 81036,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256869,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324946",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2024-01-03T23:19:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324946",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-03T00:00:00-05:00",
    "actual_end_date": "2024-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "SANDOZ ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214774,
    "drug": {
      "current_status": "MARKETED",
      "id": 11944,
      "drug_code": 69776,
      "updated_date": "2025-12-03T00:30:50-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254432,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02245676",
      "brand_name": "ESTRADOT 25",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457033"
    },
    "created_date": "2024-01-03T23:40:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245676",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2024-02-23T00:00:00-05:00",
    "actual_start_date": "2024-01-03T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTRADOT 25",
    "en_drug_common_name": "ESTRADOT 25",
    "fr_drug_brand_name": "ESTRADOT 25",
    "fr_drug_common_name": "ESTRADOT 25",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214777,
    "drug": {
      "current_status": "MARKETED",
      "id": 20566,
      "drug_code": 82301,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257274,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257273,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337428",
      "brand_name": "SANDOZ IRBESARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2024-01-03T23:42:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337428",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-03T00:00:00-05:00",
    "actual_end_date": "2024-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-20T03:03:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "en_drug_common_name": "IRBESARTAN HCT",
    "fr_drug_brand_name": "SANDOZ IRBESARTAN HCT",
    "fr_drug_common_name": "IRBESARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214781,
    "drug": {
      "current_status": "MARKETED",
      "id": 12436,
      "drug_code": 71020,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254578,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246820",
      "brand_name": "SANDOZ METFORMIN FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2024-01-03T23:48:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246820",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-03T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ METFORMIN FC",
    "en_drug_common_name": "METFORMIN FC",
    "fr_drug_brand_name": "SANDOZ METFORMIN FC",
    "fr_drug_common_name": "METFORMIN FC",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214845,
    "drug": {
      "current_status": "MARKETED",
      "id": 10566,
      "drug_code": 66078,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254010,
          "ingredient": {
            "id": 2796,
            "ingredient_code": 11996,
            "en_name": "VERTEPORFIN",
            "fr_name": "Vertéporfine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02242367",
      "brand_name": "VISUDYNE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141121001"
    },
    "created_date": "2024-01-04T18:03:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242367",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "S01LA",
    "atc_description": "OCULAR VASCULAR DISORDER AGENTS",
    "anticipated_start_date": "2024-01-09T00:00:00-05:00",
    "estimated_end_date": "2024-02-29T00:00:00-05:00",
    "actual_end_date": "2024-02-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-01T17:05:44-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISUDYNE",
    "en_drug_common_name": "VERTEPORFIN",
    "fr_drug_brand_name": "Visudyne",
    "fr_drug_common_name": "Vertéporfine",
    "en_ingredients": "VERTEPORFIN",
    "fr_ingredients": "Vertéporfine",
    "drug_strength": "15MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "15 mg vial (1X15ML)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214848,
    "drug": {
      "current_status": "MARKETED",
      "id": 12002,
      "drug_code": 69890,
      "updated_date": "2025-12-03T00:30:50-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254453,
          "ingredient": {
            "id": 2972,
            "ingredient_code": 12759,
            "en_name": "VALGANCICLOVIR",
            "fr_name": "Valganciclovir (Chlorhydrate de valganciclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "450",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245777",
      "brand_name": "VALCYTE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147203001"
    },
    "created_date": "2024-01-04T18:11:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245777",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2024-01-05T00:00:00-05:00",
    "estimated_end_date": "2024-02-05T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VALCYTE",
    "en_drug_common_name": "VALGANCICLOVIR",
    "fr_drug_brand_name": "Valcyte",
    "fr_drug_common_name": "Valganciclovir (Chlorhydrate de valganciclovir)",
    "en_ingredients": "VALGANCICLOVIR",
    "fr_ingredients": "Valganciclovir (Chlorhydrate de valganciclovir)",
    "drug_strength": "450MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214966,
    "drug": {
      "current_status": "MARKETED",
      "id": 10168,
      "drug_code": 65010,
      "updated_date": "2025-12-03T00:30:43-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253855,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02241377",
      "brand_name": "METADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621001"
    },
    "created_date": "2024-01-05T15:55:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241377",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N07BC",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2024-03-25T00:00:00-04:00",
    "actual_start_date": "2023-12-08T00:00:00-05:00",
    "actual_end_date": "2024-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-28T01:33:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METADOL",
    "en_drug_common_name": "Metadol 10 mg/mL 100mL",
    "fr_drug_brand_name": "Metadol",
    "fr_drug_common_name": "Metadol 10 mg/mL 100mL",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 214969,
    "drug": {
      "current_status": "MARKETED",
      "id": 12846,
      "drug_code": 71959,
      "updated_date": "2025-12-03T00:30:54-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254689,
          "ingredient": {
            "id": 2756,
            "ingredient_code": 6417,
            "en_name": "METHADONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthadone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247698",
      "brand_name": "METADOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144621002"
    },
    "created_date": "2024-01-05T15:57:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247698",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N07BC",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2024-02-29T00:00:00-05:00",
    "actual_start_date": "2023-12-20T00:00:00-05:00",
    "actual_end_date": "2024-02-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-01T14:28:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METADOL",
    "en_drug_common_name": "Metadol 1 mg Tabs",
    "fr_drug_brand_name": "Metadol",
    "fr_drug_common_name": "Metadol 1 mg Comp",
    "en_ingredients": "METHADONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthadone",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215019,
    "drug": {
      "current_status": "MARKETED",
      "id": 27596,
      "drug_code": 89826,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259974,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413612",
      "brand_name": "TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2024-01-05T16:52:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413612",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2024-08-31T00:00:00-04:00",
    "estimated_end_date": "2024-12-03T00:00:00-05:00",
    "actual_start_date": "2024-08-31T00:00:00-04:00",
    "actual_end_date": "2024-09-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2025-05-21T12:02:35-04:00",
    "status": "resolved",
    "en_comments": "in allocation",
    "fr_comments": "en allocation",
    "en_drug_brand_name": "TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30, 500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215021,
    "drug": {
      "current_status": "MARKETED",
      "id": 56332,
      "drug_code": 95168,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262476,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463571",
      "brand_name": "TARO-GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934002"
    },
    "created_date": "2024-01-05T16:53:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463571",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2025-03-28T00:00:00-04:00",
    "actual_start_date": "2023-12-11T00:00:00-05:00",
    "actual_end_date": "2025-05-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-20T20:44:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "TARO-GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215033,
    "drug": {
      "current_status": "MARKETED",
      "id": 26404,
      "drug_code": 88746,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259534,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402610",
      "brand_name": "TARO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666003"
    },
    "created_date": "2024-01-05T18:22:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402610",
    "company_name": "SUN PHARMA CANADA INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2023-12-01T00:00:00-05:00",
    "actual_end_date": "2024-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:54:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "TARO-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215056,
    "drug": {
      "current_status": "MARKETED",
      "id": 62765,
      "drug_code": 92332,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261058,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438941",
      "brand_name": "ACH-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2024-01-05T19:03:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438941",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-09-16T00:00:00-04:00",
    "actual_start_date": "2024-01-05T00:00:00-05:00",
    "actual_end_date": "2024-09-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-20T13:17:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ACH-Rosuvastatin",
    "fr_drug_common_name": "Rosuvastatine",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215061,
    "drug": {
      "current_status": "MARKETED",
      "id": 55427,
      "drug_code": 95437,
      "updated_date": "2025-05-15T02:35:55-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262599,
          "ingredient": {
            "id": 1230,
            "ingredient_code": 1209,
            "en_name": "ACITRETIN",
            "fr_name": "Acitrétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466074",
      "brand_name": "TARO-ACITRETIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122473002"
    },
    "created_date": "2024-01-05T19:33:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466074",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D05BB",
    "atc_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
    "actual_start_date": "2023-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-05T17:43:52-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TARO-ACITRETIN",
    "en_drug_common_name": "ACITRETIN",
    "fr_drug_brand_name": "TARO-ACITRETIN",
    "fr_drug_common_name": "ACITRETIN",
    "en_ingredients": "ACITRETIN",
    "fr_ingredients": "Acitrétine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215064,
    "drug": {
      "current_status": "MARKETED",
      "id": 56342,
      "drug_code": 95438,
      "updated_date": "2025-05-15T02:35:55-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262600,
          "ingredient": {
            "id": 1230,
            "ingredient_code": 1209,
            "en_name": "ACITRETIN",
            "fr_name": "Acitrétine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02466082",
      "brand_name": "TARO-ACITRETIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122473001"
    },
    "created_date": "2024-01-05T19:35:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466082",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D05BB",
    "atc_description": "ANTIPSORIATICS FOR SYSTEMIC USE",
    "actual_start_date": "2023-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-05T17:44:17-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TARO-ACITRETIN",
    "en_drug_common_name": "ACITRETIN",
    "fr_drug_brand_name": "TARO-ACITRETIN",
    "fr_drug_common_name": "ACITRETIN",
    "en_ingredients": "ACITRETIN",
    "fr_ingredients": "Acitrétine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215067,
    "drug": {
      "current_status": "MARKETED",
      "id": 22554,
      "drug_code": 85053,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258106,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365650",
      "brand_name": "TARO-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-05T19:37:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365650",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2023-12-19T00:00:00-05:00",
    "actual_end_date": "2024-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:42:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-ANASTROZOLE",
    "en_drug_common_name": "ANASTROZOLE",
    "fr_drug_brand_name": "TARO-ANASTROZOLE",
    "fr_drug_common_name": "ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215070,
    "drug": {
      "current_status": "MARKETED",
      "id": 27482,
      "drug_code": 8972,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251115,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00716618",
      "brand_name": "BETADERM CRM 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67692",
      "number_of_ais": "1",
      "ai_group_no": "0106299002"
    },
    "created_date": "2024-01-05T19:42:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00716618",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2023-11-29T00:00:00-05:00",
    "actual_end_date": "2024-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:39:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BETADERM CRM 0.05%",
    "en_drug_common_name": "BETADERM",
    "fr_drug_brand_name": "BETADERM CRM 0.05%",
    "fr_drug_common_name": "BETADERM",
    "en_ingredients": "BETAMETHASONE",
    "fr_ingredients": "Bétaméthasone",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215073,
    "drug": {
      "current_status": "MARKETED",
      "id": 101522,
      "drug_code": 100110,
      "updated_date": "2021-02-08T05:57:15-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266063,
          "ingredient": {
            "id": 3194,
            "ingredient_code": 13053,
            "en_name": "BORTEZOMIB",
            "fr_name": "Bortézomib (Bortézomib, ester boronique de mannitol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02511932",
      "brand_name": "TARO-BORTEZOMIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150433002"
    },
    "created_date": "2024-01-05T19:46:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02511932",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "L01XG",
    "estimated_end_date": "2024-06-28T00:00:00-04:00",
    "actual_start_date": "2023-12-01T00:00:00-05:00",
    "actual_end_date": "2024-07-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-07-27T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Import Ban for manufacturing site in Halol, India",
    "fr_comments": "Import ban at manufacturing site in Halol, India",
    "en_drug_brand_name": "TARO-BORTEZOMIB",
    "en_drug_common_name": "BORTEZOMIB",
    "fr_drug_brand_name": "TARO-BORTEZOMIB",
    "fr_drug_common_name": "BORTEZOMIB",
    "en_ingredients": "BORTEZOMIB",
    "fr_ingredients": "Bortezomib",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "2.5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215076,
    "drug": {
      "current_status": "MARKETED",
      "id": 22684,
      "drug_code": 85224,
      "updated_date": "2025-12-03T00:31:47-05:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258177,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02367394",
      "brand_name": "TARO-CARBAMAZEPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108674002"
    },
    "created_date": "2024-01-05T19:56:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367394",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2023-08-03T00:00:00-04:00",
    "actual_end_date": "2024-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:44:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CARBAMAZEPINE",
    "en_drug_common_name": "CARBAMAZEPINE",
    "fr_drug_brand_name": "TARO-CARBAMAZEPINE",
    "fr_drug_common_name": "CARBAMAZEPINE",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "450",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215079,
    "drug": {
      "current_status": "MARKETED",
      "id": 30404,
      "drug_code": 92456,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261109,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        },
        {
          "id": 8261108,
          "ingredient": {
            "id": 500,
            "ingredient_code": 6850,
            "en_name": "BENZOYL PEROXIDE",
            "fr_name": "Peroxyde de benzoyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02440180",
      "brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242561001"
    },
    "created_date": "2024-01-05T19:59:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440180",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "estimated_end_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2023-11-22T00:00:00-05:00",
    "actual_end_date": "2024-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:46:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "en_drug_common_name": "CLINDA/BENZOYL",
    "fr_drug_brand_name": "TARO-CLINDAMYCIN/BENZOYL PEROXIDE GEL",
    "fr_drug_common_name": "CLINDA/BENZOYL",
    "en_ingredients": "CLINDAMYCIN\r\nBENZOYL PEROXIDE",
    "fr_ingredients": "Peroxyde de benzoyle",
    "drug_strength": "1%\r\n5%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "45",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215082,
    "drug": {
      "current_status": "MARKETED",
      "id": 11866,
      "drug_code": 69610,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254398,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245523",
      "brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2024-01-05T20:01:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245523",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2023-10-02T00:00:00-04:00",
    "actual_end_date": "2024-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:48:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL CREAM USP, 0.05%",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "454",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215085,
    "drug": {
      "current_status": "MARKETED",
      "id": 11864,
      "drug_code": 69609,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254397,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245522",
      "brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2024-01-05T20:03:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245522",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "estimated_end_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:50:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
    "en_drug_common_name": "CLOBETASOL",
    "fr_drug_brand_name": "TARO-CLOBETASOL TOPICAL SOLUTION USP, 0.05%",
    "fr_drug_common_name": "CLOBETASOL",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215088,
    "drug": {
      "current_status": "MARKETED",
      "id": 100342,
      "drug_code": 98731,
      "updated_date": "2020-04-03T06:54:38-04:00",
      "company": {
        "id": 68,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5241,
        "mfr_code": "TAR08",
        "name": "TARO PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "130 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264930,
          "ingredient": {
            "id": 1660,
            "ingredient_code": 2442,
            "en_name": "CLOMIPRAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de clomipramine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02497506",
      "brand_name": "TARO-CLOMIPRAMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109212003"
    },
    "created_date": "2024-01-05T20:05:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02497506",
    "company_name": "TARO PHARMACEUTICALS INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2023-12-08T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T14:52:28-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TARO-CLOMIPRAMINE",
    "en_drug_common_name": "CLOMIPRAMINE",
    "fr_drug_brand_name": "TARO-CLOMIPRAMINE",
    "fr_drug_common_name": "CLOMIPRAMINE",
    "en_ingredients": "CLOMIPRAMINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clomipramine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215207,
    "drug": {
      "current_status": "MARKETED",
      "id": 101775,
      "drug_code": 100192,
      "updated_date": "2021-05-07T05:13:39-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8266107,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02512645",
      "brand_name": "APO-DOXYCYCLINE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED RELEASE CAPSULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105569008"
    },
    "created_date": "2024-01-05T22:43:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02512645",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-12T22:50:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DOXYCYCLINE MR",
    "en_drug_common_name": "DOXYCYCLINE",
    "fr_drug_brand_name": "APO-DOXYCYCLINE MR",
    "fr_drug_common_name": "DOXYCYCLINE",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE (IMMEDIATE AND DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération immédiate et retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215212,
    "drug": {
      "current_status": "MARKETED",
      "id": 26972,
      "drug_code": 89232,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259717,
          "ingredient": {
            "id": 2120,
            "ingredient_code": 109,
            "en_name": "TETRABENAZINE",
            "fr_name": "Tétrabénazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02407590",
      "brand_name": "APO-TETRABENAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128227001"
    },
    "created_date": "2024-01-05T22:50:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407590",
    "company_name": "APOTEX INC",
    "atc_number": "N07XX",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-02T22:44:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TETRABENAZINE",
    "en_drug_common_name": "TETRABENZINE",
    "fr_drug_brand_name": "APO-TETRABENZINE",
    "fr_drug_common_name": "TETRABENZINE",
    "en_ingredients": "TETRABENAZINE",
    "fr_ingredients": "Tétrabénazine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215215,
    "drug": {
      "current_status": "MARKETED",
      "id": 27336,
      "drug_code": 8959,
      "updated_date": "2025-05-15T02:30:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251113,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00755834",
      "brand_name": "APO-TIMOP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "67661",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2024-01-05T22:51:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00755834",
    "company_name": "APOTEX INC",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2024-07-05T00:00:00-04:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-28T15:31:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TIMOP",
    "en_drug_common_name": "TIMOLOL",
    "fr_drug_brand_name": "APO-TIMOLOL",
    "fr_drug_common_name": "TIMOLOL",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "Timolol",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215218,
    "drug": {
      "current_status": "MARKETED",
      "id": 15496,
      "drug_code": 76117,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255549,
          "ingredient": {
            "id": 902,
            "ingredient_code": 1864,
            "en_name": "FLECAINIDE ACETATE",
            "fr_name": "Acétate de flécaïnide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02275538",
      "brand_name": "APO-FLECAINIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116696004"
    },
    "created_date": "2024-01-05T22:52:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02275538",
    "company_name": "APOTEX INC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-16T15:53:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FLECAINIDE",
    "en_drug_common_name": "FLECAINIDE",
    "fr_drug_brand_name": "APO-FLECAINIDE",
    "fr_drug_common_name": "FLECAINIDE",
    "en_ingredients": "FLECAINIDE ACETATE",
    "fr_ingredients": "Acétate de flécaïnide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215221,
    "drug": {
      "current_status": "MARKETED",
      "id": 13770,
      "drug_code": 73646,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254957,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251531",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2024-01-05T22:54:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251531",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-04T00:00:00-05:00",
    "actual_end_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-02T22:47:31-05:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215224,
    "drug": {
      "current_status": "MARKETED",
      "id": 3152,
      "drug_code": 18040,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252242,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02147653",
      "brand_name": "APO-TRAZODONE D TABLETS 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80254",
      "number_of_ais": "1",
      "ai_group_no": "0115713003"
    },
    "created_date": "2024-01-05T22:56:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02147653",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-03-01T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-02-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-01T15:56:49-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRAZODONE D TABLETS 150MG",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "APO-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215227,
    "drug": {
      "current_status": "MARKETED",
      "id": 28560,
      "drug_code": 90680,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260361,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422085",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485003"
    },
    "created_date": "2024-01-05T22:57:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422085",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T15:41:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215230,
    "drug": {
      "current_status": "MARKETED",
      "id": 6984,
      "drug_code": 4736,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250676,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00550957",
      "brand_name": "APO PREDNISONE TAB 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "58593",
      "number_of_ais": "1",
      "ai_group_no": "0106321002"
    },
    "created_date": "2024-01-05T22:58:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00550957",
    "company_name": "APOTEX INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2024-01-19T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-12T22:46:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO PREDNISONE TAB 50MG",
    "en_drug_common_name": "PREDNISONE",
    "fr_drug_brand_name": "APO-PREDNISONE",
    "fr_drug_common_name": "PREDNISONE",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215233,
    "drug": {
      "current_status": "MARKETED",
      "id": 12114,
      "drug_code": 70136,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254482,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246010",
      "brand_name": "APO-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923005"
    },
    "created_date": "2024-01-05T22:59:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246010",
    "company_name": "APOTEX INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-22T15:02:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METOPROLOL",
    "en_drug_common_name": "METOPROLOL",
    "fr_drug_brand_name": "APO-METOPROLOL",
    "fr_drug_common_name": "METOPROLOL",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215236,
    "drug": {
      "current_status": "MARKETED",
      "id": 101228,
      "drug_code": 99744,
      "updated_date": "2020-12-09T00:57:56-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8265820,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8265819,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8265818,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8265817,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8265816,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.215",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8265815,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02508087",
      "brand_name": "TRI-CIRA 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "6",
      "ai_group_no": "0636783002"
    },
    "created_date": "2024-01-05T23:01:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02508087",
    "company_name": "APOTEX INC",
    "atc_number": "G03AB",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-02T22:48:08-05:00",
    "status": "resolved",
    "en_comments": "28 BLS available",
    "fr_comments": "28 BLS disponible",
    "en_drug_brand_name": "TRI-CIRA 21",
    "en_drug_common_name": "NORGESTIMATE / ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "TRI-CIRA 21",
    "fr_drug_common_name": "NORGESTIMATE / ETHINYL ESTRADIOL",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE",
    "fr_ingredients": "Éthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate",
    "drug_strength": "0.035MG\r\n0.25MG\r\n0.035MG\r\n0.215MG\r\n0.035MG\r\n0.18MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215239,
    "drug": {
      "current_status": "MARKETED",
      "id": 28564,
      "drug_code": 90682,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260363,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422107",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485001"
    },
    "created_date": "2024-01-05T23:03:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422107",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T15:42:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215242,
    "drug": {
      "current_status": "MARKETED",
      "id": 28562,
      "drug_code": 90681,
      "updated_date": "2025-05-15T02:34:15-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260362,
          "ingredient": {
            "id": 3072,
            "ingredient_code": 12346,
            "en_name": "TADALAFIL",
            "fr_name": "Tadalafil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02422093",
      "brand_name": "APO-TADALAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149485004"
    },
    "created_date": "2024-01-05T23:05:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02422093",
    "company_name": "APOTEX INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-01-31T00:00:00-05:00",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "actual_end_date": "2024-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-26T22:39:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TADALAFIL",
    "en_drug_common_name": "TADALAFIL",
    "fr_drug_brand_name": "APO-TADALAFIL",
    "fr_drug_common_name": "TADALAFIL",
    "en_ingredients": "TADALAFIL",
    "fr_ingredients": "Tadalafil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215247,
    "drug": {
      "current_status": "DORMANT",
      "id": 29202,
      "drug_code": 91232,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369149,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427826",
      "brand_name": "APO-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2024-01-05T23:09:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427826",
    "company_name": "APOTEX INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-01-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-19T21:35:48-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "APO-EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215310,
    "drug": {
      "current_status": "DORMANT",
      "id": 23808,
      "drug_code": 86482,
      "updated_date": "2025-12-03T02:32:30-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368729,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379007",
      "brand_name": "JAMP-VITAMIN D",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2024-01-08T20:55:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379007",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2024-11-30T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2025-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-23T04:41:22-05:00",
    "status": "resolved",
    "en_comments": "New DIN 02546876 available",
    "fr_comments": "Nouveau DIN 02546876 disponible",
    "en_drug_brand_name": "JAMP-VITAMIN D",
    "en_drug_common_name": "Vitamin D3 Tablets",
    "fr_drug_brand_name": "JAMP-VITAMIN D",
    "fr_drug_common_name": "Comprimés de Vitamine D3",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215313,
    "drug": {
      "current_status": "DORMANT",
      "id": 23808,
      "drug_code": 86482,
      "updated_date": "2025-12-03T02:32:30-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368729,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379007",
      "brand_name": "JAMP-VITAMIN D",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2024-01-08T20:57:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379007",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2024-11-30T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2025-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-23T04:44:13-05:00",
    "status": "resolved",
    "en_comments": "New DIN 02546876 available",
    "fr_comments": "Nouveau DIN 02546876 disponible",
    "en_drug_brand_name": "JAMP-VITAMIN D",
    "en_drug_common_name": "Vitamin D3 Tablets",
    "fr_drug_brand_name": "JAMP-Vitamine D",
    "fr_drug_common_name": "Comprimés de Vitamine D3",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215316,
    "drug": {
      "current_status": "DORMANT",
      "id": 23808,
      "drug_code": 86482,
      "updated_date": "2025-12-03T02:32:30-05:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368729,
          "ingredient": {
            "id": 590,
            "ingredient_code": 4922,
            "en_name": "VITAMIN D3",
            "fr_name": "Vitamine D3"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379007",
      "brand_name": "JAMP-VITAMIN D",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108524005"
    },
    "created_date": "2024-01-08T21:00:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379007",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A11CC",
    "atc_description": "VIT A AND D, INCL COMBINATIONS OF THE TWO",
    "estimated_end_date": "2024-11-30T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2025-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-23T04:46:44-05:00",
    "status": "resolved",
    "en_comments": "New DIN 02546876 available",
    "fr_comments": "Nouveau DIN 02546876 disponible",
    "en_drug_brand_name": "JAMP-VITAMIN D",
    "en_drug_common_name": "Vitamin D3 Tablets",
    "fr_drug_brand_name": "JAMP-Vitamin D",
    "fr_drug_common_name": "Comprimés de Vitamine D3",
    "en_ingredients": "VITAMIN D3",
    "fr_ingredients": "Vitamine D3",
    "drug_strength": "10000UNIT",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215319,
    "drug": {
      "current_status": "MARKETED",
      "id": 24734,
      "drug_code": 87302,
      "updated_date": "2025-12-03T00:32:00-05:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8258929,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.02",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258928,
          "ingredient": {
            "id": 3794,
            "ingredient_code": 21354,
            "en_name": "LEVOMEFOLATE CALCIUM",
            "fr_name": "Levomefolate Calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.451",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258927,
          "ingredient": {
            "id": 3190,
            "ingredient_code": 13375,
            "en_name": "DROSPIRENONE",
            "fr_name": "Drospirénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.00",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258926,
          "ingredient": {
            "id": 3794,
            "ingredient_code": 21354,
            "en_name": "LEVOMEFOLATE CALCIUM",
            "fr_name": "Levomefolate Calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.451",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387433",
      "brand_name": "YAZ PLUS",
      "brand_name_fr": "",
      "descriptor": "PINK TAB CONTAINS DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LIGHT ORANGE TAB CONTAINS LEVOMEFOLATE CALCIUM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0453183001"
    },
    "created_date": "2024-01-08T21:24:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387433",
    "company_name": "BAYER INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2024-01-19T00:00:00-05:00",
    "estimated_end_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-01-18T19:11:25-05:00",
    "status": "avoided_shortage",
    "en_comments": "Production Issues.",
    "fr_comments": "Éditions de production.",
    "en_drug_brand_name": "YAZ PLUS",
    "en_drug_common_name": "Drospirenone/ estradiol/ Levomefolate Calcium",
    "fr_drug_brand_name": "Yaz Plus",
    "fr_drug_common_name": "Drospirénone / Éthinyl estradiol",
    "en_ingredients": "LEVOMEFOLATE CALCIUM\r\nLEVOMEFOLATE CALCIUM\r\nETHINYL ESTRADIOL\r\nDROSPIRENONE",
    "fr_ingredients": "Éthinylestradiol\r\nDrospirénone",
    "drug_strength": "0.451MG\r\n0.451MG\r\n0.02MG\r\n3.00MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215326,
    "drug": {
      "current_status": "MARKETED",
      "id": 14470,
      "drug_code": 74727,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255211,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261928",
      "brand_name": "SANDOZ-DICLOFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114417002"
    },
    "created_date": "2024-01-08T21:56:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261928",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2024-04-19T00:00:00-04:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ-DICLOFENAC",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "SANDOZ-DICLOFENAC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "50MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL\r\nRECTAL",
    "drug_route_fr": "Rectale\r\nRectale",
    "drug_package_quantity": "30SUP",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215330,
    "drug": {
      "current_status": "MARKETED",
      "id": 30320,
      "drug_code": 92370,
      "updated_date": "2025-05-15T02:34:43-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261078,
          "ingredient": {
            "id": 1510,
            "ingredient_code": 157,
            "en_name": "DOCETAXEL",
            "fr_name": "Docétaxel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02439336",
      "brand_name": "DOCETAXEL INJECTION",
      "brand_name_fr": "DOCÉTAXEL INJECTION",
      "descriptor": "20MG/2ML; 80MG/8ML; 160MG/16ML VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127884002"
    },
    "created_date": "2024-01-08T21:59:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439336",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01CD",
    "atc_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-05T18:46:27-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "DOCETAXEL INJECTION",
    "en_drug_common_name": "DOCETAXEL",
    "fr_drug_brand_name": "DOCETAXEL INJECTION",
    "fr_drug_common_name": "DOCETAXEL",
    "en_ingredients": "DOCETAXEL",
    "fr_ingredients": "Docétaxel",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215335,
    "drug": {
      "current_status": "MARKETED",
      "id": 17490,
      "drug_code": 78530,
      "updated_date": "2025-05-15T02:32:00-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256166,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02299968",
      "brand_name": "SANDOZ ENALAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152325002"
    },
    "created_date": "2024-01-08T22:01:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02299968",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2024-10-11T00:00:00-04:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-10-08T00:47:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENALAPRIL",
    "en_drug_common_name": "ENALAPRIL",
    "fr_drug_brand_name": "SANDOZ ENALAPRIL",
    "fr_drug_common_name": "ENALAPRIL",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215339,
    "drug": {
      "current_status": "MARKETED",
      "id": 3278,
      "drug_code": 18315,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252297,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145901",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80543",
      "number_of_ais": "1",
      "ai_group_no": "0108698003"
    },
    "created_date": "2024-01-08T22:03:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02145901",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "HYDROMORPHONE",
    "fr_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "fr_drug_common_name": "HYDROMORPHONE",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215343,
    "drug": {
      "current_status": "MARKETED",
      "id": 17876,
      "drug_code": 78939,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256270,
          "ingredient": {
            "id": 3442,
            "ingredient_code": 8280,
            "en_name": "PHENOBARBITAL SODIUM",
            "fr_name": "Phénobarbital sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02304082",
      "brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105985003"
    },
    "created_date": "2024-01-08T22:04:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02304082",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AA",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-04-04T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
    "en_drug_common_name": "PHENOBARBITAL",
    "fr_drug_brand_name": "PHENOBARBITAL SODIUM INJECTION, USP",
    "fr_drug_common_name": "PHENOBARBITAL",
    "en_ingredients": "PHENOBARBITAL SODIUM",
    "fr_ingredients": "Phénobarbital sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215347,
    "drug": {
      "current_status": "MARKETED",
      "id": 17144,
      "drug_code": 78176,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256049,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02296446",
      "brand_name": "SANDOZ OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-08T22:06:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296446",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-03T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500GRC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215358,
    "drug": {
      "current_status": "MARKETED",
      "id": 10660,
      "drug_code": 66277,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254041,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254040,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "17",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254039,
          "ingredient": {
            "id": 634,
            "ingredient_code": 4993,
            "en_name": "DEXPANTHENOL",
            "fr_name": "Dexpanthénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254038,
          "ingredient": {
            "id": 632,
            "ingredient_code": 4962,
            "en_name": "BIOTIN",
            "fr_name": "Biotine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254037,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254036,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254035,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254034,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254033,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254032,
          "ingredient": {
            "id": 636,
            "ingredient_code": 5008,
            "en_name": "PYRIDOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pyridoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254031,
          "ingredient": {
            "id": 738,
            "ingredient_code": 4918,
            "en_name": "VITAMIN K1",
            "fr_name": "Vitamine K1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254030,
          "ingredient": {
            "id": 424,
            "ingredient_code": 703,
            "en_name": "VITAMIN D",
            "fr_name": "Vitamine D"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254029,
          "ingredient": {
            "id": 426,
            "ingredient_code": 704,
            "en_name": "VITAMIN A",
            "fr_name": "Vitamine A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02242529",
      "brand_name": "MULTI-12/K1 PEDIATRIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "13",
      "ai_group_no": "1341461001"
    },
    "created_date": "2024-01-08T22:19:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242529",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XC",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2024-01-26T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Baxter item: 6461. Product is available on allocation based on 100% of historical volumes",
    "fr_comments": "Baxter item : 6461. Produit disponible sous allocation selon 100% des volumes de l'historique d'achat",
    "en_drug_brand_name": "MULTI-12/K1 PEDIATRIC",
    "en_drug_common_name": "MULTI-12/K1 PED",
    "fr_drug_brand_name": "MULTI-12/K1 PEDIATRIC",
    "fr_drug_common_name": "MULTI-12/K1 PED",
    "en_ingredients": "VITAMIN B12\r\nFOLIC ACID\r\nBIOTIN\r\nVITAMIN K1\r\nVITAMIN E\r\nDEXPANTHENOL\r\nNICOTINAMIDE\r\nPYRIDOXINE HYDROCHLORIDE\r\nVITAMIN B2\r\nVITAMIN B1\r\nVITAMIN D\r\nVITAMIN A\r\nASCORBIC ACID",
    "fr_ingredients": "Vitamine B12\r\nAcide folique\r\nBiotine\r\nVitamine K1\r\nVitamine E\r\nDexpanthénol\r\nNicotinamide\r\nChlorhydrate de pyridoxine\r\nVitanine B2\r\nVitamine B1\r\nVitamine D\r\nVitamine A",
    "drug_strength": "1MCG\r\n140MCG\r\n20MCG\r\n0.2MG\r\n7UNIT\r\n5MG\r\n17MG\r\n1MG\r\n1.4MG\r\n1.2MG\r\n400UNIT\r\n2300UNIT\r\n80MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "SINGLE DOSE 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215362,
    "drug": {
      "current_status": "MARKETED",
      "id": 3530,
      "drug_code": 18860,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252392,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148447",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81140",
      "number_of_ais": "1",
      "ai_group_no": "0100662002"
    },
    "created_date": "2024-01-09T03:07:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148447",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2024-01-25T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-02-06T02:41:18-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "Minims® - Phenylephrine HCL 2.5%",
    "fr_drug_brand_name": "Minims Phenylephrine",
    "fr_drug_common_name": "Minims® - Phenylephrine HCL 2.5%",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "2.5%",
    "drug_dosage_form": "SOLUTION\r\nDROPS",
    "drug_dosage_form_fr": "Solution\r\nGouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215365,
    "drug": {
      "current_status": "MARKETED",
      "id": 3476,
      "drug_code": 18759,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252376,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148455",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81033",
      "number_of_ais": "1",
      "ai_group_no": "0100662005"
    },
    "created_date": "2024-01-09T03:09:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148455",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2024-01-25T00:00:00-05:00",
    "actual_start_date": "2024-01-08T00:00:00-05:00",
    "actual_end_date": "2024-01-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-02-06T02:40:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "Phenylephrine HCL 10%",
    "fr_drug_brand_name": "Phenylephrine HCL 10%",
    "fr_drug_common_name": "Phenylephrine HCL 10%",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10%",
    "drug_dosage_form": "SOLUTION\r\nDROPS",
    "drug_dosage_form_fr": "Solution\r\nGouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215416,
    "drug": {
      "current_status": "MARKETED",
      "id": 100433,
      "drug_code": 98796,
      "updated_date": "2020-06-16T22:21:13-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265003,
          "ingredient": {
            "id": 3750,
            "ingredient_code": 21018,
            "en_name": "DIENOGEST",
            "fr_name": "Diénogest"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02498189",
      "brand_name": "JAMP DIENOGEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153021001"
    },
    "created_date": "2024-01-09T16:56:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02498189",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "G03DB",
    "atc_description": "PROGESTOGENS",
    "estimated_end_date": "2024-01-26T00:00:00-05:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-01-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP DIENOGEST",
    "en_drug_common_name": "Dienogest Tablets",
    "fr_drug_brand_name": "JAMP Dienogest",
    "fr_drug_common_name": "Comprimés de diénogest",
    "en_ingredients": "DIENOGEST",
    "fr_ingredients": "Diénogest",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "2x14",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215434,
    "drug": {
      "current_status": "MARKETED",
      "id": 8588,
      "drug_code": 60218,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253479,
          "ingredient": {
            "id": 422,
            "ingredient_code": 1950,
            "en_name": "ACYCLOVIR",
            "fr_name": "Acyclovir (Acyclovir sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02236926",
      "brand_name": "ACYCLOVIR SODIUM INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115506007"
    },
    "created_date": "2024-01-09T21:32:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236926",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2023-12-15T00:00:00-05:00",
    "estimated_end_date": "2024-03-01T00:00:00-05:00",
    "actual_start_date": "2023-12-15T00:00:00-05:00",
    "actual_end_date": "2024-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-31T17:10:18-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Acyclovir Sodium Injection 50 mg/mL SD Vial 20 mL effective December 15, 2023, until March 1, 2024.\r\nEffective December 1, 2023, allocations for our Acyclovir Sodium Injection 50 mg/mL SD Vial 10 mL will be increased to cover 100% of historical monthly demand of the 10 mL plus 100% of historical monthly demand of the 20 mL at a 2:1 ratio.",
    "fr_comments": "Fresenius Kabi Canada Ltée a le regret de vous aviser qu’en raison de retards de production, une interruption d’approvisionnement va toucher sa présentation d’Acyclovir sodique injectable à 50 mg/mL en fioles DU de 20 mL du 15 décembre 2023 au 1 mars 2024.\r\n\r\nDès le 1er décembre 2023, les allocations sur l’Acyclovir sodique injectable à 50 mg/mL en fioles de 10 mL seront augmentées pour couvrir 100 % de la demande mensuelle historique du 10 mL plus 100 % de la demande mensuelle historique du 20 mL selon un ratio de 2:1.",
    "en_drug_brand_name": "ACYCLOVIR SODIUM INJECTION",
    "en_drug_common_name": "ACYCLOVIR SODIUM INJECTION",
    "fr_drug_brand_name": "Acyclovir sodique injectable",
    "fr_drug_common_name": "Acyclovir sodique injectable",
    "en_ingredients": "ACYCLOVIR",
    "fr_ingredients": "Acyclovir",
    "drug_strength": "50MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215437,
    "drug": {
      "current_status": "MARKETED",
      "id": 26638,
      "drug_code": 88928,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 1632,
        "created_date": "2017-03-09T13:24:59-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 14507,
        "mfr_code": "",
        "name": "EISAI LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6925 CENTURY AVE, SUITE 701",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 7K2",
        "post_office_box": "",
        "contact_information": "Tammy Mitchell-Moore - Director, Regulatory Affairs\r\n905-814-2312 / tammy_mitchellmoore@eisai.com"
      },
      "drug_ingredients": [
        {
          "id": 8259604,
          "ingredient": {
            "id": 3850,
            "ingredient_code": 22049,
            "en_name": "PERAMPANEL",
            "fr_name": "Pérampanel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404567",
      "brand_name": "FYCOMPA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154211006"
    },
    "created_date": "2024-01-09T22:49:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404567",
    "company_name": "EISAI LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-02-05T00:00:00-05:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T21:04:52-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FYCOMPA",
    "en_drug_common_name": "perampanel",
    "fr_drug_brand_name": "FYCOMPA",
    "fr_drug_common_name": "Pérampanel",
    "en_ingredients": "PERAMPANEL",
    "fr_ingredients": "Pérampanel",
    "drug_strength": "12.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215446,
    "drug": {
      "current_status": "MARKETED",
      "id": 13624,
      "drug_code": 73449,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254924,
          "ingredient": {
            "id": 2928,
            "ingredient_code": 896,
            "en_name": "PAMIDRONATE DISODIUM",
            "fr_name": "Pamidronate disodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02249685",
      "brand_name": "PAMIDRONATE DISODIUM OMEGA 9 MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123608006"
    },
    "created_date": "2024-01-09T23:13:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02249685",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PAMIDRONATE DISODIUM OMEGA 9 MG/ML",
    "en_drug_common_name": "Pamidronate Disodium For Injection",
    "fr_drug_brand_name": "Pamidronate Disodium Omega",
    "fr_drug_common_name": "Pamidronate Disodique Pour Injection",
    "en_ingredients": "PAMIDRONATE DISODIUM",
    "fr_ingredients": "Pamidronate disodique",
    "drug_strength": "9.0MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 10mL vial /fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215470,
    "drug": {
      "current_status": "MARKETED",
      "id": 11222,
      "drug_code": 67606,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8254211,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243676",
      "brand_name": "RECOMBIVAX HB",
      "brand_name_fr": "",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119570001"
    },
    "created_date": "2024-01-10T15:53:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243676",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Doses are reserved for the public immunization program",
    "fr_comments": "Les doses restantes sont réservées au programme public de vaccination.",
    "en_drug_brand_name": "RECOMBIVAX HB",
    "en_drug_common_name": "(hepatitis B vaccine [recombinant])",
    "fr_drug_brand_name": "RECOMBIVAX HB",
    "fr_drug_common_name": "(vaccin contre l’hépatite B [ADN recombiné)",
    "en_ingredients": "HEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "HEPATITIS B SURFACE ANTIGEN",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SUSPENSION\r\nSOLUTION",
    "drug_dosage_form_fr": "Suspension\r\nSolution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "10MCG/1ML 1DOSE VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215477,
    "drug": {
      "current_status": "MARKETED",
      "id": 4826,
      "drug_code": 2657,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250432,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00362158",
      "brand_name": "DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50813",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2024-01-10T17:17:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00362158",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2024-01-10T00:00:00-05:00",
    "estimated_end_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-25T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DIAZEPAM",
    "en_drug_common_name": "DIAZEPAM",
    "fr_drug_brand_name": "DIAZEPAM",
    "fr_drug_common_name": "DIAZEPAM",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215480,
    "drug": {
      "current_status": "MARKETED",
      "id": 5086,
      "drug_code": 3076,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250482,
          "ingredient": {
            "id": 714,
            "ingredient_code": 7566,
            "en_name": "PREDNISONE",
            "fr_name": "Prednisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00271373",
      "brand_name": "WINPRED",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52735",
      "number_of_ais": "1",
      "ai_group_no": "0106321003"
    },
    "created_date": "2024-01-10T17:19:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00271373",
    "company_name": "AA PHARMA INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "anticipated_start_date": "2024-01-09T00:00:00-05:00",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_end_date": "2024-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-31T20:08:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "WINPRED",
    "en_drug_common_name": "WINPRED",
    "fr_drug_brand_name": "WINPRED",
    "fr_drug_common_name": "WINPRED",
    "en_ingredients": "PREDNISONE",
    "fr_ingredients": "Prednisone",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215507,
    "drug": {
      "current_status": "MARKETED",
      "id": 11616,
      "drug_code": 68628,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254327,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244641",
      "brand_name": "BIAXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752004"
    },
    "created_date": "2024-01-10T19:09:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244641",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2024-05-14T00:00:00-04:00",
    "actual_start_date": "2024-01-04T00:00:00-05:00",
    "actual_end_date": "2024-05-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-17T18:25:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BIAXIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "BIAXIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "105ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215518,
    "drug": {
      "current_status": "MARKETED",
      "id": 2294,
      "drug_code": 15176,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252010,
          "ingredient": {
            "id": 1122,
            "ingredient_code": 2097,
            "en_name": "PINAVERIUM BROMIDE",
            "fr_name": "Bromure de pinavérium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01950592",
      "brand_name": "DICETEL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "76857",
      "number_of_ais": "1",
      "ai_group_no": "0113429001"
    },
    "created_date": "2024-01-10T19:15:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01950592",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A03AX",
    "atc_description": "DRUGS FOR FUNCTIONAL BOWEL DISORDERS",
    "estimated_end_date": "2024-02-13T00:00:00-05:00",
    "actual_start_date": "2024-01-05T00:00:00-05:00",
    "actual_end_date": "2024-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-29T13:10:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DICETEL",
    "en_drug_common_name": "PINAVERIUM BROMIDE",
    "fr_drug_brand_name": "DICETEL",
    "fr_drug_common_name": "PINAVERIUM BROMIDE",
    "en_ingredients": "PINAVERIUM BROMIDE",
    "fr_ingredients": "Bromure de pinavérium",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4x25 CA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215527,
    "drug": {
      "current_status": "MARKETED",
      "id": 10988,
      "drug_code": 66964,
      "updated_date": "2025-12-03T00:30:46-05:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254131,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243097",
      "brand_name": "LIPITOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2024-01-10T19:19:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243097",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2024-01-11T00:00:00-05:00",
    "estimated_end_date": "2024-02-28T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-06T18:33:58-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LIPITOR",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "LIPITOR",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3x10 BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215532,
    "drug": {
      "current_status": "MARKETED",
      "id": 6780,
      "drug_code": 44262,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8253179,
          "ingredient": {
            "id": 1592,
            "ingredient_code": 5900,
            "en_name": "METHOTREXATE",
            "fr_name": "Méthotrexate (Méthotrexate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02182955",
      "brand_name": "METHOTREXATE INJECTION USP",
      "brand_name_fr": "METHOTREXATE INJECTABLE USP",
      "descriptor": "SINGLE USE VIALS. PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "T9986",
      "number_of_ais": "1",
      "ai_group_no": "0107545002"
    },
    "created_date": "2024-01-10T20:19:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02182955",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BA",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METHOTREXATE INJECTION USP",
    "en_drug_common_name": "METHOTREXATE INJECTION USP",
    "fr_drug_brand_name": "METHOTREXATE INJECTION USP",
    "fr_drug_common_name": "METHOTREXATE INJECTION USP",
    "en_ingredients": "METHOTREXATE",
    "fr_ingredients": "Méthotrexate",
    "drug_strength": "25MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL\r\nINTRACEREBROVENTRICULAR\r\nINTRACEREBROVENTRICULAR\r\nINTRAVENOUS\r\nINTRATHECAL\r\nINTRAMUSCULAR\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle\r\nIntracérébroventriculaire\r\nIntracérébroventriculaire\r\nIntraveineuse\r\nIntrathécale\r\nIntramusculaire\r\nIntra-artérielle",
    "drug_package_quantity": "1 X 2ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215535,
    "drug": {
      "current_status": "MARKETED",
      "id": 26436,
      "drug_code": 88767,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8259539,
          "ingredient": {
            "id": 2334,
            "ingredient_code": 11262,
            "en_name": "GEMCITABINE",
            "fr_name": "Gemcitabine (Chlorhydrate de gemcitabine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "38",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02402831",
      "brand_name": "GEMCITABINE INJECTION",
      "brand_name_fr": "GEMCITABINE INJECTABLE",
      "descriptor": "SINGLE-USE VIALS. 200MG/5.3ML; 1G/26.3ML; 2G/52.6ML. READY-TO-USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133122005"
    },
    "created_date": "2024-01-10T20:25:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402831",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-25T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "GEMCITABINE INJECTION",
    "en_drug_common_name": "GEMCITABINE INJECTION",
    "fr_drug_brand_name": "GEMCITABINE INJECTION",
    "fr_drug_common_name": "GEMCITABINE INJECTION",
    "en_ingredients": "GEMCITABINE",
    "fr_ingredients": "GEMCITABINE",
    "drug_strength": "38MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 X 26.3ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215539,
    "drug": {
      "current_status": "MARKETED",
      "id": 26436,
      "drug_code": 88767,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8259539,
          "ingredient": {
            "id": 2334,
            "ingredient_code": 11262,
            "en_name": "GEMCITABINE",
            "fr_name": "Gemcitabine (Chlorhydrate de gemcitabine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "38",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02402831",
      "brand_name": "GEMCITABINE INJECTION",
      "brand_name_fr": "GEMCITABINE INJECTABLE",
      "descriptor": "SINGLE-USE VIALS. 200MG/5.3ML; 1G/26.3ML; 2G/52.6ML. READY-TO-USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133122005"
    },
    "created_date": "2024-01-10T20:30:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402831",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2024-01-30T00:00:00-05:00",
    "actual_end_date": "2024-01-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-24T18:39:44-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "GEMCITABINE INJECTION",
    "en_drug_common_name": "GEMCITABINE INJECTION",
    "fr_drug_brand_name": "GEMCITABINE INJECTION",
    "fr_drug_common_name": "GEMCITABINE INJECTION",
    "en_ingredients": "GEMCITABINE",
    "fr_ingredients": "GEMCITABINE",
    "drug_strength": "38MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 X 5.3ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215589,
    "drug": {
      "current_status": "MARKETED",
      "id": 1886,
      "drug_code": 14019,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251850,
          "ingredient": {
            "id": 1008,
            "ingredient_code": 2402,
            "en_name": "DANTROLENE SODIUM",
            "fr_name": "Dantrolène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01997602",
      "brand_name": "DANTRIUM CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75516",
      "number_of_ais": "1",
      "ai_group_no": "0109855002"
    },
    "created_date": "2024-01-11T15:55:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01997602",
    "company_name": "ENDO PAR INNOVATION COMPANY, LLC",
    "atc_number": "M03CA",
    "atc_description": "MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",
    "anticipated_start_date": "2023-12-15T00:00:00-05:00",
    "estimated_end_date": "2024-01-31T00:00:00-05:00",
    "actual_end_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-07T18:28:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DANTRIUM CAPSULES",
    "en_drug_common_name": "DANTROLENE SODIUM",
    "fr_drug_brand_name": "Dantrium Capsules",
    "fr_drug_common_name": "Dantrolène sodique",
    "en_ingredients": "DANTROLENE SODIUM",
    "fr_ingredients": "Dantrolène sodique",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Capsules",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215600,
    "drug": {
      "current_status": "MARKETED",
      "id": 63995,
      "drug_code": 81328,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257038,
          "ingredient": {
            "id": 14565,
            "ingredient_code": 8044,
            "en_name": "GALLIUM CITRATE GA 67",
            "fr_name": "Citrate de gallium 67 GA"
          },
          "ingredient_supplied_ind": "I",
          "strength": "74",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02327813",
      "brand_name": "GALLIUM (GA67) CITRATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152589005"
    },
    "created_date": "2024-01-11T18:15:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327813",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09HX",
    "anticipated_start_date": "2024-01-14T00:00:00-05:00",
    "estimated_end_date": "2024-01-21T00:00:00-05:00",
    "actual_start_date": "2024-01-14T00:00:00-05:00",
    "actual_end_date": "2024-01-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-26T14:06:36-05:00",
    "status": "resolved",
    "en_comments": "Due to a mechanical issue, we were unable to execute cyclotron production of Ga-67 raw material. As a consequence, Gallium Citrate Ga 67 Injection will not be available for shipment January 14-18, 2024.\r\nThe next lot is scheduled to release Sunday, Jan 21.\r\nWe apologize for any inconvenience caused by this issue.",
    "fr_comments": "En raison d'un problème mécanique, nous n'avons pas pu exécuter la production par cyclotron de la matière première Ga-67. Par conséquent, le Gallium Citrate Ga 67 Injection ne sera pas disponible pour expédition du 14 au 18 janvier 2024.\r\nLe prochain lot devrait sortir le dimanche 21 janvier.\r\nNous nous excusons pour tout inconvénient causé par ce problème.",
    "en_drug_brand_name": "GALLIUM (GA67) CITRATE INJECTION",
    "en_drug_common_name": "Gallium (Ga 67) Citrate injection",
    "fr_drug_brand_name": "Citrate de gallium (67Ga) injectable",
    "fr_drug_common_name": "Citrate de gallium (67Ga) injectable",
    "en_ingredients": "GALLIUM CITRATE GA 67",
    "fr_ingredients": "chloride de gallium",
    "drug_strength": "74MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "6 & 12 mCi",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215603,
    "drug": {
      "current_status": "MARKETED",
      "id": 18988,
      "drug_code": 80247,
      "updated_date": "2025-12-03T00:31:23-05:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8256645,
          "ingredient": {
            "id": 3482,
            "ingredient_code": 20387,
            "en_name": "RIVAROXABAN",
            "fr_name": "Rivaroxaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316986",
      "brand_name": "XARELTO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152487001"
    },
    "created_date": "2024-01-11T18:44:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316986",
    "company_name": "BAYER INC",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2024-01-26T00:00:00-05:00",
    "estimated_end_date": "2024-02-15T00:00:00-05:00",
    "actual_start_date": "2024-02-01T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "XARELTO",
    "en_drug_common_name": "RIVAROXABAN",
    "fr_drug_brand_name": "XARELTO",
    "fr_drug_common_name": "Rivaroxaban",
    "en_ingredients": "RIVAROXABAN",
    "fr_ingredients": "Rivaroxaban",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215608,
    "drug": {
      "current_status": "MARKETED",
      "id": 101432,
      "drug_code": 99940,
      "updated_date": "2021-06-08T05:12:50-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8265928,
          "ingredient": {
            "id": 3482,
            "ingredient_code": 20387,
            "en_name": "RIVAROXABAN",
            "fr_name": "Rivaroxaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "51.7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        }
      ],
      "din": "02510162",
      "brand_name": "XARELTO",
      "brand_name_fr": "",
      "descriptor": "1MG/ML WHEN RECONSTITUTED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152487007"
    },
    "created_date": "2024-01-11T18:47:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02510162",
    "company_name": "BAYER INC",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "XARELTO",
    "en_drug_common_name": "RIVAROXABAN",
    "fr_drug_brand_name": "XARELTO",
    "fr_drug_common_name": "Rivaroxaban",
    "en_ingredients": "RIVAROXABAN",
    "fr_ingredients": "Rivaroxaban",
    "drug_strength": "51.7MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215627,
    "drug": {
      "current_status": "MARKETED",
      "id": 900,
      "drug_code": 1214,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250243,
          "ingredient": {
            "id": 548,
            "ingredient_code": 11190,
            "en_name": "KETAMINE",
            "fr_name": "Kétamine (Chlorhydrate de kétamine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00224391",
      "brand_name": "KETALAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "37465",
      "number_of_ais": "1",
      "ai_group_no": "0131360002"
    },
    "created_date": "2024-01-11T18:54:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00224391",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "N01AX",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2024-03-01T00:00:00-05:00",
    "estimated_end_date": "2024-03-21T00:00:00-04:00",
    "actual_end_date": "2024-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-19T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "KETALAR",
    "en_drug_common_name": "Ketalar",
    "fr_drug_brand_name": "Ketalar",
    "fr_drug_common_name": "Ketalar",
    "en_ingredients": "KETAMINE",
    "fr_ingredients": "KETAMINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215701,
    "drug": {
      "current_status": "MARKETED",
      "id": 10576,
      "drug_code": 6612,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250919,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00648043",
      "brand_name": "TEVA-METOPROLOL",
      "brand_name_fr": "",
      "descriptor": "FILM COATED",
      "pediatric_flag": false,
      "accession_number": "63649",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2024-01-11T20:15:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00648043",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2024-04-20T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-18T13:50:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-METOPROLOL",
    "en_drug_common_name": "METOPROLOL 100MG FC TAB",
    "fr_drug_brand_name": "TEVA-METOPROLOL 100MG FC TAB",
    "fr_drug_common_name": "METOPROLOL 100MG FC TAB",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215704,
    "drug": {
      "current_status": "MARKETED",
      "id": 1594,
      "drug_code": 13437,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251765,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01910272",
      "brand_name": "TEVA-CLOBETASOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74824",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2024-01-11T20:16:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01910272",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-30T17:48:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CLOBETASOL",
    "en_drug_common_name": "CLOBETASOL 0.05% CREAM",
    "fr_drug_brand_name": "TEVA-CLOBETASOL 0.05% CREAM",
    "fr_drug_common_name": "CLOBETASOL 0.05% CREAM",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "450g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215707,
    "drug": {
      "current_status": "MARKETED",
      "id": 1650,
      "drug_code": 13550,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251780,
          "ingredient": {
            "id": 124,
            "ingredient_code": 2585,
            "en_name": "SALBUTAMOL",
            "fr_name": "Salbutamol (Sulfate de salbutamol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01926934",
      "brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74959",
      "number_of_ais": "1",
      "ai_group_no": "0108887007"
    },
    "created_date": "2024-01-11T20:17:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01926934",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2025-11-07T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2025-11-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-11-06T18:37:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SALBUTAMOL STERINEBS P.F.",
    "en_drug_common_name": "SALBUTAMOL 1MG/ML NEBS",
    "fr_drug_brand_name": "TEVA-SALBUTAMOL 1MG/ML NEBS",
    "fr_drug_common_name": "SALBUTAMOL 1MG/ML NEBS",
    "en_ingredients": "SALBUTAMOL",
    "fr_ingredients": "Salbutamol",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "20 X 2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": true
  },
  {
    "id": 215710,
    "drug": {
      "current_status": "MARKETED",
      "id": 6290,
      "drug_code": 43143,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253032,
          "ingredient": {
            "id": 2142,
            "ingredient_code": 20300,
            "en_name": "NALTREXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naltrexone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02213826",
      "brand_name": "REVIA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9438",
      "number_of_ais": "1",
      "ai_group_no": "0118591001"
    },
    "created_date": "2024-01-11T20:18:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02213826",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N07BB",
    "atc_description": "DRUGS USED IN ADDICTIVE DISORDERS",
    "estimated_end_date": "2024-02-10T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "REVIA",
    "en_drug_common_name": "REVIA 50MG TAB",
    "fr_drug_brand_name": "REVIA 50MG TAB",
    "fr_drug_common_name": "REVIA 50MG TAB",
    "en_ingredients": "NALTREXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naltrexone",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215713,
    "drug": {
      "current_status": "MARKETED",
      "id": 8704,
      "drug_code": 60571,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253510,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237250",
      "brand_name": "TEVA-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038001"
    },
    "created_date": "2024-01-11T20:19:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237250",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-03-10T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-18T13:39:42-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN 1G TAB",
    "fr_drug_brand_name": "TEVA-TRYPTOPHAN 1G TAB",
    "fr_drug_common_name": "TRYPTOPHAN 1G TAB",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "1G",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215716,
    "drug": {
      "current_status": "MARKETED",
      "id": 9880,
      "drug_code": 64051,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253775,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240481",
      "brand_name": "TEVA-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2024-01-11T20:20:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240481",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-03-10T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T15:14:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SERTRALINE",
    "en_drug_common_name": "SERTRALINE 100MG CAPS",
    "fr_drug_brand_name": "TEVA-SERTRALINE 100MG CAPS",
    "fr_drug_common_name": "SERTRALINE 100MG CAPS",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215719,
    "drug": {
      "current_status": "MARKETED",
      "id": 11066,
      "drug_code": 67216,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254157,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "375",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243313",
      "brand_name": "TEVA-NAPROXEN EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109634004"
    },
    "created_date": "2024-01-11T20:21:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243313",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2024-03-10T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-18T13:39:09-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NAPROXEN EC",
    "en_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "fr_drug_brand_name": "TEVA-NAPROXEN-EC 375MG TAB",
    "fr_drug_common_name": "NAPROXEN-EC 375MG TAB",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "375MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215722,
    "drug": {
      "current_status": "MARKETED",
      "id": 13660,
      "drug_code": 73498,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254931,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250179",
      "brand_name": "TEVA-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2024-01-11T20:22:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250179",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-07-10T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-04T17:19:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN 40MG TAB",
    "fr_drug_brand_name": "TEVA-SIMVASTATIN 40MG TAB",
    "fr_drug_common_name": "SIMVASTATIN 40MG TAB",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215725,
    "drug": {
      "current_status": "MARKETED",
      "id": 18910,
      "drug_code": 80164,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256604,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316110",
      "brand_name": "ACT QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-11T20:23:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316110",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-03-20T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-03-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-11T14:40:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE 200MG FC TAB",
    "fr_drug_brand_name": "ACT-QUETIAPINE 200MG FC TAB",
    "fr_drug_common_name": "QUETIAPINE 200MG FC TAB",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215728,
    "drug": {
      "current_status": "MARKETED",
      "id": 19302,
      "drug_code": 80563,
      "updated_date": "2025-05-15T02:32:18-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256748,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02320185",
      "brand_name": "TEVA-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223002"
    },
    "created_date": "2024-01-11T20:24:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320185",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-25T16:50:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN 80MG TAB",
    "fr_drug_brand_name": "TEVA-TELMISARTAN 80MG TAB",
    "fr_drug_common_name": "TELMISARTAN 80MG TAB",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215731,
    "drug": {
      "current_status": "MARKETED",
      "id": 21586,
      "drug_code": 83978,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257719,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354616",
      "brand_name": "TEVA-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2024-01-11T20:25:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354616",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-02-10T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T15:09:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "fr_drug_brand_name": "TEVA-ROSUVASTATIN 10MG TAB",
    "fr_drug_common_name": "ROSUVASTATIN 10MG TAB",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 3",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215734,
    "drug": {
      "current_status": "MARKETED",
      "id": 25628,
      "drug_code": 88040,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259256,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395290",
      "brand_name": "TEVA-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781006"
    },
    "created_date": "2024-01-11T20:27:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395290",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-02T20:33:15-05:00",
    "status": "active_confirmed",
    "en_comments": "Suspended Supply",
    "en_drug_brand_name": "TEVA-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE 140MG CAPS",
    "fr_drug_brand_name": "ACT-TEMOZOLOMIDE 140MG CAPS",
    "fr_drug_common_name": "TEMOZOLOMIDE 140MG CAPS",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "140MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215737,
    "drug": {
      "current_status": "MARKETED",
      "id": 26486,
      "drug_code": 88801,
      "updated_date": "2025-05-15T02:33:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259551,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02403196",
      "brand_name": "TEVA-CLARITHROMYCIN XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752002"
    },
    "created_date": "2024-01-11T20:28:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403196",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2024-05-20T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-16T19:44:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT CLARITHROMYCIN XL",
    "en_drug_common_name": "CLARITHROMYC FC TAB",
    "fr_drug_brand_name": "ACT-CLARITHROMYC FC TAB",
    "fr_drug_common_name": "CLARITHROMYC FC TAB",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215740,
    "drug": {
      "current_status": "MARKETED",
      "id": 98311,
      "drug_code": 91376,
      "updated_date": "2020-04-03T06:52:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260653,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429330",
      "brand_name": "TEVA-DILTIAZEM XC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863006"
    },
    "created_date": "2024-01-11T20:29:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429330",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2024-05-10T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T18:07:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM XC",
    "en_drug_common_name": "DILTIAZEM XC 240MG TAB",
    "fr_drug_brand_name": "TEVA-DILTIAZEM XC 240MG TAB",
    "fr_drug_common_name": "DILTIAZEM XC 240MG TAB",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "240MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215743,
    "drug": {
      "current_status": "MARKETED",
      "id": 30354,
      "drug_code": 92405,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261093,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439654",
      "brand_name": "TEVA-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140003"
    },
    "created_date": "2024-01-11T20:31:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439654",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-22T18:30:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BUPROPION XL",
    "en_drug_common_name": "BUPROPION XL 150MG SR TAB",
    "fr_drug_brand_name": "TEVA-BUPROPION XL 150MG SR TAB",
    "fr_drug_common_name": "BUPROPION XL 150MG SR TAB",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215746,
    "drug": {
      "current_status": "MARKETED",
      "id": 30356,
      "drug_code": 92406,
      "updated_date": "2025-12-03T00:32:47-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261094,
          "ingredient": {
            "id": 2566,
            "ingredient_code": 11772,
            "en_name": "BUPROPION HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupropion"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439662",
      "brand_name": "TEVA-BUPROPION XL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131140004"
    },
    "created_date": "2024-01-11T20:32:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439662",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-22T18:30:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-BUPROPION XL",
    "en_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "fr_drug_brand_name": "TEVA-BUPROPION XL 300MG SR TAB",
    "fr_drug_common_name": "BUPROPION XL 300MG SR TAB",
    "en_ingredients": "BUPROPION HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupropion",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215751,
    "drug": {
      "current_status": "MARKETED",
      "id": 64614,
      "drug_code": 94374,
      "updated_date": "2025-05-15T02:35:29-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262060,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456753",
      "brand_name": "TEVA-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2024-01-11T20:53:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456753",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-11-20T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T17:51:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DULOXETINE",
    "en_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "fr_drug_brand_name": "TEVA-DULOXETINE HCL 30MG CAPS",
    "fr_drug_common_name": "DULOXETINE HCL 30MG CAPS",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLIST",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215754,
    "drug": {
      "current_status": "MARKETED",
      "id": 66087,
      "drug_code": 95113,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262461,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463229",
      "brand_name": "TEVA-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2024-01-11T20:55:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463229",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01EG",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-18T18:44:13-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "TEVA-EVEROLIMUS",
    "en_drug_common_name": "TEVA-EVEROLIMUS 2.5MG TABS",
    "fr_drug_brand_name": "TEVA-EVEROLIMUS 2.5MG TABS",
    "fr_drug_common_name": "EVEROLIMUS 2.5MG TABS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215757,
    "drug": {
      "current_status": "MARKETED",
      "id": 55822,
      "drug_code": 95215,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262504,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8262503,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464039",
      "brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0248401003"
    },
    "created_date": "2024-01-11T20:56:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464039",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-19T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PERINDOPRIL/INDAPAMIDE",
    "en_drug_common_name": "PERIN/INDA 8MG/2.5MG TABS",
    "fr_drug_brand_name": "TEVA-PERIN/INDA 8MG/2.5MG TABS",
    "fr_drug_common_name": "PERIN/INDA 8MG/2.5MG TABS",
    "en_ingredients": "INDAPAMIDE\r\nPERINDOPRIL ERBUMINE",
    "fr_ingredients": "Indapamide\r\nPérindopril erbumine",
    "drug_strength": "2.5MG\r\n8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215760,
    "drug": {
      "current_status": "MARKETED",
      "id": 59733,
      "drug_code": 96662,
      "updated_date": "2025-05-15T02:36:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263262,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02475863",
      "brand_name": "TEVA-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732002"
    },
    "created_date": "2024-01-11T20:57:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475863",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2024-07-31T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-01T18:44:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-MOMETASONE",
    "en_drug_common_name": "MOMETASONE FURO SPRAY 50MCG",
    "fr_drug_brand_name": "TEVA-MOMETASONE FURO SPRAY 50MCG",
    "fr_drug_common_name": "MOMETASONE FURO SPRAY 50MCG",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "18gm",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215772,
    "drug": {
      "current_status": "MARKETED",
      "id": 2584,
      "drug_code": 16179,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8252096,
          "ingredient": {
            "id": 1236,
            "ingredient_code": 521,
            "en_name": "IOPROMIDE",
            "fr_name": "Iopromide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "62",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02078600",
      "brand_name": "ULTRAVIST 300",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77966",
      "number_of_ais": "1",
      "ai_group_no": "0125805002"
    },
    "created_date": "2024-01-12T14:44:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02078600",
    "company_name": "BAYER INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-15T00:00:00-05:00",
    "estimated_end_date": "2024-06-26T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-03T18:02:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ULTRAVIST 300",
    "en_drug_common_name": "IOPROMIDE",
    "fr_drug_brand_name": "ULTRAVIST 300",
    "fr_drug_common_name": "Iopromide",
    "en_ingredients": "IOPROMIDE",
    "fr_ingredients": "Iopromide",
    "drug_strength": "62%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Intravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "150mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215779,
    "drug": {
      "current_status": "MARKETED",
      "id": 2586,
      "drug_code": 16180,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8252097,
          "ingredient": {
            "id": 1236,
            "ingredient_code": 521,
            "en_name": "IOPROMIDE",
            "fr_name": "Iopromide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "77",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02078619",
      "brand_name": "ULTRAVIST 370",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77967",
      "number_of_ais": "1",
      "ai_group_no": "0125805003"
    },
    "created_date": "2024-01-12T14:46:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02078619",
    "company_name": "BAYER INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-15T00:00:00-05:00",
    "estimated_end_date": "2024-08-30T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-21T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ULTRAVIST 370",
    "en_drug_common_name": "IOPROMIDE",
    "fr_drug_brand_name": "ULTRAVIST 370",
    "fr_drug_common_name": "Iopromide",
    "en_ingredients": "IOPROMIDE",
    "fr_ingredients": "Iopromide",
    "drug_strength": "77%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Intravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215787,
    "drug": {
      "current_status": "MARKETED",
      "id": 2586,
      "drug_code": 16180,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8252097,
          "ingredient": {
            "id": 1236,
            "ingredient_code": 521,
            "en_name": "IOPROMIDE",
            "fr_name": "Iopromide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "77",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02078619",
      "brand_name": "ULTRAVIST 370",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77967",
      "number_of_ais": "1",
      "ai_group_no": "0125805003"
    },
    "created_date": "2024-01-12T14:51:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02078619",
    "company_name": "BAYER INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-15T00:00:00-05:00",
    "estimated_end_date": "2024-04-26T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-06T15:28:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ULTRAVIST 370",
    "en_drug_common_name": "IOPROMIDE",
    "fr_drug_brand_name": "ULTRAVIST 370",
    "fr_drug_common_name": "Iopromide",
    "en_ingredients": "IOPROMIDE",
    "fr_ingredients": "Iopromide",
    "drug_strength": "77%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Intravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "100mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215790,
    "drug": {
      "current_status": "MARKETED",
      "id": 2586,
      "drug_code": 16180,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8252097,
          "ingredient": {
            "id": 1236,
            "ingredient_code": 521,
            "en_name": "IOPROMIDE",
            "fr_name": "Iopromide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "77",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02078619",
      "brand_name": "ULTRAVIST 370",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77967",
      "number_of_ais": "1",
      "ai_group_no": "0125805003"
    },
    "created_date": "2024-01-12T14:55:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02078619",
    "company_name": "BAYER INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-15T00:00:00-05:00",
    "estimated_end_date": "2024-04-02T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-14T15:02:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ULTRAVIST 370",
    "en_drug_common_name": "IOPROMIDE",
    "fr_drug_brand_name": "ULTRAVIST 370",
    "fr_drug_common_name": "Iopromide",
    "en_ingredients": "IOPROMIDE",
    "fr_ingredients": "Iopromide",
    "drug_strength": "77%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Intravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215793,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1386,
      "drug_code": 12997,
      "updated_date": "2025-12-03T01:06:00-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8290841,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926861",
      "brand_name": "FLAGYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74248",
      "number_of_ais": "1",
      "ai_group_no": "0102572004"
    },
    "created_date": "2024-01-12T15:26:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01926861",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G01AF",
    "atc_description": "ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",
    "estimated_end_date": "2024-06-21T00:00:00-04:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-06-04T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy.",
    "fr_comments": "Retard d’approvisionnement. La date de disponibilité représente la disponibilité estimée dans l'entrepôt principal de Sanofi. Les dates de disponibilité dans l’entrepôt distributeur habituel d’un client peuvent varier. Les pharmacies sont invitées à communiquer avec leur distributeur préféré pour obtenir la date de disponibilité du produit. Les patients doivent valider la disponibilité du produit auprès de leur pharmacie respective.",
    "en_drug_brand_name": "FLAGYL",
    "en_drug_common_name": "Flagyl",
    "fr_drug_brand_name": "FLAGYL",
    "fr_drug_common_name": "Flagyl",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "10%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "VAGINAL\r\nVAGINAL",
    "drug_route_fr": "Vaginale\r\nVaginale",
    "drug_package_quantity": "60g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215796,
    "drug": {
      "current_status": "MARKETED",
      "id": 1156,
      "drug_code": 12654,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8251654,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251653,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926829",
      "brand_name": "FLAGYSTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73821",
      "number_of_ais": "2",
      "ai_group_no": "0202573001"
    },
    "created_date": "2024-01-12T15:37:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01926829",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "G01AA",
    "atc_description": "ANTIINFECTIVES/ANTISEPT.,EXCL COMB WITH CORTICOST.",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-01-30T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy",
    "fr_comments": "Retard d’approvisionnement. La date de disponibilité représente la disponibilité estimée dans l'entrepôt principal de Sanofi. Les dates de disponibilité dans l’entrepôt distributeur habituel d’un client peuvent varier. Les pharmacies sont invitées à communiquer avec leur distributeur préféré pour obtenir la date de disponibilité du produit. Les patients doivent valider la disponibilité du produit auprès de leur pharmacie respective",
    "en_drug_brand_name": "FLAGYSTATIN",
    "en_drug_common_name": "Flagystatin Ovules",
    "fr_drug_brand_name": "Flagystatin Ovules",
    "fr_drug_common_name": "Flagystatin Ovules",
    "en_ingredients": "NYSTATIN\r\nMETRONIDAZOLE",
    "fr_ingredients": "Nystatine\r\nMétronidazole",
    "drug_strength": "100000UNIT\r\n500MG",
    "drug_dosage_form": "OVULE\r\nSUPPOSITORY",
    "drug_dosage_form_fr": "Ovule\r\nSuppositoire",
    "drug_route": "VAGINAL\r\nVAGINAL",
    "drug_route_fr": "Vaginale\r\nVaginale",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215839,
    "drug": {
      "current_status": "MARKETED",
      "id": 27972,
      "drug_code": 90167,
      "updated_date": "2025-05-15T02:34:09-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8260167,
          "ingredient": {
            "id": 3924,
            "ingredient_code": 22177,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN",
            "fr_name": "Protéine NadA recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260166,
          "ingredient": {
            "id": 3926,
            "ingredient_code": 22178,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN",
            "fr_name": "Protéine fHBP hybride recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260165,
          "ingredient": {
            "id": 3922,
            "ingredient_code": 22176,
            "en_name": "RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN",
            "fr_name": "Protéine NHBA hybride recombinante de Neisseria meningitidis du sérogroupe B"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8260164,
          "ingredient": {
            "id": 3928,
            "ingredient_code": 22179,
            "en_name": "OUTER MEMBRANE VESICLES",
            "fr_name": "Vésicules de membrane externe (Neisseria meningitidis group B souche NZ98/254)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02417030",
      "brand_name": "BEXSERO",
      "brand_name_fr": "",
      "descriptor": "MULTICOMPONENT MENINGOC. B VACCINE (R-DNA ADSORBED). 0.5ML PFS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0455051001"
    },
    "created_date": "2024-01-12T19:56:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417030",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07AH",
    "atc_description": "BACTERIAL VACCINES",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-10T00:00:00-05:00",
    "actual_end_date": "2024-02-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-10T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Supply available for public programs. Supply unavailable in the private market. Available in packs of 1.",
    "fr_comments": "Approvisionnement possible pour les programmes publics. Approvisionnement impossible pour le marché privé. Disponible en emballage de 1.",
    "en_drug_brand_name": "BEXSERO",
    "en_drug_common_name": "Multicomponent Meningococcal B Vaccine (recombinant, adsorbed)",
    "fr_drug_brand_name": "BEXSERO",
    "fr_drug_common_name": "Vaccin à constituants multiples contre le méningocoque B (recombinant, adsorbé)",
    "en_ingredients": "OUTER MEMBRANE VESICLES\r\nRECOMBINANT NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN\r\nRECOMBINANT NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN\r\nRECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN",
    "fr_ingredients": "Vésicules de membrane externe (Neisseria meningitidis group B souche NZ98/254)\r\nProtéine fHBP hybride recombinante de Neisseria meningitidis du sérogroupe B\r\nProtéine NadA recombinante de Neisseria meningitidis du sérogroupe B\r\nProtéine NHBA hybride recombinante de Neisseria meningitidis du sérogroupe B",
    "drug_strength": "25MCG\r\n50MCG\r\n50MCG\r\n50MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "10s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215855,
    "drug": {
      "current_status": "MARKETED",
      "id": 15160,
      "drug_code": 75626,
      "updated_date": "2025-05-15T02:31:41-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255404,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02270889",
      "brand_name": "RIVA-ALENDRONATE FC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2024-01-12T21:26:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02270889",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-18T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-ALENDRONATE",
    "en_drug_common_name": "Riva-Alendronate 70mg",
    "fr_drug_brand_name": "Riva-Alendronate 70mg",
    "fr_drug_common_name": "Riva-Alendronate 70mg",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronic Acid",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215859,
    "drug": {
      "current_status": "MARKETED",
      "id": 25272,
      "drug_code": 87753,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259160,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392259",
      "brand_name": "RIVA-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-12T21:29:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392259",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-18T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-ANASTROZOLE",
    "en_drug_common_name": "Riva-Anastrozole 1mg",
    "fr_drug_brand_name": "Riva-Anastrozole",
    "fr_drug_common_name": "Riva-Anastrozole 1mg",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215862,
    "drug": {
      "current_status": "MARKETED",
      "id": 25970,
      "drug_code": 88359,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259365,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398656",
      "brand_name": "RIVA-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-12T21:31:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398656",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-18T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-LETROZOLE",
    "en_drug_common_name": "Riva-Letrozole",
    "fr_drug_brand_name": "Riva-Letrozole",
    "fr_drug_common_name": "Riva-Letrozole 2.5mg",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215865,
    "drug": {
      "current_status": "MARKETED",
      "id": 100621,
      "drug_code": 98980,
      "updated_date": "2020-07-07T01:50:59-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265210,
          "ingredient": {
            "id": 3162,
            "ingredient_code": 13352,
            "en_name": "CINACALCET",
            "fr_name": "Cinacalcet (Chlorhydrate de cinacalcet)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02500094",
      "brand_name": "JAMP CINACALCET TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150282001"
    },
    "created_date": "2024-01-12T21:52:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02500094",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "H05BX",
    "atc_description": "ANTI-PARATHYROID HORMONES",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP CINACALCET TABLETS",
    "en_drug_common_name": "Cinacalcet Tablets",
    "fr_drug_brand_name": "JAMP Cinacalcet Tablets",
    "fr_drug_common_name": "Comprimés de Cinacalcet",
    "en_ingredients": "CINACALCET",
    "fr_ingredients": "Cinacalcet (Chlorhydrate de cinacalcet)",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215880,
    "drug": {
      "current_status": "MARKETED",
      "id": 21812,
      "drug_code": 84196,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257790,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356848",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2024-01-12T21:59:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356848",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2026-01-09T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-31T20:44:09-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol Tartrate Tablets USP",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "Comprimés de tartrate de métoprolol USP",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215883,
    "drug": {
      "current_status": "MARKETED",
      "id": 21812,
      "drug_code": 84196,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257790,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356848",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2024-01-12T22:01:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356848",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2026-01-09T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-31T20:46:03-05:00",
    "status": "active_confirmed",
    "en_comments": "Bottle 100 is no longer available.",
    "fr_comments": "Bouteille de 100 n'est plus offerte.",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol Tartrate Tablets USP",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "Comprimés de tartrate de métoprolol USP",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215886,
    "drug": {
      "current_status": "MARKETED",
      "id": 21810,
      "drug_code": 84195,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257789,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356821",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2024-01-12T22:04:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356821",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2025-09-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-09-22T21:07:09-04:00",
    "status": "resolved",
    "en_comments": "Bottle 100 is no longer available.",
    "fr_comments": "Bouteille de 100 n'est plus offerte.",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol Tartrate Tablets USP",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "Comprimés de tartrate de métoprolol USP",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215889,
    "drug": {
      "current_status": "MARKETED",
      "id": 21810,
      "drug_code": 84195,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257789,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356821",
      "brand_name": "JAMP-METOPROLOL-L",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111923002"
    },
    "created_date": "2024-01-12T22:08:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356821",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2026-01-09T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-31T20:46:49-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-METOPROLOL-L",
    "en_drug_common_name": "Metoprolol Tartrate Tablets USP",
    "fr_drug_brand_name": "JAMP-METOPROLOL-L",
    "fr_drug_common_name": "Comprimés de tartrate de métoprolol USP",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215952,
    "drug": {
      "current_status": "DORMANT",
      "id": 12994,
      "drug_code": 72246,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367645,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247936",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2024-01-12T22:59:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247936",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-12T22:59:43-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215955,
    "drug": {
      "current_status": "MARKETED",
      "id": 12992,
      "drug_code": 72245,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254746,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247935",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683005"
    },
    "created_date": "2024-01-12T23:01:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247935",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2025-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-01T05:00:02-04:00",
    "status": "active_confirmed",
    "en_comments": "To be discontinued upon inventory depletion",
    "fr_comments": "À cesser en cas d'épuisement des stocks",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215958,
    "drug": {
      "current_status": "MARKETED",
      "id": 12988,
      "drug_code": 72243,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254744,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247933",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683003"
    },
    "created_date": "2024-01-12T23:03:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247933",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2024-12-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-14T06:00:02-05:00",
    "status": "active_confirmed",
    "en_comments": "To be discontinued upon inventory depletion",
    "fr_comments": "À cesser en cas d'épuisement des stocks",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "3.125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215961,
    "drug": {
      "current_status": "MARKETED",
      "id": 12990,
      "drug_code": 72244,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254745,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247934",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2024-01-12T23:04:45-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247934",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2024-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-02T06:00:05-05:00",
    "status": "active_confirmed",
    "en_comments": "To be discontinued upon inventory depletion",
    "fr_comments": "À cesser en cas d'épuisement des stocks",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215964,
    "drug": {
      "current_status": "MARKETED",
      "id": 62326,
      "drug_code": 93081,
      "updated_date": "2025-12-03T00:32:54-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261429,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445530",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310005"
    },
    "created_date": "2024-01-12T23:06:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445530",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2024-03-01T00:00:00-05:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-02-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-01T15:47:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "DEXA,MPHETAMINE",
    "fr_drug_brand_name": "APO-AMPHETAMINE XR",
    "fr_drug_common_name": "DEXAMPHETAMINE",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Dexamphetamine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215967,
    "drug": {
      "current_status": "MARKETED",
      "id": 8456,
      "drug_code": 5917,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250847,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00585114",
      "brand_name": "APO-IBUPROFEN TAB 600MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61771",
      "number_of_ais": "1",
      "ai_group_no": "0108883003"
    },
    "created_date": "2024-01-12T23:08:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00585114",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2024-04-05T00:00:00-04:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-29T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-IBUPROFEN TAB 600MG",
    "en_drug_common_name": "IBUPROFEN",
    "fr_drug_brand_name": "APO-IBUPROFEN",
    "fr_drug_common_name": "IBUPROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215970,
    "drug": {
      "current_status": "MARKETED",
      "id": 25966,
      "drug_code": 88354,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259364,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02398591",
      "brand_name": "APO-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440002"
    },
    "created_date": "2024-01-12T23:10:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398591",
    "company_name": "APOTEX INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-15T14:32:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "APO-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "Clopidogrel",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215973,
    "drug": {
      "current_status": "MARKETED",
      "id": 18880,
      "drug_code": 80137,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256595,
          "ingredient": {
            "id": 2958,
            "ingredient_code": 12699,
            "en_name": "ALFUZOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'alfuzosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315866",
      "brand_name": "APO-ALFUZOSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146806001"
    },
    "created_date": "2024-01-12T23:11:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315866",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-22T14:54:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALFUZOSIN",
    "en_drug_common_name": "ALFUZOSIN",
    "fr_drug_brand_name": "APO-ALFUZOSIN",
    "fr_drug_common_name": "ALFUZOSIN",
    "en_ingredients": "ALFUZOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'alfuzosine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215976,
    "drug": {
      "current_status": "MARKETED",
      "id": 3490,
      "drug_code": 18779,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252382,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02167794",
      "brand_name": "APO-SOTALOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81053",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2024-01-12T23:12:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02167794",
    "company_name": "APOTEX INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-19T21:23:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SOTALOL",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "APO-SOTALOL",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215979,
    "drug": {
      "current_status": "MARKETED",
      "id": 20620,
      "drug_code": 82363,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257288,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337983",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2024-01-12T23:13:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337983",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-09T20:52:35-05:00",
    "status": "resolved",
    "en_comments": "30 BLS available",
    "fr_comments": "30 BLS disponible",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatin",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 215982,
    "drug": {
      "current_status": "MARKETED",
      "id": 49971,
      "drug_code": 94276,
      "updated_date": "2025-05-15T02:35:25-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261980,
          "ingredient": {
            "id": 2808,
            "ingredient_code": 12006,
            "en_name": "CABERGOLINE",
            "fr_name": "Cabergoline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02455897",
      "brand_name": "APO-CABERGOLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141281001"
    },
    "created_date": "2024-01-12T23:15:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02455897",
    "company_name": "APOTEX INC",
    "atc_number": "G02CB",
    "atc_description": "OTHER GYNECOLOGICALS",
    "estimated_end_date": "2024-10-18T00:00:00-04:00",
    "actual_start_date": "2024-05-28T00:00:00-04:00",
    "actual_end_date": "2024-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-10-10T16:34:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CABERGOLINE",
    "en_drug_common_name": "CABERGOLINE",
    "fr_drug_brand_name": "APO-CABERGOLINE",
    "fr_drug_common_name": "CABERGOLINE",
    "en_ingredients": "CABERGOLINE",
    "fr_ingredients": "Cabergoline",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "8 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216012,
    "drug": {
      "current_status": "MARKETED",
      "id": 102695,
      "drug_code": 101324,
      "updated_date": "2022-02-08T06:13:02-05:00",
      "company": {
        "id": 1640,
        "created_date": "2017-03-09T13:25:01-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 14907,
        "mfr_code": "",
        "name": "MARCAN PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2 GURDWARA RD., SUITE 400",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OTTAWA",
        "postal_code": "K2E 1A2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266891,
          "ingredient": {
            "id": 270,
            "ingredient_code": 2564,
            "en_name": "CLONIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de clonidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02524198",
      "brand_name": "MAR-CLONIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108891003"
    },
    "created_date": "2024-01-15T15:29:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02524198",
    "company_name": "MARCAN PHARMACEUTICALS INC",
    "atc_number": "C02AC",
    "atc_description": "ANTIADRENERGIC AGENTS, CENTRALLY ACTING",
    "anticipated_start_date": "2024-02-01T00:00:00-05:00",
    "estimated_end_date": "2024-03-31T00:00:00-04:00",
    "actual_end_date": "2024-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MAR-CLONIDINE",
    "en_drug_common_name": "CLONIDINE",
    "fr_drug_brand_name": "TEVA-CLONIDINE",
    "fr_drug_common_name": "CLONIDINE",
    "en_ingredients": "CLONIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clonidine",
    "drug_strength": "0.025MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216017,
    "drug": {
      "current_status": "DORMANT",
      "id": 100979,
      "drug_code": 99434,
      "updated_date": "2020-10-02T23:55:47-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8369766,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02504979",
      "brand_name": "BUPIVACAINE HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE BUPIVACAÏNE INJECTABLE, USP",
      "descriptor": "PRESERVATIVE-FREE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108896002"
    },
    "created_date": "2024-01-15T16:11:37-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02504979",
    "company_name": "STERIMAX INC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "discontinuation_date": "2024-05-31T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Current inventory expires on May 31, 2024.",
    "fr_discontinuation_comments": "Inventaire courant expire le 31 mai 2024.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-06-01T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "BUPIVACAINE HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "BUPIVACAINE HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "CHLORHYDRATE DE BUPIVACAINE DANS DU DEXTROSE INJECTABLE USP",
    "fr_drug_common_name": "CHLORHYDRATE DE BUPIVACAINE DANS DU DEXTROSE INJECTABLE USP",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "RETROBULBAR\r\nEPIDURAL",
    "drug_route_fr": "Rétrobulbaire\r\nÉpidurale",
    "drug_package_quantity": "10 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216024,
    "drug": {
      "current_status": "MARKETED",
      "id": 99182,
      "drug_code": 95428,
      "updated_date": "2020-04-03T06:53:27-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262598,
          "ingredient": {
            "id": 1368,
            "ingredient_code": 1988,
            "en_name": "TRANEXAMIC ACID",
            "fr_name": "Acide tranexamique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02466015",
      "brand_name": "TRANEXAMIC ACID INJECTION",
      "brand_name_fr": "",
      "descriptor": "AMPOULES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114760002"
    },
    "created_date": "2024-01-15T17:00:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02466015",
    "company_name": "AURO PHARMA INC",
    "atc_number": "B02AA",
    "atc_description": "ANTIFIBRINOLYTICS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-15T00:00:00-05:00",
    "actual_end_date": "2024-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-04-30T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Please be informed alternative pack size (Tranexamic Acid Injection 1000Mg/10Ml ()-10Ml Ampoule)  is available.",
    "en_drug_brand_name": "TRANEXAMIC ACID INJECTION",
    "en_drug_common_name": "TRANEXAMIC ACID INJECTION",
    "fr_drug_brand_name": "Tranexamic Acid Injection",
    "fr_drug_common_name": "Tranexamic Acid Injection",
    "en_ingredients": "TRANEXAMIC ACID",
    "fr_ingredients": "Acide tranexamique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216031,
    "drug": {
      "current_status": "MARKETED",
      "id": 17144,
      "drug_code": 78176,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256049,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02296446",
      "brand_name": "SANDOZ OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-15T17:53:25-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02296446",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "discontinuation_date": "2024-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-15T17:53:47-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE SDZ",
    "fr_drug_brand_name": "SANDOZ OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE SDZ",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500GRC BO",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216046,
    "drug": {
      "current_status": "MARKETED",
      "id": 20838,
      "drug_code": 8275,
      "updated_date": "2025-05-15T02:30:41-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8251077,
          "ingredient": {
            "id": 3628,
            "ingredient_code": 6212,
            "en_name": "SODIUM TETRADECYL SULFATE",
            "fr_name": "Tétradécyl sulfate de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00511234",
      "brand_name": "TROMBOJECT 1%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66606",
      "number_of_ais": "1",
      "ai_group_no": "0107541001"
    },
    "created_date": "2024-01-15T20:20:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511234",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "C05BB",
    "atc_description": "ANTIVARICOSE THERAPY",
    "estimated_end_date": "2024-04-07T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-11T19:31:43-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TROMBOJECT 1%",
    "en_drug_common_name": "Sodium Tetradecyl Sulfate Injection",
    "fr_drug_brand_name": "Tromboject 1%",
    "fr_drug_common_name": "Injection De Tétradécyl Sulfate De Sodium",
    "en_ingredients": "SODIUM TETRADECYL SULFATE",
    "fr_ingredients": "Tétradécyl sulfate de sodium",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 2mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216049,
    "drug": {
      "current_status": "MARKETED",
      "id": 4034,
      "drug_code": 19729,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8252565,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02194333",
      "brand_name": "TEGRETOL SUSPENSION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82025",
      "number_of_ais": "1",
      "ai_group_no": "0108674002"
    },
    "created_date": "2024-01-15T20:52:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194333",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2023-10-16T00:00:00-04:00",
    "estimated_end_date": "2024-02-26T00:00:00-05:00",
    "actual_start_date": "2023-10-17T00:00:00-04:00",
    "actual_end_date": "2024-02-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-22T11:54:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEGRETOL SUSPENSION",
    "en_drug_common_name": "TEGRETOL SUSPENSION 100MG/5ML 450 ML",
    "fr_drug_brand_name": "TEGRETOL SUSPENSION",
    "fr_drug_common_name": "TEGRETOL SUSPENSIO 100MG/5ML 450ML",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "100MG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "450 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216058,
    "drug": {
      "current_status": "MARKETED",
      "id": 56830,
      "drug_code": 96563,
      "updated_date": "2025-05-15T02:36:27-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263213,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475278",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2024-01-15T22:06:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475278",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-15T22:06:50-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil 5mg",
    "fr_drug_brand_name": "Donepezil",
    "fr_drug_common_name": "Donepezil 5mg",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216061,
    "drug": {
      "current_status": "MARKETED",
      "id": 56832,
      "drug_code": 96564,
      "updated_date": "2025-05-15T02:36:27-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263214,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475286",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2024-01-15T22:08:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475286",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-18T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil 10mg",
    "fr_drug_brand_name": "Donepezi",
    "fr_drug_common_name": "Donepezil 10mg",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216064,
    "drug": {
      "current_status": "MARKETED",
      "id": 31766,
      "drug_code": 94182,
      "updated_date": "2025-05-15T02:35:23-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261951,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02455013",
      "brand_name": "RIVA-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2024-01-15T22:10:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02455013",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2024-01-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-01-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-18T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-FINASTERIDE",
    "en_drug_common_name": "Riva-Finasteride 5mg",
    "fr_drug_brand_name": "RIVA-FINASTERIDE",
    "fr_drug_common_name": "RIVA-FINASTERIDE 5mg",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 & 100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216069,
    "drug": {
      "current_status": "MARKETED",
      "id": 8884,
      "drug_code": 61149,
      "updated_date": "2025-12-03T00:30:40-05:00",
      "company": {
        "id": 272,
        "created_date": "2017-03-09T13:22:39-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12428,
        "mfr_code": "",
        "name": "SANOFI PASTEUR LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "Customer Service/Service à la clientèle: 1-800-268-4171\r\nVaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146"
      },
      "drug_ingredients": [
        {
          "id": 8253543,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02237792",
      "brand_name": "AVAXIM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0165325002"
    },
    "created_date": "2024-01-15T23:36:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237792",
    "company_name": "SANOFI PASTEUR LIMITED",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "anticipated_start_date": "2024-01-19T00:00:00-05:00",
    "estimated_end_date": "2024-07-12T00:00:00-04:00",
    "actual_start_date": "2024-01-22T00:00:00-05:00",
    "actual_end_date": "2024-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-06-28T14:50:14-04:00",
    "status": "resolved",
    "en_comments": "Low stock - product available under allocation",
    "fr_comments": "Stock faible - produit disponible sous allocation",
    "en_drug_brand_name": "AVAXIM",
    "en_drug_common_name": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_drug_brand_name": "AVAXIM®",
    "fr_drug_common_name": "Vaccin inactivé contre l’hépatite A Virus",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "160UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 x 0.5 mL (single dose) syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216097,
    "drug": {
      "current_status": "MARKETED",
      "id": 2570,
      "drug_code": 16164,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252093,
          "ingredient": {
            "id": 1228,
            "ingredient_code": 2493,
            "en_name": "BUPIVACAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de bupivacaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01976168",
      "brand_name": "SENSORCAINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77950",
      "number_of_ais": "1",
      "ai_group_no": "0108896004"
    },
    "created_date": "2024-01-16T16:31:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976168",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2024-02-26T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "VR89888CA1\tSENSORCAINE 5MG/ML LIQ AMP 50X10ML CA AS",
    "en_drug_brand_name": "SENSORCAINE",
    "en_drug_common_name": "bupivacaine HCI 0.5% Plain 50x10mL Plain SU Polyamp® Duofit®",
    "fr_drug_brand_name": "Sensorcaine®",
    "fr_drug_common_name": "bupivacaine HCI 0.5% Plain 50x10mL Plain SU Polyamp® Duofit®",
    "en_ingredients": "BUPIVACAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de bupivacaïne",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "EPIDURAL\r\nBLOCK/INFILTRATION\r\nEPIDURAL\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Épidurale\r\nBloc/Infiltration\r\nÉpidurale\r\nBloc/Infiltration",
    "drug_package_quantity": "50 PE Polyamp",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216108,
    "drug": {
      "current_status": "MARKETED",
      "id": 5272,
      "drug_code": 3396,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250509,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402249",
      "brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54173",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2024-01-16T18:25:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402249",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2024-02-13T00:00:00-05:00",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_start_date": "2024-02-13T00:00:00-05:00",
    "actual_end_date": "2024-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-27T16:14:37-04:00",
    "status": "resolved",
    "en_comments": "Product not available at Omega Guelph warehouse. Product available at CPDN Calgary.",
    "fr_comments": "Le produit n’est pas disponible à l’entrepôt d’Omega à Guelph. Produit disponible chez CPDN Calgary.",
    "en_drug_brand_name": "SODIUM CHLORIDE BACTERIOSTATIC INJ",
    "en_drug_common_name": "Sodium Chloride Bacteriostatic For Injection USP",
    "fr_drug_brand_name": "Bacteriostatic Sodium Chloride for Injection USP",
    "fr_drug_common_name": "Chlorure De Sodium Bactériostatique Pour Injection USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 30mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216127,
    "drug": {
      "id": 11200,
      "drug_code": 6754,
      "updated_date": "2025-12-03T00:30:23-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250937,
          "ingredient": {
            "id": 142,
            "ingredient_code": 9117,
            "en_name": "MORPHINE SULFATE",
            "fr_name": "Sulfate de morphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00594644",
      "brand_name": "STATEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63971",
      "number_of_ais": "1",
      "ai_group_no": "0104545001"
    },
    "created_date": "2024-01-16T21:07:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00594644",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2024-03-25T00:00:00-04:00",
    "actual_start_date": "2024-01-09T00:00:00-05:00",
    "actual_end_date": "2024-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-28T12:17:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "STATEX TAB 10MG",
    "en_drug_common_name": "Statex 10mg",
    "fr_drug_brand_name": "STATEX Tabs 10mg",
    "fr_drug_common_name": "Statex 10mg Tabs",
    "en_ingredients": "MORPHINE SULFATE",
    "fr_ingredients": "Sulfate de morphine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216132,
    "drug": {
      "current_status": "MARKETED",
      "id": 65341,
      "drug_code": 81497,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257088,
          "ingredient": {
            "id": 28205,
            "ingredient_code": 20491,
            "en_name": "INDIUM IN 111 CHLORIDE",
            "fr_name": "Chlorure d'indium IN 111"
          },
          "ingredient_supplied_ind": "I",
          "strength": "111",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8257087,
          "ingredient": {
            "id": 29107,
            "ingredient_code": 13195,
            "en_name": "PENTETREOTIDE",
            "fr_name": "Pentétréotide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02329271",
      "brand_name": "OCTREOSCAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252623001"
    },
    "created_date": "2024-01-16T21:58:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02329271",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09IB",
    "anticipated_start_date": "2024-01-28T00:00:00-05:00",
    "actual_end_date": "2024-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2024-03-07T19:04:51-05:00",
    "status": "resolved",
    "en_comments": "Curium foresee a run out of one material used in the fabrication and qualifying a new compliant material will require a submission.",
    "fr_comments": "Curium prévoit la pénurie d'une matière utilisée dans la fabrication et la qualification d'un nouveau matériel nécessitera une soumission.",
    "en_drug_brand_name": "OCTREOSCAN",
    "en_drug_common_name": "Kit for the preparation of Indium In 111 Pentetreotide",
    "fr_drug_brand_name": "Octreoscan",
    "fr_drug_common_name": "Trousse pour la préparation d’Indium In 111 pentétréotide",
    "en_ingredients": "PENTETREOTIDE\r\nINDIUM IN 111 CHLORIDE",
    "fr_ingredients": "chlorure d'indium et pentetreotide",
    "drug_strength": "10MCG\r\n111MBq",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT\r\nSOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ml vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216164,
    "drug": {
      "current_status": "MARKETED",
      "id": 101134,
      "drug_code": 99623,
      "updated_date": "2020-11-09T00:55:07-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8265718,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        },
        {
          "id": 8265717,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02506882",
      "brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250083001"
    },
    "created_date": "2024-01-16T22:17:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02506882",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S02CA",
    "atc_description": "CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-31T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "en_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_brand_name": "SANDOZ CIPROFLOXACIN / DEXAMETHASONE",
    "fr_drug_common_name": "CIPROFLOXACIN / DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE\r\nCIPROFLOXACIN",
    "fr_ingredients": "Dexaméthasone\r\nCiprofloxacine",
    "drug_strength": "0.1%\r\n0.3%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OTIC",
    "drug_route_fr": "Otique",
    "drug_package_quantity": "7.5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216168,
    "drug": {
      "current_status": "MARKETED",
      "id": 103921,
      "drug_code": 100804,
      "updated_date": "2023-06-19T22:00:41-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266478,
          "ingredient": {
            "id": 4026,
            "ingredient_code": 22549,
            "en_name": "DAPAGLIFLOZIN",
            "fr_name": "Dapagliflozine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02518740",
      "brand_name": "SANDOZ DAPAGLIFLOZIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0156370002"
    },
    "created_date": "2024-01-16T22:19:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02518740",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BK",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DAPAGLIFLOZIN",
    "en_drug_common_name": "DAPAGLIFLOZIN",
    "fr_drug_brand_name": "SANDOZ DAPAGLIFLOZIN",
    "fr_drug_common_name": "DAPAGLIFLOZIN",
    "en_ingredients": "DAPAGLIFLOZIN",
    "fr_ingredients": "DAPAGLIFLOZIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216171,
    "drug": {
      "current_status": "MARKETED",
      "id": 102369,
      "drug_code": 100300,
      "updated_date": "2021-11-08T05:00:22-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8266175,
          "ingredient": {
            "id": 3848,
            "ingredient_code": 22048,
            "en_name": "DIMETHYL FUMARATE",
            "fr_name": "Fumarate de diméthyle"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02513781",
      "brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154210001"
    },
    "created_date": "2024-01-16T22:21:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02513781",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AX",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-12-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-11T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "en_drug_common_name": "DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "SANDOZ DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "fr_drug_common_name": "DIMETHYL FUMARATE DELAYED-RELEASE CAPSULES",
    "en_ingredients": "DIMETHYL FUMARATE",
    "fr_ingredients": "Fumarate de diméthyle",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "56GRC",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216175,
    "drug": {
      "current_status": "MARKETED",
      "id": 10364,
      "drug_code": 65503,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253919,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253918,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241837",
      "brand_name": "ESTALIS 250/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942006"
    },
    "created_date": "2024-01-16T22:24:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241837",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "estimated_end_date": "2024-04-19T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-24T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 250/50 MCG",
    "en_drug_common_name": "ESTALIS 250/50 MCG",
    "fr_drug_brand_name": "ESTALIS 250/50 MCG",
    "fr_drug_common_name": "ESTALIS 250/50 MCG",
    "en_ingredients": "NORETHINDRONE ACETATE\r\nESTRADIOL",
    "fr_ingredients": "Acétate de noréthindrone\r\nEstradiol",
    "drug_strength": "250MCG\r\n50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTSM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216178,
    "drug": {
      "current_status": "MARKETED",
      "id": 11410,
      "drug_code": 67943,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254254,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02244000",
      "brand_name": "ESTRADOT 50",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457035"
    },
    "created_date": "2024-01-16T22:25:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244000",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTRADOT 50",
    "en_drug_common_name": "ESTRADOT 50",
    "fr_drug_brand_name": "ESTRADOT 50",
    "fr_drug_common_name": "ESTRADOT 50",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216182,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12676,
      "drug_code": 71470,
      "updated_date": "2025-05-15T04:06:47-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8337965,
          "ingredient": {
            "id": 2166,
            "ingredient_code": 1913,
            "en_name": "CICLOPIROX OLAMINE",
            "fr_name": "Ciclopirox olamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247228",
      "brand_name": "STIEPROX SHAMPOO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115999002"
    },
    "created_date": "2024-01-17T00:18:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247228",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D01AE",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "actual_start_date": "2024-01-11T00:00:00-05:00",
    "actual_end_date": "2024-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-23T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "This product has been discontinued.",
    "fr_comments": "Ce produit a été abandonné.",
    "en_drug_brand_name": "STIEPROX SHAMPOO",
    "en_drug_common_name": "ciclopirox olamine shampoo",
    "fr_drug_brand_name": "STIEPROX SHAMPOO",
    "fr_drug_common_name": "ciclopirox olamine shampooing",
    "en_ingredients": "CICLOPIROX OLAMINE",
    "fr_ingredients": "Ciclopirox olamine",
    "drug_strength": "1.5%",
    "drug_dosage_form": "SHAMPOO",
    "drug_dosage_form_fr": "Shampoing",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "150ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216205,
    "drug": {
      "current_status": "MARKETED",
      "id": 16162,
      "drug_code": 76953,
      "updated_date": "2025-12-03T00:31:09-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255765,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283964",
      "brand_name": "SANDOZ LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182001"
    },
    "created_date": "2024-01-17T14:43:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283964",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE",
    "fr_drug_brand_name": "SANDOZ LEFLUNOMIDE",
    "fr_drug_common_name": "LEFLUNOMIDE",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216208,
    "drug": {
      "current_status": "MARKETED",
      "id": 20782,
      "drug_code": 82577,
      "updated_date": "2025-05-15T02:32:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257352,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340208",
      "brand_name": "SANDOZ TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2024-01-17T14:45:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340208",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2024-04-12T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-04-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T12:02:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "SANDOZ TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN CR",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500PRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216222,
    "drug": {
      "current_status": "MARKETED",
      "id": 7992,
      "drug_code": 5196,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250717,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00487872",
      "brand_name": "CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59900",
      "number_of_ais": "1",
      "ai_group_no": "0111925001"
    },
    "created_date": "2024-01-17T15:16:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00487872",
    "company_name": "AA PHARMA INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2024-02-09T00:00:00-05:00",
    "estimated_end_date": "2024-04-22T00:00:00-04:00",
    "actual_end_date": "2024-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-24T14:57:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216225,
    "drug": {
      "current_status": "MARKETED",
      "id": 5842,
      "drug_code": 3991,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250587,
          "ingredient": {
            "id": 2064,
            "ingredient_code": 9558,
            "en_name": "NITRAZEPAM",
            "fr_name": "Nitrazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00511528",
      "brand_name": "MOGADON",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56271",
      "number_of_ais": "1",
      "ai_group_no": "0114345001"
    },
    "created_date": "2024-01-17T15:17:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00511528",
    "company_name": "AA PHARMA INC",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "anticipated_start_date": "2024-02-05T00:00:00-05:00",
    "estimated_end_date": "2024-04-18T00:00:00-04:00",
    "actual_end_date": "2024-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-11T17:51:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MOGADON",
    "en_drug_common_name": "MOGADON",
    "fr_drug_brand_name": "MOGADON",
    "fr_drug_common_name": "MOGADON",
    "en_ingredients": "NITRAZEPAM",
    "fr_ingredients": "Nitrazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216236,
    "drug": {
      "current_status": "MARKETED",
      "id": 12788,
      "drug_code": 71749,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8254669,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02247499",
      "brand_name": "CLIMARA 25",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457033"
    },
    "created_date": "2024-01-17T16:17:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247499",
    "company_name": "BAYER INC",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "anticipated_start_date": "2024-02-09T00:00:00-05:00",
    "estimated_end_date": "2024-06-20T00:00:00-04:00",
    "actual_start_date": "2024-02-07T00:00:00-05:00",
    "actual_end_date": "2024-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-06-03T17:57:30-04:00",
    "status": "resolved",
    "en_comments": "Production Issues.",
    "fr_comments": "Problèmes de Production.",
    "en_drug_brand_name": "CLIMARA 25",
    "en_drug_common_name": "ESTRADIOL",
    "fr_drug_brand_name": "Climara",
    "fr_drug_common_name": "Estradiol",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "4'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216247,
    "drug": {
      "current_status": "MARKETED",
      "id": 61812,
      "drug_code": 97211,
      "updated_date": "2025-05-15T02:36:54-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263638,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02481650",
      "brand_name": "PERINDOPRIL ERBUMINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178003"
    },
    "created_date": "2024-01-17T16:24:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02481650",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2024-02-12T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PERINDOPRIL ERBUMINE",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "PERINDOPRIL",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216254,
    "drug": {
      "current_status": "MARKETED",
      "id": 21498,
      "drug_code": 83876,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257678,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353547",
      "brand_name": "SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2024-01-17T16:36:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353547",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-17T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "800",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216259,
    "drug": {
      "current_status": "MARKETED",
      "id": 21498,
      "drug_code": 83876,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257678,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353547",
      "brand_name": "SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417002"
    },
    "created_date": "2024-01-17T16:39:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353547",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T04:08:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "800",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216264,
    "drug": {
      "current_status": "MARKETED",
      "id": 21494,
      "drug_code": 83874,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257676,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353520",
      "brand_name": "SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417003"
    },
    "created_date": "2024-01-17T16:41:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353520",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-05-17T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-17T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216267,
    "drug": {
      "current_status": "MARKETED",
      "id": 21496,
      "drug_code": 83875,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257677,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353539",
      "brand_name": "SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2024-01-17T16:43:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353539",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-06-24T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-06T18:04:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1400",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216270,
    "drug": {
      "current_status": "MARKETED",
      "id": 25028,
      "drug_code": 87533,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259059,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389851",
      "brand_name": "ACH-TEMOZOLOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781004"
    },
    "created_date": "2024-01-17T16:44:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389851",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "estimated_end_date": "2024-09-20T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-09-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-20T13:18:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-TEMOZOLOMIDE",
    "en_drug_common_name": "TEMOZOLOMIDE",
    "fr_drug_brand_name": "ACH Témozolomide",
    "fr_drug_common_name": "Témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216273,
    "drug": {
      "current_status": "DORMANT",
      "id": 24932,
      "drug_code": 87446,
      "updated_date": "2025-12-03T02:32:31-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368812,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388936",
      "brand_name": "CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2024-01-17T17:06:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388936",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-08-30T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-08-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-15T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "CANDESARTAN",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216276,
    "drug": {
      "current_status": "MARKETED",
      "id": 21480,
      "drug_code": 83855,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257672,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353350",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2024-01-17T17:08:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353350",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-04-12T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-11T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216283,
    "drug": {
      "current_status": "MARKETED",
      "id": 21764,
      "drug_code": 84167,
      "updated_date": "2025-05-15T02:32:48-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257765,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02356538",
      "brand_name": "RABEPRAZOLE EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2024-01-17T17:13:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02356538",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-09-06T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-05T05:00:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RABEPRAZOLE EC",
    "en_drug_common_name": "RABEPRAZOLE EC",
    "fr_drug_brand_name": "RABEPRAZOLE EC",
    "fr_drug_common_name": "RABEPRAZOLE EC",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216290,
    "drug": {
      "current_status": "MARKETED",
      "id": 29140,
      "drug_code": 91164,
      "updated_date": "2025-05-15T02:34:23-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260570,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427117",
      "brand_name": "TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2024-01-17T17:19:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427117",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2024-04-20T00:00:00-04:00",
    "actual_start_date": "2024-01-12T00:00:00-05:00",
    "actual_end_date": "2024-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-05-21T12:02:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN CR",
    "fr_drug_brand_name": "TAMSULOSIN",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216303,
    "drug": {
      "current_status": "MARKETED",
      "id": 61716,
      "drug_code": 81460,
      "updated_date": "2025-05-15T02:32:29-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8257074,
          "ingredient": {
            "id": 1446,
            "ingredient_code": 8910,
            "en_name": "SODIUM THIOSULFATE",
            "fr_name": "Thiosulfate de Sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02328933",
      "brand_name": "TECHNETIUM TC 99M TSC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109248003"
    },
    "created_date": "2024-01-17T18:03:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328933",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V09XX",
    "estimated_end_date": "2024-06-01T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-06-04T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TECHNETIUM TC 99M TSC",
    "en_drug_common_name": "Kit for the Preparation of Technetium Tc 99m Sulfur Colloid Injection",
    "fr_drug_brand_name": "Technétium Tc99m TSC",
    "fr_drug_common_name": "Trousse de préparation de colloïde sulfuré au technétium Tc99m injectable",
    "en_ingredients": "SODIUM THIOSULFATE",
    "fr_ingredients": "Thiosulfate de Sodium",
    "drug_strength": "2MG",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT\r\nSOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse\r\nSolution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nORAL\r\nINTRAVENOUS\r\nINTRAPERITONEAL",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nIntrapéritonéale\r\nOrale\r\nIntraveineuse\r\nIntrapéritonéale",
    "drug_package_quantity": "5 kit package",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216454,
    "drug": {
      "current_status": "MARKETED",
      "id": 17744,
      "drug_code": 78820,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256237,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02302896",
      "brand_name": "ACT PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2024-01-18T16:51:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302896",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2025-01-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-01-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE 45MG TAB",
    "fr_drug_brand_name": "ACT-PIOGLITAZONE 45MG TAB",
    "fr_drug_common_name": "PIOGLITAZONE 45MG TAB",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216457,
    "drug": {
      "current_status": "MARKETED",
      "id": 8374,
      "drug_code": 5778,
      "updated_date": "2025-05-15T02:30:35-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250825,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250824,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00608165",
      "brand_name": "TEVA-OXYCOCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61498",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2024-01-18T16:52:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00608165",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AJ",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2024-03-31T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-03-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-07T16:50:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OXYCOCET",
    "en_drug_common_name": "OXYCOCET TABLETS UD BLST",
    "fr_drug_brand_name": "TEVA-OXYCOCET TABLETS UD BLST",
    "fr_drug_common_name": "OXYCOCET TABLETS UD BLST",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216460,
    "drug": {
      "current_status": "MARKETED",
      "id": 778,
      "drug_code": 11780,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251571,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01913670",
      "brand_name": "TEVA-GLYBURIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72689",
      "number_of_ais": "1",
      "ai_group_no": "0108708002"
    },
    "created_date": "2024-01-18T16:53:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01913670",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-03T19:35:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GLYBURIDE",
    "en_drug_common_name": "GLYBURIDE 2.5MG TAB",
    "fr_drug_brand_name": "TEVA-GLYBURIDE 2.5MG TAB",
    "fr_drug_common_name": "GLYBURIDE 2.5MG TAB",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216463,
    "drug": {
      "current_status": "MARKETED",
      "id": 11952,
      "drug_code": 69789,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254434,
          "ingredient": {
            "id": 838,
            "ingredient_code": 9766,
            "en_name": "SALICYLIC ACID",
            "fr_name": "Acide salicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8254433,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02245688",
      "brand_name": "RATIO-TOPISALIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215695003"
    },
    "created_date": "2024-01-18T16:54:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245688",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07XC",
    "atc_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-29T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Pack size is now discontinued",
    "en_drug_brand_name": "RATIO-TOPISALIC",
    "en_drug_common_name": "TOPISALIC LOTION",
    "fr_drug_brand_name": "RATIO-TOPISALIC LOTION",
    "fr_drug_common_name": "TOPISALIC LOTION",
    "en_ingredients": "SALICYLIC ACID\r\nBETAMETHASONE",
    "fr_ingredients": "Acide salicylique\r\nBétaméthasone",
    "drug_strength": "20MG\r\n0.5MG",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216466,
    "drug": {
      "current_status": "MARKETED",
      "id": 98312,
      "drug_code": 91377,
      "updated_date": "2020-04-03T06:52:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260654,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429349",
      "brand_name": "TEVA-DILTIAZEM XC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863008"
    },
    "created_date": "2024-01-18T16:55:32-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429349",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2024-05-10T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T18:02:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-DILTIAZEM XC",
    "en_drug_common_name": "DILTIAZEM XC 300MG TAB",
    "fr_drug_brand_name": "TEVA-DILTIAZEM XC 300MG TAB",
    "fr_drug_common_name": "DILTIAZEM XC 300MG TAB",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216471,
    "drug": {
      "current_status": "MARKETED",
      "id": 26640,
      "drug_code": 88929,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 1632,
        "created_date": "2017-03-09T13:24:59-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 14507,
        "mfr_code": "",
        "name": "EISAI LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6925 CENTURY AVE, SUITE 701",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 7K2",
        "post_office_box": "",
        "contact_information": "Tammy Mitchell-Moore - Director, Regulatory Affairs\r\n905-814-2312 / tammy_mitchellmoore@eisai.com"
      },
      "drug_ingredients": [
        {
          "id": 8259605,
          "ingredient": {
            "id": 3850,
            "ingredient_code": 22049,
            "en_name": "PERAMPANEL",
            "fr_name": "Pérampanel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404524",
      "brand_name": "FYCOMPA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154211002"
    },
    "created_date": "2024-01-18T17:20:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404524",
    "company_name": "EISAI LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-02-05T00:00:00-05:00",
    "actual_start_date": "2024-01-25T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T21:03:11-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FYCOMPA",
    "en_drug_common_name": "perampanel",
    "fr_drug_brand_name": "FYCOMPA",
    "fr_drug_common_name": "Pérampanel",
    "en_ingredients": "PERAMPANEL",
    "fr_ingredients": "Pérampanel",
    "drug_strength": "4.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216474,
    "drug": {
      "current_status": "MARKETED",
      "id": 26644,
      "drug_code": 88931,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 1632,
        "created_date": "2017-03-09T13:24:59-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 14507,
        "mfr_code": "",
        "name": "EISAI LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6925 CENTURY AVE, SUITE 701",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 7K2",
        "post_office_box": "",
        "contact_information": "Tammy Mitchell-Moore - Director, Regulatory Affairs\r\n905-814-2312 / tammy_mitchellmoore@eisai.com"
      },
      "drug_ingredients": [
        {
          "id": 8259607,
          "ingredient": {
            "id": 3850,
            "ingredient_code": 22049,
            "en_name": "PERAMPANEL",
            "fr_name": "Pérampanel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02404540",
      "brand_name": "FYCOMPA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0154211004"
    },
    "created_date": "2024-01-18T17:22:08-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404540",
    "company_name": "EISAI LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-02-05T00:00:00-05:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T21:04:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FYCOMPA",
    "en_drug_common_name": "perampanel",
    "fr_drug_brand_name": "FYCOMPA",
    "fr_drug_common_name": "Pérampanel",
    "en_ingredients": "PERAMPANEL",
    "fr_ingredients": "Pérampanel",
    "drug_strength": "8.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216497,
    "drug": {
      "current_status": "MARKETED",
      "id": 17320,
      "drug_code": 78368,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256099,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298384",
      "brand_name": "TEVA-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301001"
    },
    "created_date": "2024-01-18T18:42:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298384",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2025-04-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-29T13:34:28-04:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "en_drug_brand_name": "TEVA-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE 30MG TABL",
    "fr_drug_brand_name": "TEVA-RISEDRONATE 30MG TABL",
    "fr_drug_common_name": "RISEDRONATE 30MG TABL",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216506,
    "drug": {
      "current_status": "MARKETED",
      "id": 25970,
      "drug_code": 88359,
      "updated_date": "2025-05-15T02:33:44-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259365,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02398656",
      "brand_name": "RIVA-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-18T21:16:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02398656",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-01-18T00:00:00-05:00",
    "estimated_end_date": "2025-02-21T00:00:00-05:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2025-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-16T18:28:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVA-LETROZOLE",
    "en_drug_common_name": "Riva-Letrozole",
    "fr_drug_brand_name": "RIVA-LETROZOLE",
    "fr_drug_common_name": "Riva-Letrozole 2.5mg",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216509,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9252,
      "drug_code": 62267,
      "updated_date": "2025-05-15T03:58:00-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8327051,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        },
        {
          "id": 8327050,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238829",
      "brand_name": "CLAVULIN 875",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2024-01-18T21:19:50-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02238829",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "discontinuation_date": "2024-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-18T21:22:37-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLAVULIN 875",
    "en_drug_common_name": "amoxicillin / clavulanate potassium tablets",
    "fr_drug_brand_name": "CLAVULIN 875",
    "fr_drug_common_name": "amoxicilline et clavulanate de potassium en comprimés",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Acide clavulanique (Clavulanate de potassium)\r\nAmoxicilline (Trihydrate d'amoxicilline)",
    "drug_strength": "125MG\r\n875MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216518,
    "drug": {
      "current_status": "MARKETED",
      "id": 60196,
      "drug_code": 95784,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8262815,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02469170",
      "brand_name": "LUPIN-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105911001"
    },
    "created_date": "2024-01-19T03:43:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469170",
    "company_name": "LUPIN PHARMA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2024-04-01T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-04-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-04-30T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LUPIN-CEPHALEXIN",
    "en_drug_common_name": "LUPIN-CEPHALEXIN",
    "fr_drug_brand_name": "LUPIN-CEPHALEXIN",
    "fr_drug_common_name": "LUPIN-CEPHALEXIN",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100mL and 150mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216641,
    "drug": {
      "current_status": "MARKETED",
      "id": 24230,
      "drug_code": 86845,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8258718,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02382636",
      "brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "1/5/50ML SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698001"
    },
    "created_date": "2024-01-19T21:40:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382636",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2024-04-08T00:00:00-04:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T16:48:23-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "en_drug_common_name": "HYDROMORPHONE HYDROCHLORIDE INJECTION USP",
    "fr_drug_brand_name": "Chlorhydrate D'HYDROmorphone Injectable USP",
    "fr_drug_common_name": "Chlorhydrate D'HYDROmorphone Injectable USP",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10 x 5mL vial",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216646,
    "drug": {
      "current_status": "MARKETED",
      "id": 100130,
      "drug_code": 98409,
      "updated_date": "2020-04-03T06:54:25-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8264584,
          "ingredient": {
            "id": 3742,
            "ingredient_code": 20982,
            "en_name": "COLESEVELAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de Colésévélam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02494051",
      "brand_name": "APO-COLESEVELAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153000001"
    },
    "created_date": "2024-01-19T21:42:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02494051",
    "company_name": "APOTEX INC",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-06-28T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-15T13:22:39-04:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "en_drug_brand_name": "APO-COLESEVELAM",
    "en_drug_common_name": "COLESEVELAM",
    "fr_drug_brand_name": "APO-COLESEVELAM",
    "fr_drug_common_name": "COLESEVELAM",
    "en_ingredients": "COLESEVELAM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de Colésévélam",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "180 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216650,
    "drug": {
      "current_status": "MARKETED",
      "id": 722,
      "drug_code": 11626,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251557,
          "ingredient": {
            "id": 330,
            "ingredient_code": 6436,
            "en_name": "HYDRALAZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydralazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441627",
      "brand_name": "APO-HYDRALAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72441",
      "number_of_ais": "1",
      "ai_group_no": "0107444002"
    },
    "created_date": "2024-01-19T21:44:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441627",
    "company_name": "APOTEX INC",
    "atc_number": "C02DB",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "estimated_end_date": "2024-04-05T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-05T15:28:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRALAZINE",
    "en_drug_common_name": "HYDRALAZINE",
    "fr_drug_brand_name": "APO-HYDRALAZINE",
    "fr_drug_common_name": "HYDRALAZINE",
    "en_ingredients": "HYDRALAZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydralazine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216653,
    "drug": {
      "current_status": "MARKETED",
      "id": 30436,
      "drug_code": 92479,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261116,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440423",
      "brand_name": "APO-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2024-01-19T21:45:17-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440423",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-22T14:58:45-04:00",
    "status": "resolved",
    "en_comments": "100 BTL available",
    "fr_comments": "100 BTL disponible",
    "en_drug_brand_name": "APO-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "APO-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "Duloxetine",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216656,
    "drug": {
      "current_status": "MARKETED",
      "id": 7124,
      "drug_code": 48231,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253240,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229873",
      "brand_name": "APO-ACETAMINOPHEN CAPLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2024-01-19T21:46:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229873",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2024-02-23T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-23T22:32:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACETAMINOPHEN CAPLETS",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216659,
    "drug": {
      "current_status": "MARKETED",
      "id": 14138,
      "drug_code": 74173,
      "updated_date": "2025-12-03T00:31:00-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255107,
          "ingredient": {
            "id": 2776,
            "ingredient_code": 11980,
            "en_name": "LEFLUNOMIDE",
            "fr_name": "Léflunomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256495",
      "brand_name": "APO-LEFLUNOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0140182001"
    },
    "created_date": "2024-01-19T21:47:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256495",
    "company_name": "APOTEX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-09T20:48:22-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEFLUNOMIDE",
    "en_drug_common_name": "LEFLUNOMIDE",
    "fr_drug_brand_name": "APO-LEFLUNOMIDE",
    "fr_drug_common_name": "LEFLUNOMIDE",
    "en_ingredients": "LEFLUNOMIDE",
    "fr_ingredients": "Léflunomide",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216662,
    "drug": {
      "current_status": "MARKETED",
      "id": 31558,
      "drug_code": 93875,
      "updated_date": "2025-05-15T02:35:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261800,
          "ingredient": {
            "id": 610,
            "ingredient_code": 1249,
            "en_name": "FELODIPINE",
            "fr_name": "Félodipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02452367",
      "brand_name": "APO-FELODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121733003"
    },
    "created_date": "2024-01-19T21:49:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452367",
    "company_name": "APOTEX INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-09T20:47:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FELODIPINE",
    "en_drug_common_name": "FELODIPINE",
    "fr_drug_brand_name": "APO-FELODIPINE",
    "fr_drug_common_name": "FELODIPINE",
    "en_ingredients": "FELODIPINE",
    "fr_ingredients": "Félodipine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216669,
    "drug": {
      "current_status": "MARKETED",
      "id": 26534,
      "drug_code": 88837,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259581,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02403587",
      "brand_name": "APO-MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "AQUEOUS SUSPENSION. 140 DOSES.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732002"
    },
    "created_date": "2024-01-19T21:51:18-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02403587",
    "company_name": "APOTEX INC",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-22T19:03:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MOMETASONE",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "APO-MOMETASONE",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "140 MS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216672,
    "drug": {
      "current_status": "MARKETED",
      "id": 56778,
      "drug_code": 95586,
      "updated_date": "2025-05-15T02:36:02-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262687,
          "ingredient": {
            "id": 3486,
            "ingredient_code": 11359,
            "en_name": "CEFEPIME",
            "fr_name": "Céfépime (Chlorhydrate de céfépime)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02467496",
      "brand_name": "APO-CEFEPIME",
      "brand_name_fr": "APO-CEFEPIME",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150504004"
    },
    "created_date": "2024-01-19T21:52:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02467496",
    "company_name": "APOTEX INC",
    "atc_number": "J01DE",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-09T20:44:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CEFEPIME",
    "en_drug_common_name": "CEFEPIME",
    "fr_drug_brand_name": "APO-CEFEPIME",
    "fr_drug_common_name": "CEFEPIME",
    "en_ingredients": "CEFEPIME",
    "fr_ingredients": "Cefepime",
    "drug_strength": "1G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "20 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216675,
    "drug": {
      "current_status": "MARKETED",
      "id": 101654,
      "drug_code": 97306,
      "updated_date": "2021-04-08T05:02:22-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8263717,
          "ingredient": {
            "id": 3718,
            "ingredient_code": 20742,
            "en_name": "TICAGRELOR",
            "fr_name": "Ticagrélor"
          },
          "ingredient_supplied_ind": "I",
          "strength": "90",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02482630",
      "brand_name": "APO-TICAGRELOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152934001"
    },
    "created_date": "2024-01-19T21:54:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482630",
    "company_name": "APOTEX INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2024-04-05T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-29T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TICAGRELOR",
    "en_drug_common_name": "TICRAGELOR",
    "fr_drug_brand_name": "APO-TICAGRELOR",
    "fr_drug_common_name": "TICAGRELOR",
    "en_ingredients": "TICAGRELOR",
    "fr_ingredients": "Ticagrélor",
    "drug_strength": "90MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "180 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216678,
    "drug": {
      "current_status": "MARKETED",
      "id": 103980,
      "drug_code": 102655,
      "updated_date": "2023-06-19T23:14:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8268093,
          "ingredient": {
            "id": 4068,
            "ingredient_code": 22591,
            "en_name": "BROMFENAC",
            "fr_name": "Bromfénac (Bromfénac sodique sesquihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.07",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02537788",
      "brand_name": "APO-BROMFENAC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0156750001"
    },
    "created_date": "2024-01-19T21:55:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02537788",
    "company_name": "APOTEX INC",
    "atc_number": "S01BC",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2024-03-22T00:00:00-04:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-22T14:56:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BROMFENAC",
    "en_drug_common_name": "BROMFENAC",
    "fr_drug_brand_name": "APO-BROMFENAC",
    "fr_drug_common_name": "BROMFENAC",
    "en_ingredients": "BROMFENAC",
    "fr_ingredients": "Bromfenac",
    "drug_strength": "0.07%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216681,
    "drug": {
      "current_status": "MARKETED",
      "id": 62318,
      "drug_code": 93077,
      "updated_date": "2025-12-03T00:32:54-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261425,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445492",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310001"
    },
    "created_date": "2024-01-19T21:56:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445492",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2024-03-01T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-23T22:41:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE",
    "fr_drug_brand_name": "APO-AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "Amphetamine",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216684,
    "drug": {
      "current_status": "DORMANT",
      "id": 22538,
      "drug_code": 85029,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368559,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365383",
      "brand_name": "APO-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2024-01-19T21:59:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365383",
    "company_name": "APOTEX INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-16T16:27:31-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "APO-FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216687,
    "drug": {
      "current_status": "MARKETED",
      "id": 57154,
      "drug_code": 94430,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262099,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457229",
      "brand_name": "APO-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-01-19T22:09:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457229",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:09:12-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216690,
    "drug": {
      "current_status": "DORMANT",
      "id": 57158,
      "drug_code": 94432,
      "updated_date": "2025-12-03T02:32:40-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369411,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457245",
      "brand_name": "APO-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-19T22:10:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457245",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-05-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-31T21:04:47-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216693,
    "drug": {
      "current_status": "MARKETED",
      "id": 57160,
      "drug_code": 94433,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262100,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457253",
      "brand_name": "APO-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-01-19T22:11:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457253",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:09:33-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216696,
    "drug": {
      "current_status": "DORMANT",
      "id": 57162,
      "drug_code": 94434,
      "updated_date": "2025-12-03T02:32:40-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369412,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457261",
      "brand_name": "APO-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2024-01-19T22:12:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457261",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-18T17:08:35-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216699,
    "drug": {
      "current_status": "DORMANT",
      "id": 100835,
      "drug_code": 99125,
      "updated_date": "2020-09-03T01:53:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369733,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02501635",
      "brand_name": "APO-QUETIAPINE FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2024-01-19T22:13:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501635",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2022-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-23T22:51:17-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE FUMARATE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216702,
    "drug": {
      "current_status": "MARKETED",
      "id": 100836,
      "drug_code": 99126,
      "updated_date": "2020-09-03T01:53:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8265333,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02501643",
      "brand_name": "APO-QUETIAPINE FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2024-01-19T22:14:58-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501643",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-05T05:00:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE FUMARATE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216705,
    "drug": {
      "current_status": "DORMANT",
      "id": 100837,
      "drug_code": 99127,
      "updated_date": "2020-09-03T01:53:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369734,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02501651",
      "brand_name": "APO-QUETIAPINE FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-19T22:16:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501651",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-05T19:05:29-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE FUMARATE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216708,
    "drug": {
      "current_status": "DORMANT",
      "id": 100838,
      "drug_code": 99128,
      "updated_date": "2020-09-03T01:53:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369735,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02501678",
      "brand_name": "APO-QUETIAPINE FUMARATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-01-19T22:17:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501678",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-02-06T00:00:00-05:00",
    "actual_start_date": "2024-02-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-23T22:53:04-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-QUETIAPINE FUMARATE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216711,
    "drug": {
      "current_status": "DORMANT",
      "id": 51243,
      "drug_code": 94000,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369379,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453452",
      "brand_name": "APO-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496002"
    },
    "created_date": "2024-01-19T22:19:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453452",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-10T14:30:22-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "APO-OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216714,
    "drug": {
      "current_status": "MARKETED",
      "id": 51245,
      "drug_code": 94001,
      "updated_date": "2025-12-03T00:33:04-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261862,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453460",
      "brand_name": "APO-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2024-01-19T22:20:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453460",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:11:16-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN",
    "fr_drug_brand_name": "APO-OLMESARTAN",
    "fr_drug_common_name": "OLMESARTAN",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmesartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216717,
    "drug": {
      "current_status": "DORMANT",
      "id": 50646,
      "drug_code": 94018,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369391,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369390,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453622",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502003"
    },
    "created_date": "2024-01-19T22:22:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453622",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:10:31-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN/HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216720,
    "drug": {
      "current_status": "DORMANT",
      "id": 51251,
      "drug_code": 94016,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369387,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369386,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453606",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502001"
    },
    "created_date": "2024-01-19T22:23:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453606",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2024-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-16T05:00:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN/HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216723,
    "drug": {
      "current_status": "DORMANT",
      "id": 50644,
      "drug_code": 94017,
      "updated_date": "2025-12-03T02:32:39-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369389,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8369388,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02453614",
      "brand_name": "APO-OLMESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502002"
    },
    "created_date": "2024-01-19T22:26:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453614",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:10:51-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "en_drug_common_name": "OLMESARTAN/HCTZ",
    "fr_drug_brand_name": "APO-OLMESARTAN/HCTZ",
    "fr_drug_common_name": "OLMESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216726,
    "drug": {
      "current_status": "DORMANT",
      "id": 25506,
      "drug_code": 87942,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368844,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394278",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2024-01-19T22:30:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394278",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-18T17:07:52-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216729,
    "drug": {
      "current_status": "DORMANT",
      "id": 25508,
      "drug_code": 87943,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368845,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "225",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394286",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121007"
    },
    "created_date": "2024-01-19T22:32:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394286",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:07:27-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "225MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216732,
    "drug": {
      "current_status": "DORMANT",
      "id": 25500,
      "drug_code": 87939,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368841,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394235",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2024-01-19T22:33:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394235",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "anticipated_start_date": "2024-05-07T00:00:00-04:00",
    "actual_start_date": "2024-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T20:58:38-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216735,
    "drug": {
      "current_status": "DORMANT",
      "id": 25510,
      "drug_code": 87944,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368846,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394294",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121008"
    },
    "created_date": "2024-01-19T22:34:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394294",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-22T15:09:04-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216738,
    "drug": {
      "current_status": "DORMANT",
      "id": 25502,
      "drug_code": 87940,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368842,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394243",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2024-01-19T22:35:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394243",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-11-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T21:08:16-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216741,
    "drug": {
      "current_status": "DORMANT",
      "id": 25504,
      "drug_code": 87941,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368843,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394251",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2024-01-19T22:36:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394251",
    "company_name": "APOTEX INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-07-18T17:06:59-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216744,
    "drug": {
      "current_status": "DORMANT",
      "id": 65764,
      "drug_code": 95885,
      "updated_date": "2025-12-03T02:32:41-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369488,
          "ingredient": {
            "id": 3710,
            "ingredient_code": 20671,
            "en_name": "FINGOLIMOD",
            "fr_name": "Fingolimod (Chlorhydrate de Fingolimod)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469936",
      "brand_name": "APO-FINGOLIMOD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152886001"
    },
    "created_date": "2024-01-19T22:37:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469936",
    "company_name": "APOTEX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "actual_start_date": "2024-05-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-10T21:42:54-04:00",
    "status": "active_confirmed",
    "en_comments": "Short-dated inventory available",
    "fr_comments": "Short-dated inventory available",
    "en_drug_brand_name": "APO-FINGOLIMOD",
    "en_drug_common_name": "FINGOLIMOD",
    "fr_drug_brand_name": "APO-FINGOLIMOD",
    "fr_drug_common_name": "FINGOLIMOD",
    "en_ingredients": "FINGOLIMOD",
    "fr_ingredients": "Fingolimod",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28 BLS",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216767,
    "drug": {
      "current_status": "MARKETED",
      "id": 24108,
      "drug_code": 86734,
      "updated_date": "2025-05-15T02:33:14-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258677,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381494",
      "brand_name": "ACH-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2024-01-20T02:52:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381494",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-20T02:55:14-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "ACH-ALENDRONATE",
    "fr_drug_common_name": "ACH-ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate sodique",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216770,
    "drug": {
      "current_status": "MARKETED",
      "id": 65367,
      "drug_code": 94479,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262133,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457768",
      "brand_name": "ACH-ATORVASTATIN CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2024-01-20T02:57:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457768",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ATORVASTATIN CALCIUM",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ACH Atorvastatine",
    "fr_drug_common_name": "Atorvastatine",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90 500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216773,
    "drug": {
      "current_status": "MARKETED",
      "id": 65369,
      "drug_code": 94480,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262134,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457776",
      "brand_name": "ACH-ATORVASTATIN CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2024-01-20T02:58:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457776",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ATORVASTATIN CALCIUM",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ACH Atorvastatine",
    "fr_drug_common_name": "Atorvastatine",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216776,
    "drug": {
      "current_status": "MARKETED",
      "id": 65371,
      "drug_code": 94481,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262135,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457784",
      "brand_name": "ACH-ATORVASTATIN CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2024-01-20T02:59:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457784",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-03-05T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T21:42:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ATORVASTATIN CALCIUM",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ACH Atorvastatine",
    "fr_drug_common_name": "Atorvastatine",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216779,
    "drug": {
      "current_status": "MARKETED",
      "id": 23850,
      "drug_code": 86515,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258583,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379279",
      "brand_name": "ACH-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2024-01-20T03:00:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379279",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-16T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN CILEXETIL",
    "fr_drug_brand_name": "ACH Candésartan",
    "fr_drug_common_name": "Candésartan",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216782,
    "drug": {
      "current_status": "MARKETED",
      "id": 28952,
      "drug_code": 91025,
      "updated_date": "2025-05-15T02:34:20-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260513,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02425610",
      "brand_name": "ACH-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2024-01-20T03:04:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02425610",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-20T03:05:14-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-EZETIMIBE",
    "en_drug_common_name": "Ézétimibe",
    "fr_drug_brand_name": "ACH Ézétimibe",
    "fr_drug_common_name": "Ézétimibe",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216785,
    "drug": {
      "current_status": "MARKETED",
      "id": 27944,
      "drug_code": 90145,
      "updated_date": "2025-12-03T00:32:25-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260153,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416840",
      "brand_name": "ACH-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2024-01-20T03:06:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416840",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N02BF",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-20T03:06:22-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "GABAPENTIN CAPSULES USP",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "ACH-Gabapentine",
    "fr_drug_common_name": "Gabapentine",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216788,
    "drug": {
      "current_status": "MARKETED",
      "id": 26112,
      "drug_code": 88463,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259422,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399784",
      "brand_name": "ACH-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2024-01-20T03:07:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399784",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-03-05T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-03-08T21:43:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-LEVETIRACETAM",
    "en_drug_common_name": "Levetiracetam",
    "fr_drug_brand_name": "ACH Lévétiracétam",
    "fr_drug_common_name": "Lévétiracétam",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216791,
    "drug": {
      "current_status": "MARKETED",
      "id": 98905,
      "drug_code": 94320,
      "updated_date": "2020-04-03T06:53:11-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262030,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02456338",
      "brand_name": "ACH-OLMESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152496003"
    },
    "created_date": "2024-01-20T03:08:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02456338",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-20T03:08:33-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-OLMESARTAN",
    "en_drug_common_name": "OLMESARTAN MEDOXOMIL",
    "fr_drug_brand_name": "ACH Olmésartan",
    "fr_drug_common_name": "Olmésartan médoxomil",
    "en_ingredients": "OLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Olmésartan médoxomil",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216794,
    "drug": {
      "current_status": "MARKETED",
      "id": 27914,
      "drug_code": 90114,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260139,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416549",
      "brand_name": "ACH-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-20T03:09:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416549",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T21:43:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OMEPRAZOLE MAGNESIUM DELAYED RELEASE TABLETS",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "ACH-Oméprazole",
    "fr_drug_common_name": "Oméprazole",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216797,
    "drug": {
      "current_status": "MARKETED",
      "id": 98758,
      "drug_code": 93571,
      "updated_date": "2020-04-03T06:53:02-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261648,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02449854",
      "brand_name": "ACH-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121003"
    },
    "created_date": "2024-01-20T03:11:09-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449854",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N02BF",
    "estimated_end_date": "2024-03-06T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T21:42:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "ACH Prégabaline",
    "fr_drug_common_name": "Prégabaline",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216802,
    "drug": {
      "current_status": "MARKETED",
      "id": 24784,
      "drug_code": 87338,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258949,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387808",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2024-01-20T03:13:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387808",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T21:43:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216805,
    "drug": {
      "current_status": "MARKETED",
      "id": 24786,
      "drug_code": 87339,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258950,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387816",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2024-01-20T03:14:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387816",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-03-13T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-16T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216808,
    "drug": {
      "current_status": "MARKETED",
      "id": 24788,
      "drug_code": 87340,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258951,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387824",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-20T03:15:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387824",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-03-12T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2024-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-16T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216811,
    "drug": {
      "current_status": "MARKETED",
      "id": 24782,
      "drug_code": 87337,
      "updated_date": "2025-05-15T02:33:31-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258948,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387794",
      "brand_name": "ACH-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858001"
    },
    "created_date": "2024-01-20T03:15:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387794",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-01-20T03:16:11-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "QUETIAPINE TABLETS",
    "en_drug_common_name": "QUETIAPINE FUMARATE",
    "fr_drug_brand_name": "ACH Quétiapine",
    "fr_drug_common_name": "Quétiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (IMMEDIATE RELEASE)\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate)\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216814,
    "drug": {
      "current_status": "MARKETED",
      "id": 26960,
      "drug_code": 89217,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259715,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02407485",
      "brand_name": "ACH-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2024-01-20T03:16:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407485",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2025-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-12-20T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "ACH Telmisartan",
    "fr_drug_common_name": "Telmisartan",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216835,
    "drug": {
      "current_status": "DORMANT",
      "id": 102344,
      "drug_code": 100886,
      "updated_date": "2021-10-08T05:17:19-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369828,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02519615",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2024-01-20T20:28:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519615",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine Fumarate Extended-Release Tablets",
    "fr_drug_brand_name": "Quetiapine XR",
    "fr_drug_common_name": "Comprimés de fumarate de quétiapine à libération prolongée",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216838,
    "drug": {
      "current_status": "DORMANT",
      "id": 102320,
      "drug_code": 100887,
      "updated_date": "2021-10-08T05:17:10-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369829,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02519623",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-20T20:32:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519623",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine Fumarate Extended-Release Tablets",
    "fr_drug_brand_name": "Quetiapine XR",
    "fr_drug_common_name": "Comprimés de fumarate de quétiapine à libération prolongée",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216841,
    "drug": {
      "current_status": "MARKETED",
      "id": 102304,
      "drug_code": 100898,
      "updated_date": "2021-10-08T05:16:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266558,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02519747",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-01-20T20:36:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519747",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T16:04:42-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine Fumarate Extended-Release Tablets",
    "fr_drug_brand_name": "Quetiapine XR",
    "fr_drug_common_name": "Comprimés de fumarate de quétiapine à libération prolongée",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216844,
    "drug": {
      "current_status": "DORMANT",
      "id": 102305,
      "drug_code": 100900,
      "updated_date": "2021-10-08T05:16:57-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369830,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02519763",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2024-01-20T20:42:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519763",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "actual_end_date": "2025-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-08-01T05:00:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine Fumarate Extended-Release Tablets",
    "fr_drug_brand_name": "Quetiapine XR",
    "fr_drug_common_name": "Comprimés de fumarate de quétiapine à libération prolongée",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216847,
    "drug": {
      "current_status": "MARKETED",
      "id": 102343,
      "drug_code": 100885,
      "updated_date": "2021-10-08T05:17:19-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266547,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02519607",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-01-20T20:46:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519607",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T16:05:38-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine Fumarate Extended-Release Tablets",
    "fr_drug_brand_name": "Quetiapine XR",
    "fr_drug_common_name": "Comprimés de fumarate de quétiapine à libération prolongée",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quétiapine (Fumarate de quétiapine)",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216850,
    "drug": {
      "current_status": "MARKETED",
      "id": 28336,
      "drug_code": 90479,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260274,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420198",
      "brand_name": "JAMP-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-20T20:51:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420198",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T15:58:29-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-OMEPRAZOLE DR",
    "en_drug_common_name": "Omeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "JAMP-Omeprazole DR",
    "fr_drug_common_name": "Comprimés d’oméprazole magnésien à libération retardée",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216853,
    "drug": {
      "current_status": "MARKETED",
      "id": 28336,
      "drug_code": 90479,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260274,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420198",
      "brand_name": "JAMP-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-20T20:58:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420198",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T15:59:09-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-OMEPRAZOLE DR",
    "en_drug_common_name": "Omeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "JAMP-Omeprazole DR",
    "fr_drug_common_name": "Comprimés d’oméprazole magnésien à libération retardée",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216856,
    "drug": {
      "current_status": "MARKETED",
      "id": 28336,
      "drug_code": 90479,
      "updated_date": "2025-05-15T02:34:12-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260274,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420198",
      "brand_name": "JAMP-OMEPRAZOLE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-20T21:01:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420198",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2026-06-30T00:00:00-04:00",
    "actual_start_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-11T16:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "JAMP-OMEPRAZOLE DR",
    "en_drug_common_name": "Omeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "JAMP-Omeprazole DR",
    "fr_drug_common_name": "Comprimés d’oméprazole magnésien à libération retardée",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216886,
    "drug": {
      "current_status": "MARKETED",
      "id": 11830,
      "drug_code": 69441,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 334,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4763,
        "mfr_code": "NNA08",
        "name": "NOVO NORDISK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "101-2476 ARGENTIA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 6M1",
        "post_office_box": "",
        "contact_information": "1 800 465 4334"
      },
      "drug_ingredients": [
        {
          "id": 8254389,
          "ingredient": {
            "id": 2920,
            "ingredient_code": 12335,
            "en_name": "INSULIN ASPART",
            "fr_name": "Insuline asparte"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02245397",
      "brand_name": "NOVORAPID",
      "brand_name_fr": "",
      "descriptor": "10ML VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0144802001"
    },
    "created_date": "2024-01-22T14:26:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245397",
    "company_name": "NOVO NORDISK CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "anticipated_start_date": "2024-01-22T00:00:00-05:00",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVORAPID",
    "en_drug_common_name": "Novorapid",
    "fr_drug_brand_name": "NOVORAPID",
    "fr_drug_common_name": "NOVORAPID",
    "en_ingredients": "INSULIN ASPART",
    "fr_ingredients": "Insuline asparte",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1x10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216889,
    "drug": {
      "current_status": "MARKETED",
      "id": 1220,
      "drug_code": 1275,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250253,
          "ingredient": {
            "id": 310,
            "ingredient_code": 7486,
            "en_name": "TESTOSTERONE ENANTHATE",
            "fr_name": "Énanthate de testosterone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00029246",
      "brand_name": "DELATESTRYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "38398",
      "number_of_ais": "1",
      "ai_group_no": "0106403001"
    },
    "created_date": "2024-01-22T14:39:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00029246",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "G03BA",
    "atc_description": "ANDROGENS",
    "estimated_end_date": "2024-01-26T00:00:00-05:00",
    "actual_start_date": "2024-01-03T00:00:00-05:00",
    "actual_end_date": "2024-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-02-01T16:23:13-05:00",
    "status": "resolved",
    "en_comments": "Capacity Problem in Packaging",
    "fr_comments": "Capacity Problem in Packaging",
    "en_drug_brand_name": "DELATESTRYL",
    "en_drug_common_name": "DELATESTRYL",
    "fr_drug_brand_name": "DELATESTRYL",
    "fr_drug_common_name": "DELATESTRYL",
    "en_ingredients": "TESTOSTERONE ENANTHATE",
    "fr_ingredients": "Énanthate de testosterone",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216921,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12676,
      "drug_code": 71470,
      "updated_date": "2025-05-15T04:06:47-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8337965,
          "ingredient": {
            "id": 2166,
            "ingredient_code": 1913,
            "en_name": "CICLOPIROX OLAMINE",
            "fr_name": "Ciclopirox olamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247228",
      "brand_name": "STIEPROX SHAMPOO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115999002"
    },
    "created_date": "2024-01-22T18:04:37-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247228",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D01AE",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "discontinuation_date": "2024-01-22T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-23T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "STIEPROX SHAMPOO",
    "en_drug_common_name": "ciclopirox olamine shampoo",
    "fr_drug_brand_name": "STIEPROX SHAMPOO",
    "fr_drug_common_name": "ciclopirox olamine shampooing",
    "en_ingredients": "CICLOPIROX OLAMINE",
    "fr_ingredients": "Ciclopirox olamine",
    "drug_strength": "1.5%",
    "drug_dosage_form": "SHAMPOO",
    "drug_dosage_form_fr": "Shampoing",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "All pack sizes / Tous les formats",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216942,
    "drug": {
      "current_status": "MARKETED",
      "id": 2918,
      "drug_code": 17123,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252186,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02049384",
      "brand_name": "ZESTRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79273",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2024-01-22T19:47:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02049384",
    "company_name": "SEARCHLIGHT PHARMA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2024-03-01T00:00:00-05:00",
    "estimated_end_date": "2024-09-15T00:00:00-04:00",
    "actual_start_date": "2024-04-05T00:00:00-04:00",
    "actual_end_date": "2024-11-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2024-11-11T16:32:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZESTRIL",
    "en_drug_common_name": "ZESTRIL",
    "fr_drug_brand_name": "ZESTRIL",
    "fr_drug_common_name": "ZESTRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216953,
    "drug": {
      "current_status": "MARKETED",
      "id": 14102,
      "drug_code": 74134,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255092,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02256118",
      "brand_name": "MYLAN-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2024-01-22T20:22:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256118",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-05-02T00:00:00-04:00",
    "actual_start_date": "2024-01-22T00:00:00-05:00",
    "actual_end_date": "2024-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T18:34:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "MYLAN-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216963,
    "drug": {
      "current_status": "DORMANT",
      "id": 60232,
      "drug_code": 97053,
      "updated_date": "2025-05-15T06:56:02-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8369581,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02479974",
      "brand_name": "MYCOPHENOLATE MOFETIL FOR INJECTION USP",
      "brand_name_fr": "MOFÉTIL MYCOPHÉNOLATE POUR INJECTION USP",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2024-01-22T21:09:26-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02479974",
    "company_name": "STERIMAX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "discontinuation_date": "2024-06-30T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Product will no longer be available upon the depletion of the limited inventory at McKesson.",
    "fr_supply_disruption_mitigation": "Le produit ne sera plus disponible dès l'épuisement des quantités limitées chez McKesson.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-08-07T19:54:29-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MYCOPHENOLATE MOFETIL FOR INJECTION USP",
    "en_drug_common_name": "MYCOPHENOLATE MOFETIL FOR INJECTION USP",
    "fr_drug_brand_name": "MOFÉTIL MYCOPHÉNOLATE POUR INJECTION USP 500 MG",
    "fr_drug_common_name": "MOFÉTIL MYCOPHÉNOLATE POUR INJECTION USP 500 MG",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "4 VIALS",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216966,
    "drug": {
      "current_status": "MARKETED",
      "id": 5268,
      "drug_code": 3394,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250507,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "mEq",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402206",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
      "brand_name_fr": "CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54169",
      "number_of_ais": "1",
      "ai_group_no": "0100273003"
    },
    "created_date": "2024-01-22T21:12:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402206",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2025-09-30T00:00:00-04:00",
    "estimated_end_date": "2025-12-19T00:00:00-05:00",
    "actual_start_date": "2025-10-03T00:00:00-04:00",
    "actual_end_date": "2025-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-12-12T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Product on allocation",
    "fr_comments": "Produit en allocation",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
    "en_drug_common_name": "Potassium Chloride for Injection Concentrate",
    "fr_drug_brand_name": "CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ",
    "fr_drug_common_name": "Chlorure de potassium",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "20mEq",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 20mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216968,
    "drug": {
      "current_status": "MARKETED",
      "id": 5268,
      "drug_code": 3394,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250507,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "mEq",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402206",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
      "brand_name_fr": "CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54169",
      "number_of_ais": "1",
      "ai_group_no": "0100273003"
    },
    "created_date": "2024-01-22T21:12:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402206",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2024-01-22T00:00:00-05:00",
    "actual_end_date": "2024-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-01T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Please note that the product is available on allocation.",
    "fr_comments": "Veuillez noter que le produit est disponible en allocation.",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
    "en_drug_common_name": "Potassium Chloride for Injection Concentrate",
    "fr_drug_brand_name": "Potassium Chloride Injection Concentrate",
    "fr_drug_common_name": "Chlorure de potassium pour injection concentré",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "20mEq",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 20mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 216971,
    "drug": {
      "current_status": "MARKETED",
      "id": 8262,
      "drug_code": 5613,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250788,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250787,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250786,
          "ingredient": {
            "id": 426,
            "ingredient_code": 704,
            "en_name": "VITAMIN A",
            "fr_name": "Vitamine A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250785,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250784,
          "ingredient": {
            "id": 758,
            "ingredient_code": 5000,
            "en_name": "D-PANTOTHENIC ACID",
            "fr_name": "Acide d-pantothénique (D-pantothénate de calcium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250783,
          "ingredient": {
            "id": 424,
            "ingredient_code": 703,
            "en_name": "VITAMIN D",
            "fr_name": "Vitamine D"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250782,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250781,
          "ingredient": {
            "id": 1634,
            "ingredient_code": 11169,
            "en_name": "VITAMIN B6",
            "fr_name": "Vitamine B6"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250780,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00586315",
      "brand_name": "MULTI 1000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61105",
      "number_of_ais": "9",
      "ai_group_no": "0915828001"
    },
    "created_date": "2024-01-22T22:14:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00586315",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A11BA",
    "atc_description": "MULTIVITAMINS, PLAIN",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-04-06T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MULTI 1000",
    "en_drug_common_name": "MULTI 1000",
    "fr_drug_brand_name": "MULTI 1000",
    "fr_drug_common_name": "MULTI 1000",
    "en_ingredients": "VITAMIN B6\r\nNICOTINAMIDE\r\nVITAMIN B2\r\nVITAMIN B1\r\nVITAMIN E\r\nVITAMIN D\r\nVITAMIN A\r\nASCORBIC ACID\r\nD-PANTOTHENIC ACID",
    "fr_ingredients": "Vitamine B6\r\nNicotinamide\r\nVitanine B2\r\nVitamine B1\r\nVitamine E\r\nVitamine D\r\nVitamine A\r\nAcide d-pantothénique",
    "drug_strength": "1.2MG\r\n10MG\r\n1MG\r\n4.5MG\r\n1UNIT\r\n100UNIT\r\n1000UNIT\r\n100MG\r\n2.6MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217029,
    "drug": {
      "current_status": "MARKETED",
      "id": 61834,
      "drug_code": 97301,
      "updated_date": "2025-05-15T02:37:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8263711,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8263710,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02482584",
      "brand_name": "SANDOZ AMOXI-CLAV TABLET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2024-01-23T20:19:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02482584",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMOXI-CLAV TABLET",
    "en_drug_common_name": "AMOXI-CLAV TABLET",
    "fr_drug_brand_name": "SANDOZ AMOXI-CLAV TABLET",
    "fr_drug_common_name": "AMOXI-CLAV TABLET",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG\r\n875MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217033,
    "drug": {
      "current_status": "MARKETED",
      "id": 13446,
      "drug_code": 73126,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254874,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248758",
      "brand_name": "SANDOZ CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2024-01-23T20:22:27-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248758",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-01T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN",
    "fr_drug_brand_name": "SANDOZ CIPROFLOXACIN",
    "fr_drug_common_name": "CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217037,
    "drug": {
      "current_status": "MARKETED",
      "id": 27080,
      "drug_code": 89327,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259757,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02408538",
      "brand_name": "CLINDAMYCIN IV INFUSION",
      "brand_name_fr": "",
      "descriptor": "900MG/50ML MINIBAGS. SINGLE USE.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830010"
    },
    "created_date": "2024-01-23T20:25:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408538",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2024-04-05T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-04-04T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CLINDAMYCIN IV INFUSION",
    "en_drug_common_name": "CLINDAMYCIN IV INFUSION",
    "fr_drug_brand_name": "CLINDAMYCIN IV INFUSION",
    "fr_drug_common_name": "CLINDAMYCIN IV INFUSION",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCINE",
    "drug_strength": "18MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10LIIF",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217041,
    "drug": {
      "current_status": "MARKETED",
      "id": 10362,
      "drug_code": 65502,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253917,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        },
        {
          "id": 8253916,
          "ingredient": {
            "id": 1006,
            "ingredient_code": 7498,
            "en_name": "NORETHINDRONE ACETATE",
            "fr_name": "Acétate de noréthindrone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02241835",
      "brand_name": "ESTALIS 140/50 MCG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0242942005"
    },
    "created_date": "2024-01-23T22:01:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241835",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03FA",
    "atc_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-02-20T03:02:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTALIS 140/50 MCG",
    "en_drug_common_name": "ESTALIS 140/50 MCG",
    "fr_drug_brand_name": "ESTALIS 140/50 MCG",
    "fr_drug_common_name": "ESTALIS 140/50 MCG",
    "en_ingredients": "NORETHINDRONE ACETATE\r\nESTRADIOL",
    "fr_ingredients": "Acétate de noréthindrone\r\nEstradiol",
    "drug_strength": "140MCG\r\n50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTSM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217044,
    "drug": {
      "current_status": "MARKETED",
      "id": 11408,
      "drug_code": 67942,
      "updated_date": "2025-12-03T00:30:48-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254253,
          "ingredient": {
            "id": 1290,
            "ingredient_code": 7419,
            "en_name": "ESTRADIOL",
            "fr_name": "Estradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02243999",
      "brand_name": "ESTRADOT 37.5",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106457034"
    },
    "created_date": "2024-01-23T22:05:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243999",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G03CA",
    "atc_description": "ESTROGENS",
    "estimated_end_date": "2024-05-03T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESTRADOT 37.5",
    "en_drug_common_name": "ESTRADOT 37.5",
    "fr_drug_brand_name": "ESTRADOT 37.5",
    "fr_drug_common_name": "ESTRADOT 37.5",
    "en_ingredients": "ESTRADIOL",
    "fr_ingredients": "Estradiol",
    "drug_strength": "37.5MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8TTS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217049,
    "drug": {
      "current_status": "MARKETED",
      "id": 17772,
      "drug_code": 78841,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256245,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02303086",
      "brand_name": "HEPARIN SODIUM INJECTION USP    (MULTIDOSE VIAL-WITH PRESERVATIVE)",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596004"
    },
    "created_date": "2024-01-23T22:11:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303086",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2024-02-23T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "fr_drug_brand_name": "HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "fr_drug_common_name": "HEPARIN SODIUM INJECTION USP        (MULTIDOSE VIAL-WITH PRESERVATIVE)",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "1000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "30ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217053,
    "drug": {
      "current_status": "MARKETED",
      "id": 21312,
      "drug_code": 83711,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257546,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351870",
      "brand_name": "SANDOZ RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2024-01-23T22:13:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351870",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2024-03-23T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-04T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN ODT",
    "fr_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "fr_drug_common_name": "SANDOZ RIZATRIPTAN ODT",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN ODT",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6ODT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217056,
    "drug": {
      "current_status": "MARKETED",
      "id": 26008,
      "drug_code": 88394,
      "updated_date": "2025-05-15T02:33:46-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259379,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02399032",
      "brand_name": "SANDOZ SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584001"
    },
    "created_date": "2024-01-23T22:14:29-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02399032",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-06T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ SOLIFENACIN",
    "en_drug_common_name": "SOLIFENACIN",
    "fr_drug_brand_name": "SANDOZ SOLIFENACIN",
    "fr_drug_common_name": "SOLIFENACIN",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217075,
    "drug": {
      "current_status": "DORMANT",
      "id": 1308,
      "drug_code": 12887,
      "updated_date": "2025-12-03T02:32:14-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366698,
          "ingredient": {
            "id": 208,
            "ingredient_code": 5440,
            "en_name": "BETHANECHOL CHLORIDE",
            "fr_name": "Chlorure de béthanéchol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01947923",
      "brand_name": "DUVOID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74117",
      "number_of_ais": "1",
      "ai_group_no": "0107779003"
    },
    "created_date": "2024-01-24T13:13:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01947923",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N07AB",
    "atc_description": "PARASYMPATHOMIMETICS",
    "actual_start_date": "2023-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-24T13:14:16-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "DUVOID",
    "en_drug_common_name": "BETHANECHOL CHLORIDE",
    "fr_drug_brand_name": "Duvoid",
    "fr_drug_common_name": "Chlorure de béthanéchol",
    "en_ingredients": "BETHANECHOL CHLORIDE",
    "fr_ingredients": "Chlorure de béthanéchol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Tab",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217088,
    "drug": {
      "current_status": "MARKETED",
      "id": 1674,
      "drug_code": 13591,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8251786,
          "ingredient": {
            "id": 924,
            "ingredient_code": 11177,
            "en_name": "LODOXAMIDE",
            "fr_name": "Lodoxamide (Trométhamine de lodoxamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00893560",
      "brand_name": "ALOMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75012",
      "number_of_ais": "1",
      "ai_group_no": "0122561001"
    },
    "created_date": "2024-01-24T15:06:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00893560",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "anticipated_start_date": "2024-01-24T00:00:00-05:00",
    "estimated_end_date": "2024-04-15T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-04-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-04-11T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALOMIDE",
    "en_drug_common_name": "ALOMIDE SOLN. 10ML",
    "fr_drug_brand_name": "ALOMIDE",
    "fr_drug_common_name": "ALOMIDE SOLN. 10ML",
    "en_ingredients": "LODOXAMIDE",
    "fr_ingredients": "LODOXAMIDE",
    "drug_strength": "0.1%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217099,
    "drug": {
      "current_status": "MARKETED",
      "id": 8778,
      "drug_code": 60818,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 316,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4328,
        "mfr_code": "HLR07",
        "name": "HOFFMANN-LA ROCHE LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7070 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253522,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237484",
      "brand_name": "CELLCEPT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2024-01-24T18:00:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237484",
    "company_name": "HOFFMANN-LA ROCHE LIMITED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2024-01-24T00:00:00-05:00",
    "estimated_end_date": "2024-03-11T00:00:00-04:00",
    "actual_end_date": "2024-03-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-13T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CELLCEPT",
    "en_drug_common_name": "CELLCEPT",
    "fr_drug_brand_name": "CELLCEPT",
    "fr_drug_common_name": "CELLCEPT",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500MG TABS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217120,
    "drug": {
      "current_status": "MARKETED",
      "id": 18054,
      "drug_code": 79246,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 264,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7259,
        "mfr_code": "JSO08",
        "name": "JANSSEN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "19 GREEN BELT DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3C 1L9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256349,
          "ingredient": {
            "id": 3452,
            "ingredient_code": 20195,
            "en_name": "ETRAVIRINE",
            "fr_name": "Étravirine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02306778",
      "brand_name": "INTELENCE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152450001"
    },
    "created_date": "2024-01-24T19:44:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306778",
    "company_name": "JANSSEN INC",
    "atc_number": "J05AG",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2024-01-24T00:00:00-05:00",
    "estimated_end_date": "2024-02-14T00:00:00-05:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "INTELENCE",
    "en_drug_common_name": "Intelence 100 MG",
    "fr_drug_brand_name": "Intelence",
    "fr_drug_common_name": "Intelence 100MG",
    "en_ingredients": "ETRAVIRINE",
    "fr_ingredients": "Étravirine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120 Tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217125,
    "drug": {
      "current_status": "MARKETED",
      "id": 7052,
      "drug_code": 47865,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253221,
          "ingredient": {
            "id": 1652,
            "ingredient_code": 348,
            "en_name": "HEPATITIS A VACCINE, INACTIVATED",
            "fr_name": "Vaccin contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02229702",
      "brand_name": "VAQTA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126318003"
    },
    "created_date": "2024-01-24T21:57:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229702",
    "company_name": "MERCK CANADA INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2024-04-01T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-19T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Remaining doses are reserved for the public immunization program.",
    "fr_comments": "Les doses restantes sont réservées au programme public de vaccination.",
    "en_drug_brand_name": "VAQTA",
    "en_drug_common_name": "hepatitis A vaccine, purified inactivated Suspension for injection",
    "fr_drug_brand_name": "VAQTA",
    "fr_drug_common_name": "vaccin purifié inactivé contre l’hépatite A Suspension Injectable",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "50UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "50U/1ML 1DOSE VIAL (ADULT)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217128,
    "drug": {
      "current_status": "MARKETED",
      "id": 18204,
      "drug_code": 79471,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256388,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309114",
      "brand_name": "PMS-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-24T23:15:46-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309114",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2024-02-27T00:00:00-05:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-28T18:22:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LETROZOLE",
    "en_drug_common_name": "LETROZOLE",
    "fr_drug_brand_name": "PMS-LETROZOLE",
    "fr_drug_common_name": "LETROZOLE",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217220,
    "drug": {
      "current_status": "MARKETED",
      "id": 7722,
      "drug_code": 5073,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250705,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342106",
      "brand_name": "TEVA-CEPHALEXIN 125",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59604",
      "number_of_ais": "1",
      "ai_group_no": "0105911001"
    },
    "created_date": "2024-01-25T16:32:39-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342106",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2024-03-10T00:00:00-05:00",
    "actual_start_date": "2023-09-12T00:00:00-04:00",
    "actual_end_date": "2024-03-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-18T13:36:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 125",
    "en_drug_common_name": "CEPHALEXIN SUSP 125MG/5ML",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN SUSP 125MG/5ML",
    "fr_drug_common_name": "CEPHALEXIN SUSP 125MG/5ML",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100ml",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217223,
    "drug": {
      "current_status": "MARKETED",
      "id": 16066,
      "drug_code": 76860,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255736,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282984",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2024-01-25T16:33:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282984",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2024-05-10T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-05-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-09T17:59:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "FENTANYL TDS 100MCG/H PATCH",
    "fr_drug_brand_name": "TEVA-FENTANYL TDS 100MCG/H PATCH",
    "fr_drug_common_name": "FENTANYL TDS 100MCG/H PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217226,
    "drug": {
      "current_status": "MARKETED",
      "id": 17050,
      "drug_code": 78072,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256015,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295415",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2024-01-25T16:35:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295415",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-03-20T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-03-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-21T14:56:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 20MG TABLETS",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE 20MG TABLETS",
    "fr_drug_common_name": "OMEPRAZOLE 20MG TABLETS",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 & 500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217229,
    "drug": {
      "current_status": "MARKETED",
      "id": 17048,
      "drug_code": 78071,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256014,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295407",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643003"
    },
    "created_date": "2024-01-25T16:36:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295407",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-03-20T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-14T20:15:51-04:00",
    "status": "resolved",
    "en_comments": "Duplicate Entry",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 10MG TABLETS",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE",
    "fr_drug_common_name": "TEVA-OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217231,
    "drug": {
      "current_status": "MARKETED",
      "id": 17048,
      "drug_code": 78071,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256014,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295407",
      "brand_name": "TEVA-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643003"
    },
    "created_date": "2024-01-25T16:36:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295407",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-06-20T00:00:00-04:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-20T15:34:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE 10MG TABLETS",
    "fr_drug_brand_name": "TEVA-OMEPRAZOLE 10MG TABLETS",
    "fr_drug_common_name": "OMEPRAZOLE 10MG TABLETS",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217234,
    "drug": {
      "current_status": "MARKETED",
      "id": 18924,
      "drug_code": 80190,
      "updated_date": "2025-12-03T00:31:21-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256613,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316390",
      "brand_name": "TEVA-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2024-01-25T16:37:14-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02316390",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-03-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-01T18:21:27-04:00",
    "status": "resolved",
    "en_comments": "Item (Pack size) is discontinued",
    "fr_comments": "Item (Pack size) is discontinued",
    "en_drug_brand_name": "TEVA-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN 75MG TABLETS",
    "fr_drug_brand_name": "TEVA-IRBESARTAN 75MG TABLETS",
    "fr_drug_common_name": "IRBESARTAN 75MG TABLETS",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217237,
    "drug": {
      "current_status": "MARKETED",
      "id": 22598,
      "drug_code": 85119,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258143,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02366339",
      "brand_name": "TEVA-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2024-01-25T16:38:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02366339",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-08T16:15:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN 32MG TABS",
    "fr_drug_brand_name": "TEVA-CANDESARTAN 32MG TABS",
    "fr_drug_common_name": "CANDESARTAN 32MG TABS",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "pp 30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217240,
    "drug": {
      "current_status": "MARKETED",
      "id": 55341,
      "drug_code": 93402,
      "updated_date": "2025-12-03T00:32:56-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261559,
          "ingredient": {
            "id": 1126,
            "ingredient_code": 8298,
            "en_name": "DEXTROAMPHETAMINE SULFATE",
            "fr_name": "Sulfate de dextroamphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02448327",
      "brand_name": "TEVA-DEXTROAMPHETAMINE SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105933001"
    },
    "created_date": "2024-01-25T16:39:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02448327",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-17T00:00:00-05:00",
    "actual_end_date": "2024-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-25T16:46:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT DEXTROAMPHETAMINE SR",
    "en_drug_common_name": "DEXTROAMPHETAMINE SRCAP 15MG",
    "fr_drug_brand_name": "ACT-DEXTROAMPHETAMINE SRCAP 15MG",
    "fr_drug_common_name": "DEXTROAMPHETAMINE SRCAP 15MG",
    "en_ingredients": "DEXTROAMPHETAMINE SULFATE",
    "fr_ingredients": "Sulfate de dextroamphétamine",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217254,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 32170,
      "drug_code": 9888,
      "updated_date": "2025-12-03T01:04:37-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8286015,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00808539",
      "brand_name": "TEVA-DICLOFENAC EC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69244",
      "number_of_ais": "1",
      "ai_group_no": "0114417003"
    },
    "created_date": "2024-01-25T18:35:47-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00808539",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2024-01-25T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-26T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEVA-DICLOFENAC EC",
    "en_drug_common_name": "DICLOFENAC EC 25MG",
    "fr_drug_brand_name": "TEVA-DICLOFENAC EC 25MG",
    "fr_drug_common_name": "DICLOFENAC EC 25MG",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217261,
    "drug": {
      "current_status": "MARKETED",
      "id": 23332,
      "drug_code": 85917,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258412,
          "ingredient": {
            "id": 3742,
            "ingredient_code": 20982,
            "en_name": "COLESEVELAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de Colésévélam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373955",
      "brand_name": "LODALIS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153000001"
    },
    "created_date": "2024-01-25T18:47:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373955",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2024-02-19T00:00:00-05:00",
    "estimated_end_date": "2024-03-27T00:00:00-04:00",
    "actual_start_date": "2024-02-06T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2025-04-15T13:22:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LODALIS",
    "en_drug_common_name": "LODALIS",
    "fr_drug_brand_name": "LODALIS",
    "fr_drug_common_name": "LODALIS",
    "en_ingredients": "COLESEVELAM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de Colésévélam",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217264,
    "drug": {
      "current_status": "MARKETED",
      "id": 12682,
      "drug_code": 71480,
      "updated_date": "2025-12-03T00:30:53-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254640,
          "ingredient": {
            "id": 3034,
            "ingredient_code": 12077,
            "en_name": "PIMECROLIMUS",
            "fr_name": "Pimécrolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02247238",
      "brand_name": "ELIDEL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149001001"
    },
    "created_date": "2024-01-25T19:17:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247238",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D11AH",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "anticipated_start_date": "2024-03-15T00:00:00-04:00",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_end_date": "2024-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-02-22T15:15:26-05:00",
    "status": "avoided_shortage",
    "en_comments": "Capacity Problem in Production",
    "fr_comments": "Capacity Problem in Production",
    "en_drug_brand_name": "ELIDEL",
    "en_drug_common_name": "ELIDEL",
    "fr_drug_brand_name": "ELIDEL",
    "fr_drug_common_name": "ELIDEL",
    "en_ingredients": "PIMECROLIMUS",
    "fr_ingredients": "Pimécrolimus",
    "drug_strength": "1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "30g",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217267,
    "drug": {
      "current_status": "MARKETED",
      "id": 14714,
      "drug_code": 75010,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255283,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.04",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02264633",
      "brand_name": "RETIN-A MICRO",
      "brand_name_fr": "",
      "descriptor": "MICROSPHERES GEL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112395006"
    },
    "created_date": "2024-01-25T19:20:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264633",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "anticipated_start_date": "2024-04-16T00:00:00-04:00",
    "estimated_end_date": "2024-04-28T00:00:00-04:00",
    "actual_start_date": "2024-04-15T00:00:00-04:00",
    "actual_end_date": "2024-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-04-30T14:22:22-04:00",
    "status": "resolved",
    "en_comments": "Capacity Problem in production",
    "fr_comments": "problème de capacité en production",
    "en_drug_brand_name": "RETIN-A MICRO",
    "en_drug_common_name": "RETIN-A MICRO",
    "fr_drug_brand_name": "RETIN-A MICRO",
    "fr_drug_common_name": "RETIN-A MICRO",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.04%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217270,
    "drug": {
      "current_status": "MARKETED",
      "id": 100158,
      "drug_code": 98457,
      "updated_date": "2020-04-03T06:54:27-04:00",
      "company": {
        "id": 1460,
        "created_date": "2017-03-09T13:24:29-05:00",
        "updated_date": "2025-05-15T02:30:22-04:00",
        "company_code": 13985,
        "mfr_code": "",
        "name": "GENERIC MEDICAL PARTNERS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1500 DON MILLS ROAD, SUITE 711",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M3B 3K4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264653,
          "ingredient": {
            "id": 3490,
            "ingredient_code": 1739,
            "en_name": "CLADRIBINE",
            "fr_name": "Cladribine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02494574",
      "brand_name": "CLADRIBINE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124270001"
    },
    "created_date": "2024-01-25T20:04:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02494574",
    "company_name": "GENERIC MEDICAL PARTNERS INC",
    "atc_number": "L01BB",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2024-01-25T00:00:00-05:00",
    "estimated_end_date": "2024-02-15T00:00:00-05:00",
    "actual_start_date": "2024-01-25T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Cladribine Injection 1mg/ml 10 ml vial UPC 870573001434 is now available. It is not on allocation. Normal demand levels can be supplied.",
    "fr_comments": "La cladribine injectable à 1 mg/ml en fioles de 10 ml, CUP 870573001434, est maintenant disponible. Elle n’est pas en allocation. On est en mesure d’honorer les niveaux normaux de demande.",
    "en_drug_brand_name": "CLADRIBINE INJECTION",
    "en_drug_common_name": "CLADRIBINE INJECTION",
    "fr_drug_brand_name": "Cladribine Injectable",
    "fr_drug_common_name": "Cladribine Injectable",
    "en_ingredients": "CLADRIBINE",
    "fr_ingredients": "Cladribine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1mg/ml 10ml Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217288,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2024-01-26T15:09:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-01-26T00:00:00-05:00",
    "estimated_end_date": "2024-02-18T00:00:00-05:00",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2024-02-13T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Temperature requirements during distribution were not met",
    "fr_comments": "Les exigences de température lors de la distribution n'ont pas été respectées.",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 240",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "RECTAL\r\nORAL\r\nINTRA-ARTICULAR\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Rectale\r\nOrale\r\nIntra-articulaire\r\nIntravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217300,
    "drug": {
      "current_status": "MARKETED",
      "id": 20168,
      "drug_code": 81611,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257152,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "54",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330377",
      "brand_name": "APO-METHYLPHENIDATE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2024-01-26T15:57:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330377",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2024-02-23T00:00:00-05:00",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2024-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-23T22:36:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "en_drug_common_name": "METHYLPHENIDATE",
    "fr_drug_brand_name": "APO-METHYLPHENIDATE ER",
    "fr_drug_common_name": "METHYLPHENIDATE",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "54MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217342,
    "drug": {
      "current_status": "MARKETED",
      "id": 65365,
      "drug_code": 94478,
      "updated_date": "2025-05-15T02:35:36-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8262132,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457741",
      "brand_name": "ACH-ATORVASTATIN CALCIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2024-01-26T16:42:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457741",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-03-13T00:00:00-04:00",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2024-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-16T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ATORVASTATIN CALCIUM",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "ACH-Atorvastatine",
    "fr_drug_common_name": "Atorvastatine calcique",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatine calcique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217355,
    "drug": {
      "current_status": "MARKETED",
      "id": 20640,
      "drug_code": 82411,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257292,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338459",
      "brand_name": "ACH-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-26T16:47:07-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338459",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2025-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-12-30T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-LETROZOLE",
    "en_drug_common_name": "LETROZOLE",
    "fr_drug_brand_name": "ACH Létrozole",
    "fr_drug_common_name": "Létrozole",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217358,
    "drug": {
      "current_status": "MARKETED",
      "id": 62761,
      "drug_code": 92330,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8261056,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438925",
      "brand_name": "ACH-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2024-01-26T16:49:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438925",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-09-03T00:00:00-04:00",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "actual_end_date": "2024-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-09-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "ACH Rosuvastatine",
    "fr_drug_common_name": "ROSUVASTATINE",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATINE",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217363,
    "drug": {
      "current_status": "MARKETED",
      "id": 23854,
      "drug_code": 86517,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8258585,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379295",
      "brand_name": "ACH-CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220004"
    },
    "created_date": "2024-01-26T17:00:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379295",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2024-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-01-27T06:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACH-CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN CILEXETIL",
    "fr_drug_brand_name": "ACH Candésartan",
    "fr_drug_common_name": "Candésartan",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217366,
    "drug": {
      "current_status": "MARKETED",
      "id": 25594,
      "drug_code": 88003,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259248,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394871",
      "brand_name": "MINT-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2024-01-26T17:51:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394871",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2025-12-30T00:00:00-05:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-31T18:04:42-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MINT-ALENDRONATE",
    "en_drug_common_name": "Alendronate",
    "fr_drug_brand_name": "Mint- Alendronate",
    "fr_drug_common_name": "Alendronate",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate",
    "drug_strength": "70.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4 count Blisters",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217369,
    "drug": {
      "current_status": "MARKETED",
      "id": 25438,
      "drug_code": 87879,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259220,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393573",
      "brand_name": "MINT-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-26T17:53:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393573",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ANASTROZOLE",
    "en_drug_common_name": "Anastrazole",
    "fr_drug_brand_name": "Mint- Anastrazole",
    "fr_drug_common_name": "Anastrazole",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 count blisters",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217372,
    "drug": {
      "current_status": "MARKETED",
      "id": 101230,
      "drug_code": 99746,
      "updated_date": "2020-12-09T00:57:56-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265827,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02508109",
      "brand_name": "MINT-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-26T17:55:33-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02508109",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "estimated_end_date": "2025-12-31T00:00:00-05:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-31T18:04:03-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MINT-LETROZOLE",
    "en_drug_common_name": "Letrozole",
    "fr_drug_brand_name": "Mint-Letrozole",
    "fr_drug_common_name": "Letrozole",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 count blisters",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217375,
    "drug": {
      "current_status": "MARKETED",
      "id": 19030,
      "drug_code": 80298,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256661,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317451",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2024-01-26T17:57:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317451",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint- Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217378,
    "drug": {
      "current_status": "MARKETED",
      "id": 19032,
      "drug_code": 80299,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256662,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317478",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2024-01-26T17:58:43-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317478",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-09-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-08-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:43:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint- Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217381,
    "drug": {
      "current_status": "MARKETED",
      "id": 19034,
      "drug_code": 80300,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256663,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317486",
      "brand_name": "MINT-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2024-01-26T17:59:47-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317486",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "Mint- Pravastatin",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217384,
    "drug": {
      "current_status": "DORMANT",
      "id": 102503,
      "drug_code": 101133,
      "updated_date": "2021-12-08T06:08:30-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369840,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02522187",
      "brand_name": "MINT-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-01-26T18:04:40-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02522187",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-11T15:00:55-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MINT-QUETIAPINE XR",
    "en_drug_common_name": "quetiapine",
    "fr_drug_brand_name": "Mint-Quetiapine XR",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217387,
    "drug": {
      "current_status": "DORMANT",
      "id": 102504,
      "drug_code": 101134,
      "updated_date": "2021-12-08T06:08:31-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369841,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02522195",
      "brand_name": "MINT-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2024-01-26T18:06:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02522195",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-12-30T00:00:00-05:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-10-31T18:04:24-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MINT-QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine",
    "fr_drug_brand_name": "Mint-Quetiapine XR",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217390,
    "drug": {
      "current_status": "DORMANT",
      "id": 102505,
      "drug_code": 101135,
      "updated_date": "2021-12-08T06:08:31-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369842,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02522209",
      "brand_name": "MINT-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-26T18:09:34-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02522209",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine",
    "fr_drug_brand_name": "Mint-Quetiapine XR",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217393,
    "drug": {
      "current_status": "MARKETED",
      "id": 102506,
      "drug_code": 101136,
      "updated_date": "2021-12-08T06:08:31-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266721,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02522217",
      "brand_name": "MINT-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-01-26T18:11:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02522217",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine",
    "fr_drug_brand_name": "Mint-Quetiapine XR",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217396,
    "drug": {
      "current_status": "DORMANT",
      "id": 102507,
      "drug_code": 101137,
      "updated_date": "2021-12-08T06:08:31-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369843,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02522225",
      "brand_name": "MINT-QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2024-01-26T18:12:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02522225",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2025-05-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-04-11T15:01:45-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "MINT-QUETIAPINE XR",
    "en_drug_common_name": "Quetiapine",
    "fr_drug_brand_name": "Mint-Quetiapine XR",
    "fr_drug_common_name": "Quetiapine",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": true,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217399,
    "drug": {
      "current_status": "MARKETED",
      "id": 2654,
      "drug_code": 16462,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252122,
          "ingredient": {
            "id": 426,
            "ingredient_code": 704,
            "en_name": "VITAMIN A",
            "fr_name": "Vitamine A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "660",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252121,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252120,
          "ingredient": {
            "id": 636,
            "ingredient_code": 5008,
            "en_name": "PYRIDOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pyridoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252119,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252118,
          "ingredient": {
            "id": 634,
            "ingredient_code": 4993,
            "en_name": "DEXPANTHENOL",
            "fr_name": "Dexpanthénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252117,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252116,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252115,
          "ingredient": {
            "id": 632,
            "ingredient_code": 4962,
            "en_name": "BIOTIN",
            "fr_name": "Biotine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252114,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252113,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8252112,
          "ingredient": {
            "id": 424,
            "ingredient_code": 703,
            "en_name": "VITAMIN D",
            "fr_name": "Vitamine D"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252111,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.72",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02100606",
      "brand_name": "MULTI 12",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "78353",
      "number_of_ais": "12",
      "ai_group_no": "1223086001"
    },
    "created_date": "2024-01-26T18:44:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02100606",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XC",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2024-05-15T00:00:00-04:00",
    "actual_end_date": "2024-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-05-22T05:00:03-04:00",
    "status": "resolved",
    "fr_comments": "Baxter item: 6420",
    "en_drug_brand_name": "MULTI 12 INJECTION",
    "en_drug_common_name": "MULTI 12 INJECTION",
    "fr_drug_brand_name": "MULTI 12 INJECTION",
    "fr_drug_common_name": "MULTI 12 INJECTION",
    "en_ingredients": "VITAMIN B12\r\nFOLIC ACID\r\nBIOTIN\r\nVITAMIN E\r\nDEXPANTHENOL\r\nPYRIDOXINE HYDROCHLORIDE\r\nNICOTINAMIDE\r\nVITAMIN B2\r\nVITAMIN B1\r\nVITAMIN D\r\nVITAMIN A\r\nASCORBIC ACID",
    "fr_ingredients": "Vitamine B12\r\nAcide folique\r\nBiotine\r\nVitamine E\r\nDexpanthénol\r\nChlorhydrate de pyridoxine\r\nNicotinamide\r\nVitanine B2\r\nVitamine B1\r\nVitamine D\r\nVitamine A",
    "drug_strength": "1MCG\r\n80MCG\r\n12MCG\r\n2UNIT\r\n3MG\r\n0.8MG\r\n8MG\r\n0.72MG\r\n0.6MG\r\n40UNIT\r\n660UNIT\r\n20MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "25ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217406,
    "drug": {
      "current_status": "MARKETED",
      "id": 11504,
      "drug_code": 68259,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254280,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244292",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685004"
    },
    "created_date": "2024-01-26T19:38:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244292",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T16:24:47-05:00",
    "status": "resolved",
    "en_comments": "Available in the 1x120 dose format.",
    "fr_comments": "Disponible en format de 1 x 120 doses.",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "125MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x60",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217411,
    "drug": {
      "current_status": "MARKETED",
      "id": 6726,
      "drug_code": 44186,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253160,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "647",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172747",
      "brand_name": "OMNIPAQUE 300",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9820",
      "number_of_ais": "1",
      "ai_group_no": "0116846004"
    },
    "created_date": "2024-01-26T20:32:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172747",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-12T00:00:00-05:00",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-02-13T00:00:00-05:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 300",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 300",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "647MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "RECTAL\r\nORAL\r\nINTRA-ARTICULAR\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Rectale\r\nOrale\r\nIntra-articulaire\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217414,
    "drug": {
      "current_status": "MARKETED",
      "id": 3432,
      "drug_code": 18694,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8252351,
          "ingredient": {
            "id": 1460,
            "ingredient_code": 250,
            "en_name": "IODIXANOL",
            "fr_name": "Iodixanol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "652",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145774",
      "brand_name": "VISIPAQUE 320",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80967",
      "number_of_ais": "1",
      "ai_group_no": "0126988002"
    },
    "created_date": "2024-01-26T20:36:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02145774",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-01-31T00:00:00-05:00",
    "estimated_end_date": "2024-02-13T00:00:00-05:00",
    "actual_start_date": "2024-02-01T00:00:00-05:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-15T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISIPAQUE 320",
    "en_drug_common_name": "iodixanol injection USP",
    "fr_drug_brand_name": "Visipaque 320",
    "fr_drug_common_name": "iodixanol injectable USP",
    "en_ingredients": "IODIXANOL",
    "fr_ingredients": "Iodixanol",
    "drug_strength": "652MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRA-ARTERIAL\r\nINTRAVENOUS\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntra-artérielle\r\nIntraveineuse\r\nIntra-artérielle",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217417,
    "drug": {
      "current_status": "MARKETED",
      "id": 6726,
      "drug_code": 44186,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253160,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "647",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172747",
      "brand_name": "OMNIPAQUE 300",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9820",
      "number_of_ais": "1",
      "ai_group_no": "0116846004"
    },
    "created_date": "2024-01-26T20:39:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172747",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-01-29T00:00:00-05:00",
    "estimated_end_date": "2024-02-21T00:00:00-05:00",
    "actual_start_date": "2024-01-30T00:00:00-05:00",
    "actual_end_date": "2024-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-24T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 300",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 300",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "647MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "RECTAL\r\nORAL\r\nINTRA-ARTICULAR\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Rectale\r\nOrale\r\nIntra-articulaire\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217420,
    "drug": {
      "current_status": "MARKETED",
      "id": 3432,
      "drug_code": 18694,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8252351,
          "ingredient": {
            "id": 1460,
            "ingredient_code": 250,
            "en_name": "IODIXANOL",
            "fr_name": "Iodixanol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "652",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02145774",
      "brand_name": "VISIPAQUE 320",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80967",
      "number_of_ais": "1",
      "ai_group_no": "0126988002"
    },
    "created_date": "2024-01-26T20:41:15-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02145774",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2024-02-01T00:00:00-05:00",
    "estimated_end_date": "2024-02-21T00:00:00-05:00",
    "actual_start_date": "2024-02-01T00:00:00-05:00",
    "actual_end_date": "2024-02-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-24T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VISIPAQUE 320",
    "en_drug_common_name": "iodixanol injection USP",
    "fr_drug_brand_name": "Visipaque 320",
    "fr_drug_common_name": "iodixanol injectable USP",
    "en_ingredients": "IODIXANOL",
    "fr_ingredients": "Iodixanol",
    "drug_strength": "652MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRA-ARTERIAL\r\nINTRAVENOUS\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntra-artérielle\r\nIntraveineuse\r\nIntra-artérielle",
    "drug_package_quantity": "200 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217425,
    "drug": {
      "current_status": "MARKETED",
      "id": 1010,
      "drug_code": 1239,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250249,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037826",
      "brand_name": "SODIUM CHLORIDE IRRIGATION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "37933",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2024-01-26T21:13:12-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037826",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2024-03-01T00:00:00-05:00",
    "estimated_end_date": "2024-04-15T00:00:00-04:00",
    "actual_start_date": "2024-02-18T00:00:00-05:00",
    "actual_end_date": "2024-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-24T14:45:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SODIUM CHLORIDE IRRIGATION USP",
    "en_drug_common_name": "Sodium Chloride Irrigation USP",
    "fr_drug_brand_name": "Chlorure de sodium à irrigation USP",
    "fr_drug_common_name": "Chlorure de sodium à irrigation USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "IRRIGATION\r\nINTRAPERITONEAL\r\nINTRAPERITONEAL\r\nIRRIGATION",
    "drug_route_fr": "Irrigation\r\nIntrapéritonéale\r\nIntrapéritonéale\r\nIrrigation",
    "drug_package_quantity": "3000 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217469,
    "drug": {
      "current_status": "MARKETED",
      "id": 13296,
      "drug_code": 72892,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254822,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248538",
      "brand_name": "APO-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038003"
    },
    "created_date": "2024-01-26T22:51:51-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248538",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-04-05T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-05T15:41:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN",
    "fr_drug_brand_name": "APO-TRYPTOPHAN",
    "fr_drug_common_name": "TRYPTOPHAN",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217472,
    "drug": {
      "current_status": "MARKETED",
      "id": 15716,
      "drug_code": 76426,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255619,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278685",
      "brand_name": "APO-MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066002"
    },
    "created_date": "2024-01-26T22:53:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278685",
    "company_name": "APOTEX INC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2024-05-24T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-24T17:13:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIDODRINE",
    "en_drug_common_name": "MIDODRINE",
    "fr_drug_brand_name": "APO-MIDODRINE",
    "fr_drug_common_name": "MIDODRINE",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217475,
    "drug": {
      "current_status": "MARKETED",
      "id": 27302,
      "drug_code": 89545,
      "updated_date": "2025-12-03T00:32:20-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259870,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259869,
          "ingredient": {
            "id": 3190,
            "ingredient_code": 13375,
            "en_name": "DROSPIRENONE",
            "fr_name": "Drospirénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02410796",
      "brand_name": "ZAMINE 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250430001"
    },
    "created_date": "2024-01-26T22:55:00-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410796",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-08T15:30:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZAMINE 28",
    "en_drug_common_name": "DROSPIRENONE / ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "ZAMINE",
    "fr_drug_common_name": "DROSPIRENONE / ETHINYL ESTRADIOL",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nDROSPIRENONE",
    "fr_ingredients": "Éthinylestradiol\r\nDrospirénone",
    "drug_strength": "0.03MG\r\n3MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217478,
    "drug": {
      "current_status": "MARKETED",
      "id": 17036,
      "drug_code": 78061,
      "updated_date": "2025-05-15T02:31:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256009,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295318",
      "brand_name": "APO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2024-01-26T22:56:42-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295318",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-16T15:37:27-05:00",
    "status": "resolved",
    "en_comments": "30 BLS available",
    "fr_comments": "30 BLS disponbile",
    "en_drug_brand_name": "APO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "APO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217481,
    "drug": {
      "current_status": "MARKETED",
      "id": 26908,
      "drug_code": 89182,
      "updated_date": "2025-05-15T02:33:56-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259696,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02407124",
      "brand_name": "APO-GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED RELEASE BREAKABLE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2024-01-26T22:58:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407124",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-08-02T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-31T20:35:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217484,
    "drug": {
      "current_status": "DORMANT",
      "id": 4154,
      "drug_code": 20011,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367037,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02211076",
      "brand_name": "APO-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82310",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2024-01-26T22:59:52-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02211076",
    "company_name": "APOTEX INC",
    "atc_number": "N05BE",
    "atc_description": "ANXIOLYTICS",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-02T22:57:42-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-BUSPIRONE",
    "en_drug_common_name": "BUSPIRONE",
    "fr_drug_brand_name": "APO-BUSPIRONE",
    "fr_drug_common_name": "BUSPIRONE",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217487,
    "drug": {
      "current_status": "MARKETED",
      "id": 11788,
      "drug_code": 69269,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254376,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02245247",
      "brand_name": "APO-GLICLAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934001"
    },
    "created_date": "2024-01-26T23:01:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245247",
    "company_name": "APOTEX INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-25T00:00:00-05:00",
    "actual_end_date": "2024-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-15T14:20:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-GLICLAZIDE",
    "en_drug_common_name": "GLICLAZIDE",
    "fr_drug_brand_name": "APO-GLICLAZIDE",
    "fr_drug_common_name": "GLICLAZIDE",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217490,
    "drug": {
      "current_status": "MARKETED",
      "id": 11906,
      "drug_code": 69723,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254417,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254416,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245623",
      "brand_name": "APO-AMOXI CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2024-01-26T23:02:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245623",
    "company_name": "APOTEX INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "hc_updated_date": "2024-03-01T16:11:18-05:00",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-23T00:00:00-05:00",
    "actual_end_date": "2024-02-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-01T16:11:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI CLAV",
    "en_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "fr_drug_brand_name": "APO-AMOXICLAV",
    "fr_drug_common_name": "AMOXICILLIN CLAVULANIC ACID",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG\r\n875MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217493,
    "drug": {
      "current_status": "MARKETED",
      "id": 12992,
      "drug_code": 72245,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254746,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247935",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683005"
    },
    "created_date": "2024-01-26T23:06:14-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247935",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_discontinuation_date": "2025-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-08-06T19:35:25-04:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217496,
    "drug": {
      "current_status": "MARKETED",
      "id": 12988,
      "drug_code": 72243,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254744,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247933",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683003"
    },
    "created_date": "2024-01-26T23:07:38-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247933",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_discontinuation_date": "2024-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-26T23:09:31-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "3.125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217499,
    "drug": {
      "current_status": "MARKETED",
      "id": 12990,
      "drug_code": 72244,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254745,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247934",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2024-01-26T23:08:45-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247934",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_discontinuation_date": "2024-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-26T23:08:56-05:00",
    "status": "to_be_discontinued",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": true,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217504,
    "drug": {
      "current_status": "DORMANT",
      "id": 12994,
      "drug_code": 72246,
      "updated_date": "2025-05-15T06:55:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367645,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247936",
      "brand_name": "APO-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2024-01-26T23:11:10-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247936",
    "company_name": "APOTEX INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "discontinuation_date": "2024-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-27T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "APO-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "APO-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217529,
    "drug": {
      "current_status": "MARKETED",
      "id": 8440,
      "drug_code": 589,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250161,
          "ingredient": {
            "id": 664,
            "ingredient_code": 8926,
            "en_name": "EPINEPHRINE",
            "fr_name": "Épinéphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250160,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00001791",
      "brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "23890",
      "number_of_ais": "2",
      "ai_group_no": "0201284001"
    },
    "created_date": "2024-01-29T17:03:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00001791",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_start_date": "2024-01-16T00:00:00-05:00",
    "actual_end_date": "2024-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-07T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "VR44553CA1\tXYLOCAIN AD20MG:5MCG/ML MDV10X20ML CA AS",
    "en_drug_brand_name": "XYLOCAINE 1% W EPINEPHRINE 1:100000",
    "en_drug_common_name": "lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial",
    "fr_drug_brand_name": "Xylocaine®",
    "fr_drug_common_name": "lidocaine HCI 1% w/epin. 1:100M 10x20mL MD Vial",
    "en_ingredients": "EPINEPHRINE\r\nLIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Épinéphrine\r\nChlorhydrate de lidocaïne",
    "drug_strength": "0.01MG\r\n10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "BLOCK/INFILTRATION\r\nBLOCK/INFILTRATION",
    "drug_route_fr": "Bloc/Infiltration\r\nBloc/Infiltration",
    "drug_package_quantity": "10 vials",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217532,
    "drug": {
      "current_status": "MARKETED",
      "id": 3330,
      "drug_code": 18491,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8252308,
          "ingredient": {
            "id": 1408,
            "ingredient_code": 954,
            "en_name": "OFLOXACIN",
            "fr_name": "Ofloxacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02143291",
      "brand_name": "OCUFLOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80750",
      "number_of_ais": "1",
      "ai_group_no": "0122759007"
    },
    "created_date": "2024-01-29T17:51:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02143291",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "anticipated_start_date": "2024-02-10T00:00:00-05:00",
    "estimated_end_date": "2024-05-24T00:00:00-04:00",
    "actual_start_date": "2024-02-13T00:00:00-05:00",
    "actual_end_date": "2024-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-05-27T11:30:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OCUFLOX",
    "en_drug_common_name": "Ocuflox",
    "fr_drug_brand_name": "Ocuflox 0.3%",
    "fr_drug_common_name": "Ocuflox",
    "en_ingredients": "OFLOXACIN",
    "fr_ingredients": "Ofloxacine",
    "drug_strength": "0.3%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5mL  bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217583,
    "drug": {
      "current_status": "MARKETED",
      "id": 10344,
      "drug_code": 65465,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253909,
          "ingredient": {
            "id": 2774,
            "ingredient_code": 5927,
            "en_name": "CYCLOPHOSPHAMIDE",
            "fr_name": "Cyclophosphamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02241800",
      "brand_name": "PROCYTOX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107630004"
    },
    "created_date": "2024-01-29T19:07:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241800",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2024-01-29T00:00:00-05:00",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-28T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PROCYTOX",
    "en_drug_common_name": "Cyclophosphamide for injection, 2G powdered vial",
    "fr_drug_brand_name": "PROCYTOX",
    "fr_drug_common_name": "Cyclophosphamide for injection",
    "en_ingredients": "CYCLOPHOSPHAMIDE",
    "fr_ingredients": "Cyclophosphamide",
    "drug_strength": "2000MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000 mg (20 mg/mL) (2638B5035)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217630,
    "drug": {
      "current_status": "MARKETED",
      "id": 21036,
      "drug_code": 83266,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8257463,
          "ingredient": {
            "id": 1540,
            "ingredient_code": 188,
            "en_name": "CEFPROZIL",
            "fr_name": "Cefprozil (Monohydrate de cefprozil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347253",
      "brand_name": "AURO-CEFPROZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127613002"
    },
    "created_date": "2024-01-29T20:11:06-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347253",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2024-05-31T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-05-31T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CEFPROZIL",
    "en_drug_common_name": "AURO-CEFPROZIL",
    "fr_drug_brand_name": "AURO-CEFPROZIL",
    "fr_drug_common_name": "AURO-CEFPROZIL",
    "en_ingredients": "CEFPROZIL",
    "fr_ingredients": "Cefprozil",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217633,
    "drug": {
      "current_status": "MARKETED",
      "id": 24152,
      "drug_code": 86776,
      "updated_date": "2025-05-15T02:33:19-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258694,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381923",
      "brand_name": "AURO-CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207001"
    },
    "created_date": "2024-01-29T20:13:02-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381923",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-CIPROFLOXACIN",
    "en_drug_common_name": "AURO-CIPROFLOXACIN",
    "fr_drug_brand_name": "AURO-CIPROFLOXACIN",
    "fr_drug_common_name": "AURO-CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217636,
    "drug": {
      "current_status": "MARKETED",
      "id": 57222,
      "drug_code": 95804,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262823,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02469308",
      "brand_name": "AURO-DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2024-01-29T20:14:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469308",
    "company_name": "AURO PHARMA INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2024-06-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-06-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-06-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-DUTASTERIDE",
    "en_drug_common_name": "AURO-DUTASTERIDE",
    "fr_drug_brand_name": "AURO-DUTASTERIDE",
    "fr_drug_common_name": "AURO-DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3x10 Blst and 100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217639,
    "drug": {
      "current_status": "MARKETED",
      "id": 59247,
      "drug_code": 96573,
      "updated_date": "2025-05-15T02:36:27-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263219,
          "ingredient": {
            "id": 3686,
            "ingredient_code": 20636,
            "en_name": "LACOSAMIDE",
            "fr_name": "Lacosamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475359",
      "brand_name": "AURO-LACOSAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152810003"
    },
    "created_date": "2024-01-29T20:16:23-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475359",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-07-31T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-07-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LACOSAMIDE",
    "en_drug_common_name": "AURO-LACOSAMIDE",
    "fr_drug_brand_name": "Auro-Lacosamide",
    "fr_drug_common_name": "Auro-Lacosamide",
    "en_ingredients": "LACOSAMIDE",
    "fr_ingredients": "Lacosamide",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217643,
    "drug": {
      "current_status": "MARKETED",
      "id": 59243,
      "drug_code": 96571,
      "updated_date": "2025-05-15T02:36:27-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8263217,
          "ingredient": {
            "id": 3686,
            "ingredient_code": 20636,
            "en_name": "LACOSAMIDE",
            "fr_name": "Lacosamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02475332",
      "brand_name": "AURO-LACOSAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152810001"
    },
    "created_date": "2024-01-29T20:18:38-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02475332",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-02-15T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LACOSAMIDE",
    "en_drug_common_name": "AURO-LACOSAMIDE",
    "fr_drug_brand_name": "Auro-Lacosamide",
    "fr_drug_common_name": "Auro-Lacosamide",
    "en_ingredients": "LACOSAMIDE",
    "fr_ingredients": "Lacosamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217646,
    "drug": {
      "current_status": "MARKETED",
      "id": 24094,
      "drug_code": 86720,
      "updated_date": "2025-12-03T00:31:55-05:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258672,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381370",
      "brand_name": "AURO-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134006"
    },
    "created_date": "2024-01-29T20:19:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381370",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-03-29T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LAMOTRIGINE",
    "en_drug_common_name": "AURO-LAMOTRIGINE",
    "fr_drug_brand_name": "Auro-Lacosamide",
    "fr_drug_common_name": "Auro-Lacosamide",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217649,
    "drug": {
      "current_status": "MARKETED",
      "id": 23478,
      "drug_code": 86064,
      "updated_date": "2025-05-15T02:33:04-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8258472,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375249",
      "brand_name": "AURO-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2024-01-29T20:21:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375249",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-16T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-LEVETIRACETAM",
    "en_drug_common_name": "AURO-LEVETIRACETAM",
    "fr_drug_brand_name": "Auro-Levetiracetam",
    "fr_drug_common_name": "Auro-Levetiracetam",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217652,
    "drug": {
      "current_status": "MARKETED",
      "id": 30216,
      "drug_code": 92264,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261037,
          "ingredient": {
            "id": 1118,
            "ingredient_code": 10147,
            "en_name": "METFORMIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de metformine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02438275",
      "brand_name": "AURO-METFORMIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101773001"
    },
    "created_date": "2024-01-29T20:23:11-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02438275",
    "company_name": "AURO PHARMA INC",
    "atc_number": "A10BA",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2024-04-17T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-04-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-04-17T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-METFORMIN",
    "en_drug_common_name": "AURO-METFORMIN",
    "fr_drug_brand_name": "Auro-Metformin",
    "fr_drug_common_name": "Auro-Metformin",
    "en_ingredients": "METFORMIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de metformine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "360's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217655,
    "drug": {
      "current_status": "MARKETED",
      "id": 56380,
      "drug_code": 95926,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262886,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470284",
      "brand_name": "AURO-METRONIDAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102572003"
    },
    "created_date": "2024-01-29T20:24:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470284",
    "company_name": "AURO PHARMA INC",
    "atc_number": "P01AB",
    "atc_description": "AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS.",
    "estimated_end_date": "2024-05-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-05-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-METRONIDAZOLE",
    "en_drug_common_name": "AURO-METRONIDAZOLE",
    "fr_drug_brand_name": "Auro-Metronidazole",
    "fr_drug_common_name": "Auro-Metronidazole",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217658,
    "drug": {
      "current_status": "MARKETED",
      "id": 28764,
      "drug_code": 90881,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260432,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424096",
      "brand_name": "AURO-PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169003"
    },
    "created_date": "2024-01-29T20:25:49-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424096",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-14T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-PRAMIPEXOLE",
    "en_drug_common_name": "AURO-PRAMIPEXOLE",
    "fr_drug_brand_name": "AURO-PRAMIPEXOLE",
    "fr_drug_common_name": "AURO-PRAMIPEXOLE",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217661,
    "drug": {
      "current_status": "MARKETED",
      "id": 25054,
      "drug_code": 87569,
      "updated_date": "2025-05-15T02:33:37-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8259080,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390248",
      "brand_name": "AURO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-29T20:28:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390248",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2024-09-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-09-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-09-14T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-QUETIAPINE",
    "en_drug_common_name": "AURO-QUETIAPINE",
    "fr_drug_brand_name": "AURO-QUETIAPINE",
    "fr_drug_common_name": "AURO-QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's and 500's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217664,
    "drug": {
      "current_status": "MARKETED",
      "id": 30648,
      "drug_code": 92691,
      "updated_date": "2025-12-03T00:32:51-05:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8261258,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02442574",
      "brand_name": "AURO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2024-01-29T20:30:20-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02442574",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-09-30T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-09-28T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ROSUVASTATIN",
    "en_drug_common_name": "AURO-ROSUVASTATIN",
    "fr_drug_brand_name": "Auro-Rosuvastatin",
    "fr_drug_common_name": "Auro-Rosuvastatin",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "Rosuvastatin",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "90's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217667,
    "drug": {
      "current_status": "MARKETED",
      "id": 103594,
      "drug_code": 101910,
      "updated_date": "2023-02-08T05:01:07-05:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8267411,
          "ingredient": {
            "id": 3440,
            "ingredient_code": 20179,
            "en_name": "SITAGLIPTIN",
            "fr_name": "Sitagliptine (Phosphate de sitagliptine monohydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02529874",
      "brand_name": "AURO-SITAGLIPTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152414003"
    },
    "created_date": "2024-01-29T20:32:21-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02529874",
    "company_name": "AURO PHARMA INC",
    "atc_number": "A10BH",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-07-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-07-17T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-SITAGLIPTIN",
    "en_drug_common_name": "AURO-SITAGLIPTIN",
    "fr_drug_brand_name": "AURO-SITAGLIPTIN",
    "fr_drug_common_name": "AURO-SITAGLIPTIN",
    "en_ingredients": "SITAGLIPTIN",
    "fr_ingredients": "SITAGLIPTIN",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217670,
    "drug": {
      "current_status": "MARKETED",
      "id": 51731,
      "drug_code": 94747,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262258,
          "ingredient": {
            "id": 3020,
            "ingredient_code": 12251,
            "en_name": "TENOFOVIR DISOPROXIL FUMARATE",
            "fr_name": "Fumarate de ténofovir disoproxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460173",
      "brand_name": "AURO-TENOFOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152569001"
    },
    "created_date": "2024-01-29T20:33:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460173",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2024-11-15T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-11-14T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-TENOFOVIR",
    "en_drug_common_name": "AURO-TENOFOVIR",
    "fr_drug_brand_name": "Auro-Tenofovir",
    "fr_drug_common_name": "Auro-Tenofovir",
    "en_ingredients": "TENOFOVIR DISOPROXIL FUMARATE",
    "fr_ingredients": "Fumarate de ténofovir disoproxil",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217675,
    "drug": {
      "current_status": "MARKETED",
      "id": 27658,
      "drug_code": 89887,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260011,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414201",
      "brand_name": "AURO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2024-01-29T20:35:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414201",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-02-28T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-27T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VALSARTAN",
    "en_drug_common_name": "AURO-VALSARTAN",
    "fr_drug_brand_name": "AURO-VALSARTAN",
    "fr_drug_common_name": "AURO-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217678,
    "drug": {
      "current_status": "MARKETED",
      "id": 27660,
      "drug_code": 89888,
      "updated_date": "2025-05-15T02:34:04-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260012,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414228",
      "brand_name": "AURO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2024-01-29T20:37:13-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414228",
    "company_name": "AURO PHARMA INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-10-31T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-10-29T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-VALSARTAN",
    "en_drug_common_name": "AURO-VALSARTAN",
    "fr_drug_brand_name": "AURO-VALSARTAN",
    "fr_drug_common_name": "AURO-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217681,
    "drug": {
      "current_status": "MARKETED",
      "id": 18866,
      "drug_code": 80117,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256585,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315645",
      "brand_name": "MINT-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938001"
    },
    "created_date": "2024-01-29T21:18:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315645",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-03-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-TOPIRAMATE",
    "en_drug_common_name": "Topiramate",
    "fr_drug_brand_name": "Mint-Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217684,
    "drug": {
      "current_status": "MARKETED",
      "id": 18868,
      "drug_code": 80118,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256586,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315653",
      "brand_name": "MINT-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2024-01-29T21:20:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315653",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-09-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:51:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-TOPIRAMATE",
    "en_drug_common_name": "Topiramate",
    "fr_drug_brand_name": "Mint-Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217687,
    "drug": {
      "current_status": "MARKETED",
      "id": 18870,
      "drug_code": 80119,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256587,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315661",
      "brand_name": "MINT-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938006"
    },
    "created_date": "2024-01-29T21:22:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315661",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-09-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-05T19:51:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-TOPIRAMATE",
    "en_drug_common_name": "Topiramate",
    "fr_drug_brand_name": "Mint-Topiramate",
    "fr_drug_common_name": "Topiramate",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217690,
    "drug": {
      "current_status": "MARKETED",
      "id": 66434,
      "drug_code": 97017,
      "updated_date": "2025-12-03T00:33:57-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263517,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02479508",
      "brand_name": "MINT-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055001"
    },
    "created_date": "2024-01-29T21:25:59-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02479508",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-30T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin",
    "fr_drug_brand_name": "Mint-Atorvastatin",
    "fr_drug_common_name": "Atorvastatin",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217693,
    "drug": {
      "current_status": "MARKETED",
      "id": 66436,
      "drug_code": 97018,
      "updated_date": "2025-12-03T00:33:57-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263518,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02479516",
      "brand_name": "MINT-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2024-01-29T21:28:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02479516",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-30T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin",
    "fr_drug_brand_name": "Mint-Atorvastatin",
    "fr_drug_common_name": "Atorvastatin",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217696,
    "drug": {
      "current_status": "MARKETED",
      "id": 66438,
      "drug_code": 97019,
      "updated_date": "2025-12-03T00:33:57-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263519,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02479524",
      "brand_name": "MINT-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2024-01-29T21:30:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02479524",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-01-18T00:00:00-05:00",
    "actual_end_date": "2024-01-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-01-30T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINT-ATORVASTATIN",
    "en_drug_common_name": "Atorvastatin",
    "fr_drug_brand_name": "Mint-Atorvastatin",
    "fr_drug_common_name": "Atorvastatin",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 count bottle",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217731,
    "drug": {
      "current_status": "MARKETED",
      "id": 6728,
      "drug_code": 44187,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253161,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "755",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172755",
      "brand_name": "OMNIPAQUE 350",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9821",
      "number_of_ais": "1",
      "ai_group_no": "0116846006"
    },
    "created_date": "2024-01-30T13:51:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172755",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "hc_updated_date": "2024-02-09T13:30:37-05:00",
    "anticipated_start_date": "2024-02-15T00:00:00-05:00",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_end_date": "2024-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:37:57-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "OMNIPAQUE 350",
    "en_drug_common_name": "Iohexal Injection USP",
    "fr_drug_brand_name": "OMNIPAQUE 350",
    "fr_drug_common_name": "Iohexol Injection USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "755MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVASCULAR\r\nINTRAVASCULAR",
    "drug_route_fr": "Orale\r\nIntravasculaire\r\nIntravasculaire",
    "drug_package_quantity": "500 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217766,
    "drug": {
      "current_status": "MARKETED",
      "id": 21464,
      "drug_code": 83846,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257667,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353245",
      "brand_name": "GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929001"
    },
    "created_date": "2024-01-30T15:23:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353245",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N02BF",
    "estimated_end_date": "2024-03-16T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-15T03:23:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217783,
    "drug": {
      "current_status": "MARKETED",
      "id": 21496,
      "drug_code": 83875,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257677,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353539",
      "brand_name": "SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2024-01-30T15:33:54-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353539",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2024-05-29T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-17T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "sertraline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217790,
    "drug": {
      "current_status": "DORMANT",
      "id": 24930,
      "drug_code": 87445,
      "updated_date": "2025-12-03T02:32:31-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368811,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388928",
      "brand_name": "CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220002"
    },
    "created_date": "2024-01-30T15:38:56-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388928",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2024-04-26T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217793,
    "drug": {
      "current_status": "MARKETED",
      "id": 21478,
      "drug_code": 83854,
      "updated_date": "2025-05-15T02:32:45-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257671,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02353342",
      "brand_name": "LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843001"
    },
    "created_date": "2024-01-30T15:42:04-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02353342",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217798,
    "drug": {
      "current_status": "MARKETED",
      "id": 31924,
      "drug_code": 94443,
      "updated_date": "2025-05-15T02:35:34-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262109,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457377",
      "brand_name": "MYCOPHENOLATE MOFETIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2024-01-30T15:53:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457377",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T04:03:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYCOPHENOLATE MOFETIL",
    "en_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "fr_drug_brand_name": "MYCOPHENOLATE MOFETIL",
    "fr_drug_common_name": "MYCOPHENOLATE MOFETIL",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217809,
    "drug": {
      "current_status": "MARKETED",
      "id": 50670,
      "drug_code": 94535,
      "updated_date": "2025-05-15T02:35:38-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262165,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02458241",
      "brand_name": "SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584001"
    },
    "created_date": "2024-01-30T16:00:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02458241",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2024-07-26T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-06-27T13:17:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SOLIFENACIN",
    "en_drug_common_name": "SOLIFENACIN",
    "fr_drug_brand_name": "SOLIFENACIN",
    "fr_drug_common_name": "SOLIFENACIN",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217816,
    "drug": {
      "current_status": "MARKETED",
      "id": 21414,
      "drug_code": 83801,
      "updated_date": "2025-12-03T00:31:37-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257651,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02352753",
      "brand_name": "AMOXICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2024-01-30T16:03:48-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352753",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2024-04-22T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-04-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMOXICILLIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "AMOXICILLIN",
    "fr_drug_common_name": "AMOXICILLIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "ML150",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217829,
    "drug": {
      "current_status": "MARKETED",
      "id": 23226,
      "drug_code": 85801,
      "updated_date": "2025-05-15T02:33:02-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258389,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258388,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02372908",
      "brand_name": "IRBESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086003"
    },
    "created_date": "2024-01-30T16:08:25-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02372908",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2024-03-18T00:00:00-04:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-03-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-18T02:57:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN/HCTZ",
    "en_drug_common_name": "IRBESARTAN/HCTZ",
    "fr_drug_brand_name": "IRBESARTAN/HCTZ",
    "fr_drug_common_name": "IRBESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "25MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217832,
    "drug": {
      "current_status": "MARKETED",
      "id": 22510,
      "drug_code": 84980,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258079,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364921",
      "brand_name": "CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2024-01-30T16:09:55-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364921",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2024-02-09T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-13T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217835,
    "drug": {
      "current_status": "MARKETED",
      "id": 1222,
      "drug_code": 12753,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251671,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.01",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926462",
      "brand_name": "VITAMIN A ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73943",
      "number_of_ais": "1",
      "ai_group_no": "0112395003"
    },
    "created_date": "2024-01-30T16:11:58-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01926462",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "discontinuation_date": "2024-05-22T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-05-23T15:38:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VITAMIN A ACID",
    "en_drug_common_name": "VITAMIN A ACID",
    "fr_drug_brand_name": "VITAMIN A ACID",
    "fr_drug_common_name": "VITAMIN A ACID",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.01%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217837,
    "drug": {
      "current_status": "MARKETED",
      "id": 29528,
      "drug_code": 91561,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260710,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02431173",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2024-01-30T16:12:01-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02431173",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-02-02T00:00:00-05:00",
    "actual_start_date": "2024-01-29T00:00:00-05:00",
    "actual_end_date": "2024-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-09T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217843,
    "drug": {
      "current_status": "MARKETED",
      "id": 1094,
      "drug_code": 12544,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251639,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926489",
      "brand_name": "VITAMIN A ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73664",
      "number_of_ais": "1",
      "ai_group_no": "0112395001"
    },
    "created_date": "2024-01-30T16:14:55-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01926489",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "discontinuation_date": "2024-02-07T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-04-25T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-02-08T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "VITAMIN A ACID",
    "en_drug_common_name": "VITAMIN A ACID",
    "fr_drug_brand_name": "VITAMIN A ACID",
    "fr_drug_common_name": "VITAMIN A ACID",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.05%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217848,
    "drug": {
      "current_status": "MARKETED",
      "id": 1224,
      "drug_code": 12754,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251672,
          "ingredient": {
            "id": 346,
            "ingredient_code": 5054,
            "en_name": "TRETINOIN",
            "fr_name": "Trétinoïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01926470",
      "brand_name": "VITAMIN A ACID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73944",
      "number_of_ais": "1",
      "ai_group_no": "0112395002"
    },
    "created_date": "2024-01-30T16:17:24-05:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "01926470",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "D10AD",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "discontinuation_date": "2024-02-07T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-02-08T06:00:04-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "VITAMIN A ACID",
    "en_drug_common_name": "VITAMIN A ACID",
    "fr_drug_brand_name": "VITAMIN A ACID",
    "fr_drug_common_name": "VITAMIN A ACID",
    "en_ingredients": "TRETINOIN",
    "fr_ingredients": "Trétinoïne",
    "drug_strength": "0.025%",
    "drug_dosage_form": "GEL",
    "drug_dosage_form_fr": "Gel",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "25g",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217867,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2024-01-30T16:34:30-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2024-02-01T00:00:00-05:00",
    "actual_start_date": "2024-01-24T00:00:00-05:00",
    "actual_end_date": "2024-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-29T13:10:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "NAPROXEN ESOMEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "fr_drug_common_name": "NAPROXEN ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE\r\nNAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "20MG\r\n500MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217870,
    "drug": {
      "current_status": "MARKETED",
      "id": 2064,
      "drug_code": 14381,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8251953,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02024187",
      "brand_name": "MYLAN-CLOBETASOL CREAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75994",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2024-01-30T16:35:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02024187",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2024-06-03T00:00:00-04:00",
    "estimated_end_date": "2024-07-02T00:00:00-04:00",
    "actual_end_date": "2024-04-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-01T18:31:02-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-CLOBETASOL CREAM",
    "en_drug_common_name": "CLOBETASOL PROPIONATE",
    "fr_drug_brand_name": "MYLAN-CLOBETASOL CREAM",
    "fr_drug_common_name": "CLOBETASOL PROPIONATE",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "50G",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217873,
    "drug": {
      "current_status": "MARKETED",
      "id": 6304,
      "drug_code": 43175,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8253034,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216213",
      "brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9488",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2024-01-30T16:37:19-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216213",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2024-06-19T00:00:00-04:00",
    "actual_start_date": "2024-06-14T00:00:00-04:00",
    "actual_end_date": "2024-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-18T18:34:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "en_drug_common_name": "CLOBETASOL PROPIONATE",
    "fr_drug_brand_name": "MYLAN-CLOBETASOL SCALP APPLICATION",
    "fr_drug_common_name": "CLOBETASOL PROPIONATE",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "1BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217876,
    "drug": {
      "current_status": "MARKETED",
      "id": 22402,
      "drug_code": 84782,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8258033,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258032,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362821",
      "brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251555008"
    },
    "created_date": "2024-01-30T16:46:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362821",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10BX",
    "atc_description": "LIPID MODIFYING AGENTS, COMBINATIONS",
    "actual_start_date": "2023-08-07T00:00:00-04:00",
    "actual_end_date": "2024-08-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-08-27T17:28:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN AMLODIPINE",
    "fr_drug_brand_name": "MYLAN-AMLODIPINE/ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN AMLODIPINE",
    "en_ingredients": "ATORVASTATIN\r\nAMLODIPINE",
    "fr_ingredients": "ATORVASTATIN AMLODIPINE",
    "drug_strength": "80MG\r\n10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1x90 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217887,
    "drug": {
      "current_status": "MARKETED",
      "id": 102884,
      "drug_code": 101593,
      "updated_date": "2022-05-08T05:13:50-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8267129,
          "ingredient": {
            "id": 3454,
            "ingredient_code": 13310,
            "en_name": "AMBRISENTAN",
            "fr_name": "Ambrisentan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02526875",
      "brand_name": "SANDOZ AMBRISENTAN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152452001"
    },
    "created_date": "2024-01-30T19:33:36-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02526875",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C02KX",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "estimated_end_date": "2024-04-19T00:00:00-04:00",
    "actual_start_date": "2024-01-30T00:00:00-05:00",
    "actual_end_date": "2024-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-04-24T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMBRISENTAN TABLETS",
    "en_drug_common_name": "AMBRISENTAN TABLETS",
    "fr_drug_brand_name": "SANDOZ AMBRISENTAN TABLETS",
    "fr_drug_common_name": "AMBRISENTAN TABLETS",
    "en_ingredients": "AMBRISENTAN",
    "fr_ingredients": "Ambrisentan",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217890,
    "drug": {
      "current_status": "MARKETED",
      "id": 51283,
      "drug_code": 94884,
      "updated_date": "2025-05-15T02:35:44-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262336,
          "ingredient": {
            "id": 274,
            "ingredient_code": 1327,
            "en_name": "GLICLAZIDE",
            "fr_name": "Gliclazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02461331",
      "brand_name": "SANDOZ GLICLAZIDE MR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119934003"
    },
    "created_date": "2024-01-30T19:36:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02461331",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2024-01-30T00:00:00-05:00",
    "actual_end_date": "2024-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-03T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Long Term Back order",
    "fr_comments": "Rupture long terme",
    "en_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "en_drug_common_name": "GLICLAZIDE MR",
    "fr_drug_brand_name": "SANDOZ GLICLAZIDE MR",
    "fr_drug_common_name": "GLICLAZIDE MR",
    "en_ingredients": "GLICLAZIDE",
    "fr_ingredients": "Gliclazide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217902,
    "drug": {
      "current_status": "MARKETED",
      "id": 19508,
      "drug_code": 80824,
      "updated_date": "2025-12-03T00:31:24-05:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8256816,
          "ingredient": {
            "id": 3446,
            "ingredient_code": 11382,
            "en_name": "GRANISETRON",
            "fr_name": "Granisétron (Chlorhydrate de granisétron)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02322765",
      "brand_name": "GRANISETRON HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123183001"
    },
    "created_date": "2024-01-30T22:27:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02322765",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2024-03-15T00:00:00-04:00",
    "actual_start_date": "2024-02-06T00:00:00-05:00",
    "actual_end_date": "2024-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-03-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "GRANISETRON HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "Granisetron Hydrochloride Injection",
    "fr_drug_brand_name": "Granisetron Hydrochloride Injection",
    "fr_drug_common_name": "Chlorhydrate De Granisétron Injectable",
    "en_ingredients": "GRANISETRON",
    "fr_ingredients": "Chlorhydrate de Granisétron",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1 x 4 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217917,
    "drug": {
      "current_status": "MARKETED",
      "id": 25272,
      "drug_code": 87753,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 12,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 5034,
        "mfr_code": "RIV07",
        "name": "LABORATOIRE RIVA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOUL. INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259160,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392259",
      "brand_name": "RIVA-ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-31T14:30:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392259",
    "company_name": "LABORATOIRE RIVA INC.",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-05-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-05-22T05:00:04-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "RIVA-ANASTROZOLE",
    "en_drug_common_name": "Riva-Anastrozole",
    "fr_drug_brand_name": "RIVA-ANASTROZOLE",
    "fr_drug_common_name": "RIVA-ANASTROZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217935,
    "drug": {
      "current_status": "MARKETED",
      "id": 4018,
      "drug_code": 19701,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252558,
          "ingredient": {
            "id": 280,
            "ingredient_code": 8750,
            "en_name": "MAGNESIUM SULFATE",
            "fr_name": "Sulfate de magnésium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139499",
      "brand_name": "MAGNESIUM SULFATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81997",
      "number_of_ais": "1",
      "ai_group_no": "0105356002"
    },
    "created_date": "2024-01-31T18:13:26-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139499",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2024-02-02T00:00:00-05:00",
    "estimated_end_date": "2024-04-30T00:00:00-04:00",
    "actual_start_date": "2024-02-02T00:00:00-05:00",
    "actual_end_date": "2024-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-05-02T14:52:41-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Magnesium Sulfate Injection, USP 500 mg/mL PBP Vial 50 mL effective February 5, 2024, until April 30, 2024.\r\n\r\nDuring this time, our Magnesium Sulfate Injection, USP 500 mg/mL SD Vial 10 mL is available for substitution.",
    "fr_comments": "Fresenius Kabi Canada Ltée a le regret de vous aviser qu’en raison de retards de production, une interruption d’approvisionnement va toucher sa présentation de Sulfate de magnésium injectable, USP à 500 mg en fioles GFP de 50 mL du 5 février 2024 au 30 avril 2024.\r\n\r\nAu cours de cette période, notre présentation de Sulfate de magnésium injectable, USP à 500 mg/mL en fioles DU de 10 mL sera disponible en guise de substitut.",
    "en_drug_brand_name": "MAGNESIUM SULFATE INJECTION, USP",
    "en_drug_common_name": "MAGNESIUM SULFATE INJECTION, USP",
    "fr_drug_brand_name": "Sulfate de magnésium injectable, USP",
    "fr_drug_common_name": "Sulfate de magnésium injectable, USP",
    "en_ingredients": "MAGNESIUM SULFATE",
    "fr_ingredients": "Sulfate de magnésium",
    "drug_strength": "500MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "50 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217938,
    "drug": {
      "current_status": "MARKETED",
      "id": 11710,
      "drug_code": 68945,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254351,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244947",
      "brand_name": "KETOROLAC TROMETHAMINE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121995002"
    },
    "created_date": "2024-01-31T18:18:22-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244947",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2024-02-01T00:00:00-05:00",
    "estimated_end_date": "2024-02-20T00:00:00-05:00",
    "actual_end_date": "2024-02-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-20T21:24:50-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Ketorolac Tromethamine Injection, USP 30 mg/mL SD Vial 1 mL effective February 1, 2024, until February 20, 2024.",
    "fr_comments": "Fresenius Kabi Canada Ltée a le regret de vous aviser qu’en raison de retards de production, une interruption d’approvisionnement va toucher sa présentation de Kétorolac trométhamine injectable à 30 mg/mL en fioles DU de 1 mL du 1 février 2024 au 20 février 2024",
    "en_drug_brand_name": "KETOROLAC TROMETHAMINE INJECTION, USP",
    "en_drug_common_name": "KETOROLAC TROMETHAMINE INJECTION, USP",
    "fr_drug_brand_name": "Kétorolac trométhamine injectable USP",
    "fr_drug_common_name": "Kétorolac trométhamine injectable USP",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "30MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217948,
    "drug": {
      "current_status": "MARKETED",
      "id": 12452,
      "drug_code": 71082,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254584,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246859",
      "brand_name": "AA-FENO-SUPER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895002"
    },
    "created_date": "2024-01-31T20:23:03-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246859",
    "company_name": "AA PHARMA INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2024-02-01T00:00:00-05:00",
    "estimated_end_date": "2024-04-03T00:00:00-04:00",
    "actual_end_date": "2024-03-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-21T12:59:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AA-FENO-SUPER",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "Fénofibrate",
    "fr_drug_common_name": "Fénofibrate",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 Bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217970,
    "drug": {
      "current_status": "MARKETED",
      "id": 8958,
      "drug_code": 61332,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 190,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 5181,
        "mfr_code": "SRO08",
        "name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2695 NORTH SHERIDAN WAY, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5K 2N6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253549,
          "ingredient": {
            "id": 2144,
            "ingredient_code": 7364,
            "en_name": "SOMATROPIN",
            "fr_name": "Somatropine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02237971",
      "brand_name": "SAIZEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131827001"
    },
    "created_date": "2024-01-31T21:33:37-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237971",
    "company_name": "EMD SERONO, A DIVISION OF EMD INC., CANADA",
    "atc_number": "H01AC",
    "atc_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
    "anticipated_start_date": "2024-02-01T00:00:00-05:00",
    "estimated_end_date": "2024-03-01T00:00:00-05:00",
    "actual_start_date": "2024-02-01T00:00:00-05:00",
    "actual_end_date": "2024-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2024-02-29T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SAIZEN",
    "en_drug_common_name": "somatropin for injection",
    "fr_drug_brand_name": "SAIZEN",
    "fr_drug_common_name": "somatropine pour injection",
    "en_ingredients": "SOMATROPIN",
    "fr_ingredients": "Somatropine",
    "drug_strength": "5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217972,
    "drug": {
      "current_status": "MARKETED",
      "id": 103179,
      "drug_code": 101913,
      "updated_date": "2022-09-08T05:13:37-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267414,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02529904",
      "brand_name": "ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-31T21:34:28-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02529904",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-02-05T00:00:00-05:00",
    "actual_start_date": "2024-05-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-20T14:04:00-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ANASTROZOLE",
    "en_drug_common_name": "Anastrozole",
    "fr_drug_brand_name": "Anastrozole",
    "fr_drug_common_name": "Anastrozole",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217977,
    "drug": {
      "current_status": "MARKETED",
      "id": 103179,
      "drug_code": 101913,
      "updated_date": "2022-09-08T05:13:37-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8267414,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02529904",
      "brand_name": "ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2024-01-31T21:38:24-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02529904",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-04-24T00:00:00-04:00",
    "estimated_end_date": "2025-06-01T00:00:00-04:00",
    "actual_start_date": "2024-08-10T00:00:00-04:00",
    "actual_end_date": "2025-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-19T19:32:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ANASTROZOLE",
    "en_drug_common_name": "Anastrozole",
    "fr_drug_brand_name": "Anastrozole",
    "fr_drug_common_name": "Anastrozole",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217980,
    "drug": {
      "current_status": "MARKETED",
      "id": 28388,
      "drug_code": 90516,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260285,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420597",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2024-01-31T21:42:10-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420597",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2024-08-05T00:00:00-04:00",
    "estimated_end_date": "2025-07-30T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil",
    "fr_drug_brand_name": "Donepezil",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217983,
    "drug": {
      "current_status": "MARKETED",
      "id": 28390,
      "drug_code": 90517,
      "updated_date": "2025-12-03T00:32:28-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260286,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420600",
      "brand_name": "DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2024-01-31T21:45:05-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420600",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2024-08-05T00:00:00-04:00",
    "estimated_end_date": "2025-07-30T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-07-26T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL",
    "en_drug_common_name": "Donepezil",
    "fr_drug_brand_name": "Donepezil",
    "fr_drug_common_name": "Donepezil",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217986,
    "drug": {
      "current_status": "MARKETED",
      "id": 102725,
      "drug_code": 101329,
      "updated_date": "2022-02-08T06:13:24-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266893,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02524244",
      "brand_name": "LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2024-01-31T21:49:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02524244",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2024-05-01T00:00:00-04:00",
    "actual_start_date": "2024-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-11-20T14:05:29-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "LETROZOLE",
    "en_drug_common_name": "Letrozole",
    "fr_drug_brand_name": "Létrozole",
    "fr_drug_common_name": "Létrozole",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217989,
    "drug": {
      "current_status": "MARKETED",
      "id": 28018,
      "drug_code": 90198,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260189,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417359",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858006"
    },
    "created_date": "2024-01-31T22:00:35-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417359",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-07-01T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Qutiapine XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217992,
    "drug": {
      "current_status": "MARKETED",
      "id": 28020,
      "drug_code": 90199,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260190,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417367",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858004"
    },
    "created_date": "2024-01-31T22:03:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417367",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-08-29T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-09-28T00:00:00-04:00",
    "actual_end_date": "2025-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Qutiapine XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "Quetiapine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217995,
    "drug": {
      "current_status": "MARKETED",
      "id": 28024,
      "drug_code": 90200,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260191,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417375",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2024-01-31T22:04:57-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417375",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-07-01T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "Qutiapine XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 217998,
    "drug": {
      "current_status": "MARKETED",
      "id": 28026,
      "drug_code": 90201,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260192,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417383",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858005"
    },
    "created_date": "2024-01-31T22:25:31-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417383",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-07-01T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 218001,
    "drug": {
      "current_status": "MARKETED",
      "id": 28028,
      "drug_code": 90202,
      "updated_date": "2025-12-03T00:32:26-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260193,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417391",
      "brand_name": "QUETIAPINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858007"
    },
    "created_date": "2024-01-31T22:27:50-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417391",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2024-05-01T00:00:00-04:00",
    "estimated_end_date": "2025-06-27T00:00:00-04:00",
    "actual_start_date": "2024-09-10T00:00:00-04:00",
    "actual_end_date": "2025-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2025-06-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QUETIAPINE XR",
    "en_drug_common_name": "QUETIAPINE XR",
    "fr_drug_brand_name": "QUETIAPINE XR",
    "fr_drug_common_name": "QUETIAPINE XR",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 218012,
    "drug": {
      "current_status": "MARKETED",
      "id": 57707,
      "drug_code": 94976,
      "updated_date": "2025-12-03T00:33:20-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262385,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02462028",
      "brand_name": "SANDOZ LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843004"
    },
    "created_date": "2024-01-31T23:06:41-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02462028",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2024-02-16T00:00:00-05:00",
    "actual_start_date": "2024-01-31T00:00:00-05:00",
    "actual_end_date": "2024-02-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-20T19:11:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "SANDOZ LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 218015,
    "drug": {
      "current_status": "MARKETED",
      "id": 31316,
      "drug_code": 93568,
      "updated_date": "2025-05-15T02:35:11-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8261645,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02449811",
      "brand_name": "SANDOZ MOMETASONE",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121732002"
    },
    "created_date": "2024-01-31T23:08:16-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02449811",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "estimated_end_date": "2024-03-16T00:00:00-04:00",
    "actual_start_date": "2024-01-31T00:00:00-05:00",
    "actual_end_date": "2024-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-03-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MOMETASONE",
    "en_drug_common_name": "MOMETASONE",
    "fr_drug_brand_name": "SANDOZ MOMETASONE",
    "fr_drug_common_name": "MOMETASONE",
    "en_ingredients": "MOMETASONE FUROATE",
    "fr_ingredients": "Furoate de mométasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "140DOS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 218020,
    "drug": {
      "current_status": "MARKETED",
      "id": 17600,
      "drug_code": 78642,
      "updated_date": "2025-05-15T02:32:01-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256187,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301075",
      "brand_name": "SANDOZ PANTOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229002"
    },
    "created_date": "2024-01-31T23:10:53-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301075",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2024-03-08T00:00:00-05:00",
    "actual_start_date": "2024-01-31T00:00:00-05:00",
    "actual_end_date": "2024-03-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2024-03-12T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PANTOPRAZOLE",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "SANDOZ PANTOPRAZOLE",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100GRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 218024,
    "drug": {
      "current_status": "MARKETED",
      "id": 100255,
      "drug_code": 98612,
      "updated_date": "2020-04-03T06:54:33-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264818,
          "ingredient": {
            "id": 3374,
            "ingredient_code": 20127,
            "en_name": "POSACONAZOLE",
            "fr_name": "Posaconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02496259",
      "brand_name": "SANDOZ POSACONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152201002"
    },
    "created_date": "2024-01-31T23:12:44-05:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496259",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2024-04-19T00:00:00-04:00",
    "actual_start_date": "2024-01-31T00:00:00-05:00",
    "actual_end_date": "2024-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-04-24T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ POSACONAZOLE",
    "en_drug_common_name": "POSACONAZOLE",
    "fr_drug_brand_name": "SANDOZ POSACONAZOLE",
    "fr_drug_common_name": "POSACONAZOLE",
    "en_ingredients": "POSACONAZOLE",
    "fr_ingredients": "Posaconazole",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60GRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]